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Abstract
REGENERATION OF ELECTROSPUN BIORESORBABLE VASCULAR GRAFTS: A
PHENOMENON ASSOCIATED WITH VASCULAR GRAFT PROPERTIES AND MACROPHAGE
PHENOTYPES (M1/M2)

By Koyal Garg, M.S.

A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.

Virginia Commonwealth University, 2012

Director: Dr. Gary L. Bowlin
Professor, Department of Biomedical Engineering
Co-director: Dr. John J. Ryan
Professor, Department of Biology

Macrophages (MФ) and mast cells are important cell types in the context of tissue
remodeling and regeneration. Mast cells participate in the early stages of wound healing
and modulate the acute inflammatory responses to biomaterials. Mast cells can secrete a
myriad of different cytokines by the process of degranulation; the process of regulated
secretion in which preformed contents stored in their granules are rapidly released by
exocytosis. Some of these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ
xvi

phenotype. Macrophages (MΦ) are innate immune cells, crucial for tissue homeostasis,
presentation of foreign and self-antigens following infection/injury, pathogen clearance,
inflammation resolution, angiogenesis, and wound healing. MΦ display plasticity and can
acquire pro-inflammatory (M1) or angiogenic/wound healing (M2) phenotypes depending
upon the environmental stimuli. The phenotypic profile of MФ as M1 or M2 following
exposure to the biomaterial can dictate the downstream processes of tissue remodeling
and angiogenesis. An analysis of how these two cell types interact with electrospun
biomaterials and how different properties of an electrospun biomaterial impacts the MΦ
phenotype is the focus of this thesis.
Mast cells synthesize several potent angiogenic factors and can also stimulate
fibroblasts, endothelial cells and macrophages. An understanding of how they participate in
wound healing and angiogenesis is important to further our knowledge about in situ
vascular prosthetic regeneration. The adhesion, proliferation and cytokine secretion of
bone marrow derived murine mast cells (BMMC) on electrospun polydioxanone (PDO),
polycaprolactone (PCL) and silk scaffolds, as well as tissue culture plastic (TCP) has been
investigated in the presence or absence of IL-3, SCF, IgE and IgE with a crosslinking
antigen, dinitrophenol-conjugated albumin (DNP). It was previously believed that only
activated BMMCs exhibit adhesion and cytokine secretion. However, this study shows nonactivated BMMC adhesion to electrospun scaffolds. Silk scaffold was not found to be
conducive for mast cell adhesion and cytokine secretion. Activation by IgE and DNP
significantly enhanced mast cell adhesion, proliferation, migration and secretion of TNF-α,
MIP-1α and IL-13. This indicates that mast cells might play a role in MФ polarization

xvii

(M1/M2), biomaterial integration into the host tissue, regeneration, and possibly
angiogenesis.
In the next study, bone marrow derived murine macrophages (BMMΦs, 106 cells)
were seeded on TCP (24 well plate) and PDO scaffolds (15 mm discs) electrospun from
varying polymer concentrations (60, 100, and 140 mg/ml). Scaffold evaluation showed that
large polymer concentrations led to larger fiber diameters, which in turn led to larger poresizes and porosity but a smaller surface area to volume ratio. After 24 hrs of culture, the
cell lysates were analyzed for Arginase (Arg1) and inducible nitric oxide synthase (iNOS)
expression by western blot and cell culture supernatants were analyzed for Nitric oxide
(NO2-), Tumor Necrosis Factor – alpha (TNF-α), Interleukin-6 (IL-6), Vascular Endothelial
Growth Factor (VEGF), Transforming Growth Factor – beta1 (TGF-β1) and basic fibroblast
growth factor (bFGF) levels. The results indicated a correlation between Arg1 expression
and increasing fiber/pore-size, indicating that the larger fiber/pore-sizes polarize towards
a M2 phenotype. Also, the expression of iNOS was downregulated on the larger fiber/poresize. The levels of NO2- were significantly higher on the lower fiber/pore-sizes indicating an
M1 phenotype. The levels of VEGF, TGF-β1 and bFGF increased with increasing fiber/poresizes. The results showed higher Arg1 expression in M2s on the 60 mg/ml scaffold created
by the air-flow impedance method compared to the 60 mg/ml scaffold created on the solid
mandrel created by traditional electrospinning. The Arg1 expression was reduced on the
compressed 140 mg/ml PDO scaffold compared to the normal 140 mg/ml scaffold. This
result indicates that pore-size might be playing a greater role compared to fiber diameter
in BMMФ phenotype modulation.

xviii

In order to assess the angiogenic potential of BMMΦs cultured on PDO scaffolds, a
3D angiogenesis bead assay was performed using conditioned media from the BMMΦ:PDO
interaction. The results of the 3D angiogenesis bead assay showed that the conditioned
media from BMMΦs of M0 and M2 phenotypes cultured on the 140 mg/ml PDO scaffold
induced larger sprouting and higher percentage density of sprouts when compared to the
60 mg/ml PDO scaffold and TCP.
To investigate the signaling mechanism involved in this phenotypic switch, BMMΦs
were isolated from the bone marrow of MyD88 knockout (KO) mice (Jackson Laboratories)
and cultured on PDO (60 and 140 mg/ml) scaffolds (106 /disc) and TCP for 24 hrs and their
Arg1 and iNOS expression was analyzed by western blot. The expression of Arg1 and iNOS
was severely impaired on the BMMΦs from MyD88-/- mice cultured on the 140 mg/ml
scaffold when compared to the 60 mg/ml PDO scaffold and TCP. This result indicates that
scaffolds with different fiber/pore-sizes signal differently.
A subcutaneous mouse model (described in Chapter 6) was used to evaluate the
angiogenic and regenerative potential of PDO scaffolds in vivo. The DIVAA assay showed
statistically higher FITC-dextran signal intensity for the 140 mg/ml scaffold compared to
the 60 mg/ml scaffold indicating greater angiogenic response in the 140 mg/ml tube.
However, problems of high background were observed in this assay with the use of
electrospun PDO. The observed high background was probably due to the formation of
complexes between dextran and adsorbed plasma proteins on the surface of the PDO. More
studies are needed to optimize this assay for use with biomaterials such as PDO. H&E
staining of the harvested PDO tubes (60 mg/ml and 140 mg/ml) was also performed. The

xix

cross-sections of these tubes showed greater cell recruitment and infiltration into the
fibrous structures of the 140 mg/ml tube compared to the 60 mg/ml tube. This result
corroborates the in vitro result of BMMФ infiltrating deeper into the structures of the 140
mg/ml scaffold compared to the 60 mg/ml scaffold. The scaffolds were also analyzed by
immunostaining for iNOS (indicative of M1 phenotype of MФs). The results showed
statistically higher ratios of iNOS positive:negative areas on the 60 mg/ml scaffold
compared to the 140 mg/ml scaffold. Overall, these studies indicate that 140 mg/ml
scaffold supports greater cell recruitment and cell infiltration in vivo but a smaller ratio of
iNOS positive:negative areas compared to the 60 mg/ml scaffold, which supports a
predominately M1 MФ phenotype.
The studies indicate that varying properties of PDO can alter both the phenotype
and function of BMMΦs in vitro and in vivo. We have also shown that the 140 mg/ml
scaffold

signal

BMMΦs

through

MyD88-dependent

mechanisms.

A

complete

understanding of the way materials signal would allow us to control or modulate
undesirable immune reactions to biomaterials in vivo. These studies would also help
engineer

biomaterials

that

promote

angiogenesis

xx

and

regeneration

in

vivo.

Chapter I: Introduction

1

I.1 Host Response to Biomaterials
The host response to tissue injury or implanted biomaterials occurs in four main
stages: hemostasis, inflammation, proliferation, and remodeling (Figure 1). In the very
early process of implantation, injury to the tissue and vasculature activates platelets. The
activation of platelets results in the release of clotting factors that initiate hemostasis. A
provisional matrix forms on the surface of the biomaterials consisting of fibrin and
entrapped erythrocytes. This provisional matrix provides structural, biochemical and
cellular components to the process of wound healing. It serves as a substrate for cell
migration and a medium for cell signaling. In addition to the activation of clotting factors,
platelets also release several cytokines and chemokines such as platelet derived growth
factor (PDGF), Transforming growth factor beta (TGF-β1), C-X-C ligand 4 (CXCL4) and
inteleukin-1beta (IL-1β). These factors contribute to tissue repair by recruiting several
different cell types including neutrophils, macrophages and fibroblasts. Neutrophils are the
first inflammatory cell type to arrive at the wound site. They phagocytose and destroy
foreign material, bacteria and dead cell debris. Mast cells also mediate acute inflammatory
responses to implanted biomaterials by releasing granules containing enzymes, histamine,
and other factors such as IL-4 and IL-13 that modulate the inflammatory response.
Neutrophils are quickly replaced by monocytes as the predominant cell type. Three reasons
account for this phenomenon: (1) Neutrophils have a short half-life and disintegrate and
disappear after 24-48h. (2) The chemotactic factors for neutrophil migration are activated
early in the inflammatory response. (3) After emigration from the vasculature, monocytes
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differentiate into Macrophages (MФ) and these cells have a much longer life span
(~months). MФ begin to dominate the cell population by day 48-72 h post-injury.
MФ continue the process debridement and disinfection by removing apoptotic
neutrophils and bacteria. In response to microbial products such as lipopolysaccharide
(LPS) and cytokines such as interferon–gamma (IFN-γ), MФ acquire an M1 phenotype.
These MФ destroy pathogens by phagocytosis and by production of reactive nitrogen and
oxygen species, including nitric oxide (NO), peroxynitrite (ONOO-), hydrogen peroxide
(H2O2) and superoxide (O2). M1s also produce a myriad of enzymes such as matrix
metalloproteases (MMPs), collagenase, elastase and hyaluronidase and are crucial in
matrix destruction and tissue reorganization at the injured tissues. This also allows them to
quickly migrate through the injured tissues to clear pathogens and debris. Prolonged
activation of M1s can lead to tissue injury. Therefore, this phenotype must be quickly
abolished to make way for a tissue regenerative M2 phenotype. The size, shape, dimensions
and chemical and physical properties of the biomaterial may be responsible for variations
in the intensity and time duration of the inflammatory and wound healing processes. M2
macrophages are induced by a variety of signals such as IL-4, IL-13 and IL-10. M2s produce
arginase, which allows them to convert arginine to ornithine, a precursor of polyamines
and collagen, thereby contributing to the production of extracellular matrix (ECM). M2s
also produce large amounts of chitinase and chitinase-like molecules including YM1 and
YM2. These chitinase –like molecules have carbohydrate and matrix binding activity and
play a role in matrix reorganization and wound healing. M2 macrophages also release
several growth factors such as VEGF, TGF-β1 and bFGF which play a key role in the next
stage of wound healing; the proliferative phase.
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The proliferative phase of wound healing involves cellular proliferation,
angiogenesis, new ECM deposition and formation of granulation tissue. Granulation tissue
derives its name from the pink, soft granular appearance on the surface of healing wounds.
Its characteristic histological features include the proliferation of new blood vessels and
fibroblasts. The process of formation of new blood vessels from pre-existing vasculature is
angiogenesis (or neovascularization). Angiogenesis involves proliferation, maturation and
organization of endothelial cells into capillary tubes. The development of granulation tissue
also

involves

proliferating

fibroblasts

which

actively

synthesize

collagen

and

proteoglycans. In the early stages of granulation tissue development, proteoglycans
predominate; however at later stages collagen type I predominates and forms the fibrous
capsule. In the granulation tissue, some fibroblasts may take up the features of smooth
muscle cells and these cells are termed myofibroblasts. These cells are believed to be
responsible for wound contraction seen during the development of the granulation tissue.
Fibrous materials generally have a surface response composed of multinucleated giant
cells. These cells are formed by the fusion of MФ in an attempt to phagocytose the material
and are called foreign body giant cells. These cells may persist on the tissue-biomaterial
interface for the lifetime of the biomaterial. Adherent human MФ/foreign body giant cells
(FBGCs) on biomaterials produce MMP-9, tissue inhibitor of metalloproteinase (TIMP)-1
and TIMP-2 in vitro. The adherent MФ/FBGCs on a biomaterial surface can modulate ECM
remodeling/fibrosis and therefore affect biomaterial performance [1-4]. Typically
biomaterials heal with a fibrous encapsulation surrounding the biomaterial with its
interfacial foreign body reaction. This encapsulation isolates the biomaterial from the
surrounding tissue and prevents its integration with the native tissue. In normal wound
4

healing, after the deposition of new ECM, the remodeling phase of wound healing begins.
This phase is characterized by MMP and TIMP-mediated degradation and remodeling of the
newly deposited ECM, usually resulting in scar tissue formation/maturation.

Figure 1 The stages of wound healing [5].

I.2 Macrophage Polarization in Wound Healing
Macrophages belong to the mononuclear phagocyte system. This system comprises
the bone marrow monoblasts, pro-monocytes, peripheral blood monocytes and tissue
macrophages. They share a common progenitor cell with granulocytes in the bone marrow.
This common progenitor is called the colony-forming unit, granulocyte-macrophage (CFU-
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GM) because of its ability to give rise to colonies of monocytes and neutrophils in a semisolid marrow cultures. When monocytes enter the blood stream and migrate into tissues,
they undergo final differentiation to tissue macrophages. Macrophages are present
ubiquitously in all tissues and display great structural and functional heterogeneity as
histiocytes, alveolar macrophages (lungs), Kupffer cells (liver), osteoclasts (bone),
peritoneal macrophages (peritoneum), synovia type A cells (synovium), or microglia
(central nervous system). Macrophages are set into different functional states by a process
known as activation. Activation of macrophages entails increased phagocytic or
microbicidal activities and alteration of their chemotactic response and secretory activities.
Activation is a complex process involving different stimuli. Macrophages increase
performance of some functions and down regulate others. Macrophages can secrete a
repertoire of proteases and growth factors such as bFGF, GM-CSF, transforming growth
factor- alpha (TGF-α), TGF-β, insulin-like growth factor-I (IGF-I), platelet-derived growth
factor (PDGF), VEGF, and other cytokines such as IL-1, IL-6, IL-8 and TNF- α. They also
secrete neurotransmitter such as substance P, lipid mediators such as prostaglandins,
interferons, and anti-angiogenic substances such as thrombospondin 1 [6].
The specialization and activation of these cells are mainly influenced by local stimuli
[7, 8]. Classically activated macrophages (M1) are produced during cell mediated
immunity. They can arise in response to IFN-γ, which can be produced during an adaptive
immune response by T helper 1 (TH1) cells or CD8+ T cells or during an innate immune
response by natural killer (NK) cells. Alternatively activated macrophages (or wound
healing macrophages, M2) arise in response to IL-4, which can be produced during an
adaptive immune response by TH2 cells or during an innate response by granulocytes. IFN6

γ can prime macrophages to secrete pro-inflammatory cytokines, produce increased
amounts of superoxide anions and oxygen and nitrogen radicals (e.g. iNOS) to increase
killing ability. M1 macrophages produce high levels of IL-12 and modest levels of IL-10.
They also secrete IL-1, IL-6 and IL-23. M2 macrophages produce low levels of both IL-12
and IL-10. These macrophages fail to present antigen to T cells, produce minimal amounts
of pro-inflammatory cytokines and are less efficient than M1 macrophages at producing
toxic oxygen and nitrogen radicals. The M2 macrophages also have increased arginase
activity that allows them to convert arginine to ornithine, a precursor to of polyamines and
collagen, thereby contributing to the production of extracellular matrix. M2 macrophages
also produce large amounts of chitinase like molecules like YM1 and YM2. These molecules
lack chitin degrading ability, but they have carbohydrate and matrix binding ability. They
also express the antigen resistin like molecule-α (RELMα; also known as FIZZ1) [8-12]. The
activation states of MФ are hypothetical ends of a spectrum. The actual MФ phenotype is
viewed as a continuum of functional states.
Recently M2s were further divided into M2a, M2b and M2c based on their different
roles in tissue remodeling (Figure 2). M2a phenotype arises in response to IL-4 and IL-13
and these MФ are associated with Th2 responses. The M2b phenotype is induced by
immune complexes as well as agonists of TLRs or IL-1 receptors and these MФ secrete high
amounts of IL-10 but reduced IL-12. M2c phenotype is induced by IL-10 or glucocorticoids.
They produce elevated levels of IL-10 and TGF-β1 and are associated with immune
suppression and remodeling [3, 13]. In contrast, INF-γ or TNF-α primed MФs are grouped
as M1s. These MФs have decreased phagocytic capability and (FcγR)II expression. M1s
secrete pro-inflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-12, and IL-23, possess
7

anti-proliferative functions and induce Th1 responses. In addition, M1s are also crucial in
matrix destruction and tissue reorganization at injured tissues via the production of a
variety of enzymes such as MMPs, collagenase, elastase and hyaluronidase. This allows M1s
to quickly migrate through injured tissues to clear pathogens and debris [3]. Mosser et al.
suggested a spectrum of MФ phenotypes and characterized MФ populations based on three
fundamental homeostatic activities, including host defense, wound healing, and immune
regulation. MФ are grouped into three primary phenotypes: classically activated MФ for
microbicidal activity, wound-healing MФ for tissue repair, and regulatory MФ for antiinflammatory activity [12].
MФ phenotypes exhibit plasticity, meaning that a classically activated M1 can switch
to an alternatively activated M2 (Figure 3). Prolonged activation of M1s can lead to tissue
injury. Therefore, after disinfecting and debriding the wound site, the M1s must switch
over to M2s at later stages to facilitate proper tissue remodeling.
It has been established from previous studies that the fate of a tissue engineered
implant depends upon the kind of MФ response it elicits [14]. Biological responses to
implanted materials involve neutrophil mediated detoxification, followed by MФ activity to
phagocytize debris and co-ordinate remodeling events. Several different cell types
including natural killer (NK) cells, basophils, mast cells and innate lymphoid cells can
polarize macrophages to either a M1 or M2 phenotype (Figure 3). Mast cell derived
Interleukin-4 (IL-4) and IL-13 were found to be inductors of MФ fusion while TNF-α was
responsible for biomaterial adherent MФ apoptosis [15]. Mast cell derived IL-4 and IL-13
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can also lead to alternatively activated MФ (M2 phenotype) which play a role in matrix
remodeling, angiogenesis and elimination of parasites [13].
It has been demonstrated that mast cell derived TNF-α is a crucial component of
host defense against bacterial infection and is involved in recruitment of leukocytes by
establishing cytokine networks [17, 18]. MФ may also be responsible for the development
of mast cells, since removal of MФs greatly reduced the mast cell development in vitro [19].
In a recent study skin biopsies from human patients were obtained and gene
expression was analyzed on early (Day 1-2) and late stages (Day 4-8) of cutaneous wound
healing (Figure 4). It was observed that the early stage included a mix of M1 and M2
markers (11 M1 genes and 7 M2 genes) whereas the late stage expressed predominately
M2 markers (1 M1 gene and 9 M2 genes) [20].
It has been shown by Greisler et al. [21-25], Valentin et al. [26], Roh et al. [27], and
Brown et al. [28] that macrophages play a key role in the success and potential failure of
any vascular prosthetic. Tissue regeneration begins with phagocytosis of debris and ECM
remodeling and reorganization through enzymes released by the macrophage which
include proteinase, collagenase, elastase and hyaluronidase [29].
The second step involves cell recruitment, migration, proliferation and ECM
formation via the spectrum of cytokines produced by the macrophage. The third and final
step of tissue regeneration is angiogenesis, a process by which new capillaries are
generated from a pre-existing vascular system.
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Figure 2 An illustration of macrophage phenotypes, their inducers, phenotype and
functions as depicted by Kou et al. [3].
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Figure 3 Macrophage polarization in wound healing [16].

Figure 4 Gene Expression Profiling of Macrophages in cutaneous wound healing [17].
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Angiogenesis is fundamental to wound healing, reproduction and embryonic
development [18]. It results from stimulation of endothelial cells, which causes them to
proliferate and migrate towards the source of pro-angiogenic molecules. On reaching a
certain appropriate density, junctions between endothelial cells are formed, components of
ECM are produced and a new basal membrane is formed [19]. The endothelial cells then
progress to form a hollow tube. All steps in this transformation are induced by the myriad
of growth factors derived from the macrophage. The outstanding role of macrophages in
angiogenesis can be attributed to their much longer half-life as compared to granulocytes
and platelets and secretion of myriad growth factors for initiation, maintenance and
termination of the angiogenic process. Also, macrophages are resident in all tissues in
greater numbers than other blood borne cells and the distinct subtypes can always be
recruited from the blood stream. They have heterogeneous functionality and can be
activated from an inactive non-angiogenic stage to an angiogenic stage [6].
MФs bind to foreign surfaces such as biomaterials via integrin-mediated
interactions with the adsorbed protein layer on the material surfaces. MФs express
integrins with three different types of β chains: β1, β2, and β3. MФs have three β1
integrins, including α4/β1 that binds fibronectin and VCAM-1, α5/β1 that binds fibronectin
and α6/β1 that binds laminin. There are four β2 integrins, including αD/β2 and αL/β2 that
bind ICAMs, αM/β2 that binds ICAMs and various other ligands such as fibrinogen, Factor
X, elastase, and complement fragment C3bi, and αX/β2 that binds C3bi, fibrinogen, and LPS.
MФs have only one β3 integrin, αV/β3, that binds vitronectin, entactin, and ECM proteins
containing RGD- and KGAGDV- sequences. These interactions between MФ integrins and
the adsorbed cell-adhesive proteins provide intracellular signals that are crucial in
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regulating the functions of MФs, including cytoskeletal remodeling, gene transcription,
spreading, motility, proliferation, apoptosis, survival, and fusion [1, 3, 20].
MФ response to biomaterials is also dependent on their size. It has been shown that
when foreign materials are < 10 µm, MФ can effectively phagocytose them. The process of
phagocytosis leads to the formation of membrane bound phagosomes in the cytoplasm. The
phagosomes fuse with endosomes and lysosomes to form phagolysosomes, which contain
proteolytic and microbicidal substances to kill, digest and degrade the internalized
particles. On encountering larger foreign materials (10-100 µm) that cannot be engulfed by
a single MФ, multinucleated MФs or FBGCs are formed by the fusion of multiple MФs.
These FBGCs then phagocytose and digest the foreign materials. When FBGCs encounter
bulk materials that even they cannot effectively engulf, they undergo a process called
“frustrated phagocytosis”. In this process MФs release an array of substances such as
cytokines, reactive oxygen species and proteolytic enzymes in an attempt to degrade the
implanted materials [1].
I.3 Signaling Mechanisms Involved In Macrophage Polarization
Within the array of MФ surface molecules, the toll-like receptors (TLRs), specialized
membrane proteins that recognize pathogen-specific antigenic patterns, are the likely
candidates for mediating biomaterial- MФ interactions (key MФ activators). TLRs may be
found on the cell surface (TLR-1, 2, 4, 5 and 6) or intracellular (TLR-3, 7, 9). Upon ligand
exposure, TLRs couple to signaling adaptors to induce two major downstream signaling
pathways, nuclear factor kappa B (NFκB) and interferon response factor (IRF). Myeloid
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differentiation factor-88 (MyD88) is an essential adapter protein involved in TLR signaling
pathways (except TLR-3) leading to the activation of NFκB.
Different TLRs use different combinations of adaptor proteins to determine
downstream signaling. TLR4 is the only known TLR which utilizes all these adaptor
proteins [21]. The majority of TLR’s signal through MyD88, which couples the TLR to
downstream signaling kinases, eventually leading to the activation of NFκB by
translocation from the cytoplasm to the nucleus. However, MyD88 independent signaling
pathways do exist for TLR3 and TLR4. TLR4 possesses two options for signal transduction,
either to signal through MyD88 or through TIR domain containing adapter inducing
interferon-beta (TRIF), while TLR3 can signal only through TRIF [22].
MyD88 contains a death domain (DD), which can recruit other DD-containing
molecules through homotypic interactions. Upon LPS stimulation, MyD88 recruits and
activates IL-1 receptor associated kinase 4 (IRAK-4). IRAK-4 is responsible for the
subsequent recruitment, activation and degradation of IRAK-1. Another adaptor protein
TRAF6 (TNF receptor associated factor 6), is critical for the MyD88 dependent pathway
downstream of IRAK4 and IRAK1. TRAF 6 activates TAK1 (transforming growth factor-βactivated kinase 1). TAK1 then activates downstream IKK (inhibitor of κ light chain gene
enhancer in B cells (IκB) kinase) and MAPK (mitogen-activated protein kinase) pathways.
IKK complex phosphorylates IκB proteins. This phosphorylation leads to the degradation of
IκB proteins and subsequent translocation of the transcription factor NFκB, which controls
the expression of proinflammatory cytokines, in addition to other immune related genes.
The MyD88-dependent pathway can also activate p38 and c-Jun N-terminal kinase (JNK),
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leading to AP-1 activation followed by transcription of genes involved in regulation of cell
proliferation, morphogenesis, apoptosis, and differentiation.
TLR4 can also signal via a MyD88-independent pathway to stimulate the production
of the antiviral protein interferon (IFN)-β. TLR4 can recruit another TIR-domaincontaining adaptor called TRIF. Like MyD88, activated TRIF can bind to TRAF-6 to activate
NFκB. Unlike MyD88, TRIF can also bind to kinases called IκKε and TBK1. These kinases
activate transcription factors called IRFs (interferon regulatory factors) that are involved in
stimulating IFN-β transcription. Thus, the adaptor TRIF enables TLR4 signaling to induce
production of IFN-β in addition to activation of NFκB [23].
It is known that wound healing is impaired in MyD88 deficient mice, characterized
by delayed wound closure and granulation tissue formation and a decreased density of new
blood vessels [24]. In a recent study, it was demonstrated that dendritic cells can sense
polymers through a mechanism involving multiple TLR/MyD88-dependent pathways
(TLR-2, 4, 6). These TLR-polymer interactions also induced the expression of activation
markers (e.g. MHC II, CD80, CD86) and pro-inflammatory cytokines (e.g. IL-1β and TNF-α)
[25].
I.4 Angiogenesis
Endothelial cells are one of the major cell types that are involved in the
inflammatory and repair processes that occur after scaffold implantation. They participate
in these processes by releasing pro-inflammatory factors and expressing cell adhesion
molecules [44]. Endothelial cells line up the internal surface of the blood vessels that
supply the cells in organs and tissues with oxygen and nutrients to survive and which
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remove waste products. These cells are also the primary cells involved in the formation of
new blood vessels from pre-existing vasculature, a process known as angiogenesis [45].
Vasculogenesis on the other hand, refers to the first stages of vascular development,
through which precursor cells of vascular endothelium suffer differentiation, expansion
and coalescence to form a network of primitive tubules in the organism [26]. Under normal
conditions in an adult organism, angiogenesis occurs only in the reproductive cycle of
females. Angiogenesis occurs in the uterus, with the formation of the endometrium, and in
the ovaries, in the formation of corpora lutea. Therefore, the vascular network remains
quiescent, but it has the capability to start angiogenesis, especially during the process of
healing [27].
New vessels participate in the formation of temporary granulation tissue and supply
nutrients and oxygen to the growing tissue. Angiogenesis, in response to tissue damage, is
a dynamic process, fine regulated by signs present both in serum and in the local ECM.
During the healing process, the formation of new blood vessels becomes necessary to form
new granulation tissues, in which the blood vessel cells correspond to about 60% of the
repair tissue. Angiogenesis occurs in the ECM of the wound bed with the migration and the
mitogenic stimulation of endothelial cells.
The process of angiogenesis begins with the release of angiogenic factors from MФ,
platelets or ECM. Angiogenic factors are then transported to existing blood vessels in the
vicinity. At the blood vessel, the angiogenic factors bind to the receptors on the endothelial
cells. Factors such as VEGF increase vascular permeability, thereby allowing extravasation
of plasma proteins that lay down a provisional matrix for the migrating endothelial cells
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(Figure 5). However, excessive permeability of blood vessels is bad as it may lead to
circulatory collapse. Angiopoietin (Ang) 2, an inhibitor of the Tie2 signaling, loosens the
surrounding ECM by detaching smooth muscle cells. The release of matrix
metalloproteases (MMPs) which degrade the surrounding ECM, facilitate endothelial cell
migration and further proliferation. Ang 1, a ligand of the endothelial Tie2 receptor, does
not initiate endothelial network organization, but stabilizes the networks presumably by
stimulating the interaction between endothelial and periendothelial cells. Endothelial cells
assemble as solid cords that eventually acquire a lumen.
Finally, the newly formed vessels are stabilized by the recruitment of the
surrounding smooth muscle cells and pericytes that provide structural support. An
effective wound healing and long-term implant stability and survival require maintenance
of an optimal environment for endothelial cell viability and a rapid formation of functional
blood vessels. Angiogenic sprouting is controlled by a balance of activators and inhibitors.
Angiogenesis inhibitors suppress the proliferation or migration of endothelial cells include
angiostatin, endostatin, antithrombin III, interferon-β, leukemia inhibitory factor and
platelet factor 4 [26].
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Figure 5 The process of angiogenesis [28].
I.5 Electrospinning for Tissue Engineering Applications
This section has been taken from the review article published in Biomicrofluidics,
2011 Mar 30; 5(1):13403 entitled ‘Electrospinning jets and nanofibrous structures’.
A number of processing techniques such as drawing, template synthesis, phase
separation, self-assembly and electrospinning have been utilized to synthesize polymer
nanofibers for tissue engineering. Drawing is a process that can make one-by-one very long
single nanofibers. However, only a viscoelastic material that can undergo very strong
deformations can be made into nanofibers through drawing. Template synthesis uses a
nanoporous membrane as a template to make nanofibers of a solid or hollow shape. A
major drawback of the method is the inability to synthesize one-by-one continuous
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nanofibers. The phase separation method consists of dissolution, gelation, extraction using
a different solvent, followed by freezing and drying. In self-assembly procedure, preexisting, individual components organize themselves into desired patterns and functions.
However, both phase separation and self-assembly processes are very time consuming in
processing continuous polymer nanofibers. Electrospinning is an advantageous processing
method for synthesizing one-by-one continuous nanofibers from various different
polymers [29]. It’s also a very simple, straight forward, cost-effective method to generate
different types of scaffolds.
The most basic electrospinning set up consists of three major components: a high
voltage power supply, electrically conducting spinneret and collector separated at a
defined distance (Figure 6). In the laboratory, the most common set up is the syringe that
holds the polymer solution with a blunt tip needle as the spinneret. With the use of a
syringe pump, the solution can be fed at a constant and controllable rate. The electrode
from the power supply is connected to the needle holding the spinning solution to charge
the polymer solution and the other is attached to an opposite polarity collector (usually a
grounded conductor). When the high voltage (typically in the range of 0-30kV) is applied to
the spinneret, the surface of the fluid droplet held by its own surface tension gets
electrostatically charged at the spinneret tip. As a result, the drop comes under the action
of two types of electrostatic forces: mutual electrostatic repulsion between the surface
charges and the coulombic force applied by the external electric field. Due to these
electrostatic interactions, the liquid drop elongates into a conical object known as the
Taylor cone. Once the intensity of the electric field attains a certain critical value, the
electrostatic forces overcome the surface tension of the polymer solution and force the
19

ejection of the liquid jet from the tip of the Taylor cone. The liquid jet continues to be
ejected in a steady manner and the surface tension causes the droplet shape to relax again.
Before reaching the collector screen, the liquid jet elongates and solvent evaporates,
leading to the formation of a randomly oriented, non-woven mat of thin polymeric fibers on
the collector. Initially the solution jet follows a linear trajectory, but the jet begins to whip
out in chaotic fashion at some critical distance from the capillary orifice. This is referred to
as the bending instability. At the onset of this instability, the jet follows a diverging helical
path. As the jet spirals towards the collection mechanism, higher order instabilities
manifest themselves resulting in a completely chaotic trajectory. There are great
advantages of using electrospinning for tissue engineering applications. Electrospinning is
capable of producing extremely thin fibers with diameters ranging from microns down to
few nanometers. In native tissues, cells are typically about one to two orders of magnitude
bigger than the structural ECM proteins (50-300 nm). This allows the cells to be in direct
contact with many ECM fibers. Therefore, the small-size fibers mimic the structural
dimension of the ECM of several native tissues which are deposited and characterized by
well-organized hierarchical fibrous structures realigning from nanometer to millimeter
scale. The scaffolds produced by electrospinning possess a highly porous microstructure
with interconnected pores and extremely high surface-area-to-volume ratio, which is
conducive to tissue growth. In addition, it is a very versatile technique and allows the use of
a variety of polymers, blends of different polymers, and inorganic materials. Recent
advances in electrospinning have shown that integration of various substances such as
additives, biomolecules, and living cells is possible in scaffolds for tailoring different
application requirements [30].
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Figure 6 Basic Electrospinning set up.
The typical approach in tissue engineering is to use electrospun scaffolds as ECM
analogues or support substrates for the cells that have been seeded on them. The
electrospun scaffold is then expected to facilitate the anchorage, migration and
proliferation of the cells to reproduce the three dimensional structure of the tissue to be
regenerated. Electrospun scaffolds are attractive to tissue engineering because they have
biomimetic properties, characterized by fiber diameters in the sub-micron range, large
surface to volume ratio, high porosity, variable pore size distribution and the ability to be
tailored into a variety of sizes and shapes. In addition, scaffold composition and fabrication
can be controlled to match the desired properties and functionality [31-33]. A variety of
cell-electrospun matrix interactions have been reported in the literature. Typically, the
fiber diameters of these matrices conform to the structural properties of the ECM and are
on the order of 80-500 nm. It has also been reported that biocompatibility of a material
improves with decreasing fiber diameter [34]. Another parameter very crucial for cell
growth is the degree of porosity and the average pore dimension of the nanofibrous
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scaffold. Depending upon the cell type, the optimal pore diameters are 20-100 µm [35]. It
has also been reported that cells are able to easily migrate to a depth of only about 100
µm[36]. The role of fiber orientation has also been investigated. It has been observed that
growing cells tend to follow the orientation of the fibers. In addition, the production of ECM
is greater on oriented rather than non-oriented matrix fibers [37].
Several natural and synthetic electrospun polymers have been used to engineer
both hard and soft tissues. Natural polymers often lack sufficient strength upon hydration.
The mechanical stability of these natural polymers can be improved by either cross-linking
or mixing with synthetic polymers [38, 39]. One of the most plentiful proteins in the human
body is collagen. Collagen fibers display several attractive biological and structural
properties. They transmit forces, dissipate energy, prevent premature mechanical failure,
and have high water affinity, low antigenicity and good cell compatibility [40]. Various labs
have worked extensively on the electrospinning of collagen (Type I [41], II [42], III [43] and
IV [43]) and blends of collagen with both synthetic and natural polymers to produce
scaffolds for vascular [38, 44-52], skin [53-58], cartilage [59], bone [60, 61] and ligament
[62, 63], nerve [64] tissue engineering applications. Elastin is another key protein found in
the native ECM of connective tissues where elasticity and recoil are critical parameters. As
collagen and elastin are two of the most predominant proteins in the native vessel, they are
often used together as tissue engineering scaffolds for vascular scaffolds, with or without
synthetic polymers [50, 65-69]. Elastin has also been blended with PLA for urologic tissue
engineering [70]. Recently, silk fibroin (SF) has gained immense popularity in the field of
tissue engineering. SF exhibits good biocompatibility, significant crystallinity, high
elasticity, good tensile strength, toughness and resistance to failure in compression. SF was
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originally electrospun for ligament [71-78] tissue engineering but has also been used for
vascular [79-81], bone [82, 83] and skin [84] tissue engineering. For a detailed review of
both synthetic and natural electrospun polymers in tissue engineering, the readers are
referred to the works of Sell et al. [38, 39, 85, 86], Ashammakhi et al. [32] and Kumbar et al.
[87].
The technique of electrospinning has also been used extensively for drug delivery
applications. Nanofiber systems for the release of drugs are required to fulfill diverse
functions. The matrices should be able to protect the compound from decomposition,
should allow for controlled release in the targeted tissue, over a desired period of time at a
constant release rate. Kenawy et al. demonstrated the release of tetracycline hydrochloride
from electrospun matrices composed of Poly[ethylene-co-(vinyl acetate)] (PEVA), PLA, and
a 50:50 mixture of the two polymers. The fastest drug release was observed with PEVA, as
compared to PLA or the blend. Burst release was observed with PLA, and release
properties of the blend were found to be intermediate to those of the pure polymers [88]. It
was concluded that release kinetics can be altered by changing the polymer used for the
fabrication of the nanofibers. Other parameters that can impact the release kinetics
include; the morphology of the fibers, their interaction with the drug

and the drug

concentration in the fibers. It has been observed that with higher drug concentration, more
amount of drug gets enriched on the nanofiber surface, leading to a burst release [89].
In another study, water insoluble antitumor drug called paclitaxel and the
antituberculosis drug called rifampin were electrospun onto PLA nanofibers. In the
presence of proteinase K, it was found that drug release was nearly linear over time. The
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drug release was attributed to the polymer degradation by the proteinase [90]. However, in
the case of the hydrophilic drug doxorubicin, burst release was observed. It was reasoned
that the hydrophilic nature of the drug caused its accumulation on the surface of the
nanofibers, leading to burst release [91]. To circumvent this problem, Xu et al. [92]
electrospun water-oil emulsions, in which the drug was contained in the aqueous phase
and a PLA-co-PGA copolymer was contained in the oil phase. This method showed a
biomodal release pattern in which burst release was observed initially through diffusion
from the fibers, followed by linear drug release through enzymatic degradation of the
polymer by proteinase K.
Coaxial electrospinning technique has also been utilitized for drug delivery. In this
system, core immobilizes the drugs and the shell controls their diffusion out of the fibers.
Huang et al. used coaxial electrospinning to prepare PCL as the shell and two medically
pure drugs, Resveratrol and Gentamycin Sulfate, as the cores. The drugs were released in a
controlled way without any initial burst effect [93].
Environmentally sensitive polymer drug delivery systems, which can release drugs
when triggered by a stimulus (such as pH or temperature), have also been reported.
Chunder et al. demonstrated that ultrathin fibers composed of two weak polyelectrolytes
poly(acrylic acid) (PAA) and poly(allylamine hydrochloride) (PAH) could be used for the
controlled release of methylene blue (MB) through pH changes. They also showed that
temperature sensitive drug release can be obtained by depositing temperature sensitive
PAA/poly(N-isopropylacrylamide) (PNIPAAM) multilayers onto the fiber surfaces [94].
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I.6 Electrospun Bioresorbable Vascular Grafts
The native blood vessel is a highly complex and crucial organ. The complex vascular
network of the human body serves two main functions, delivery of oxygen and nutrients to
the tissues and removal of metabolites for clearance or re-oxygenation. As shown in figure
7, the artery is composed of three different layers or tunics of different compositions which
surround a hollow core or lumen through which the blood flows. The innermost layer,
surrounding the lumen is known as the intima and is made up of single layer of endothelial
cells on a basement membrane rich in collagen IV and elastin. This layer contacts the
bloodstream and endothelial cells provide a crucial barrier to platelet activation by
secreting specific molecules like nitric oxide and prevent thrombus formation. The thick
middle layer, the media, is composed of several layers of smooth muscle cells in an
extracellular matrix of collagen types I and III, elastin and proteoglycans. In elastic arteries
like the aorta, the elastic lamellae allow the artery to maintain sufficient blood pressure
with variations in hemodynamic stress of the cardiac systole and diastole. In muscular
arteries, elastin is assembled as fibers. The outermost adventitial layer is composed of
fibroblasts and randomly arranged collagen type I. This, collagen provides tensile support
and prevents vessel rupture. The proteoglycans contribute to the compressibility and the
elastin fibers give elasticity to the vessel and provide the ability to recover from pulsatile
deformations. Its elastic nature dominates the low strain mechanical response of the vessel
to blood flow and prevents pulsatile energy from being dissipated as heat The ideal
vascular prosthetic must have the following performance characteristics: ease of handling,
suture retention, ease of suture replacement, flexibility with kink resistance,
biocompatibility, durability after implantation and association with surrounding
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connective tissue, compliance matching that of the native artery, and resistance to
aneurysm formation. Also, the graft must be easily manufactured, economical, easily stored
and available in a variety of sizes [7].
Initial graft research focused on Poly(ethylene terephthalate) (Dacron) and
expanded poly(tetrafluoroethylene) (e-PTFE) as prosthetic vascular grafts. Both Dacron
and e-PTFE react with blood components and perigraft tissues in both advantageous and
injurious ways. It has been documented that monocytes and macrophages produce
cytokines such as IL-1β, IL-6, and TNF-α when incubated with Dacron and e-PTFE [8].
However, these prostheses remained permanently within the host after implantation. The
concept of a slowly absorbable graft that could stimulate rapid and controlled regenerative
process producing a “neoartery” was first described by Wesolowski et al. [9] and
Ruderman et al. [10]. These grafts were partially bioresorbable and composed of Dacron
and polylactide yarns. Bowland et al. described the use of Vicryl (a copolymer of
polyglycolide and polylactide) as a fully bioresorbable vascular graft [11]. These early
grafts were susceptible to aneurismal rupture and dilation.
Greisler et al. evaluated woven poly (glycolic acid) (PGA) grafts in a rabbit model.
Four weeks after implantation, these grafts were shown to contain an inner capsule
composed of a confluent layer of endothelial cells and smooth muscle like myofibroblasts in
the midst of dense collagen fibers. Similarly constructed and implanted Dacron grafts failed
to show the results described above [12, 13]. It is also important for the bioresorbable graft
to regenerate a complex tissue of sufficient strength before prosthetic degradation so as to
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Figure 7 Architecture of the native artery.

minimize the risk of aneurismal dilation. To circumvent this problem two or more
bioresorbable materials with different resorption rates can be combined so that the more
rapidly absorbed material induces rapid tissue ingrowth while the second material
provides structural support [14]. Such composite grafts containing 69% polyglactin 910
(PG910) and 31% polypropylene were implanted into rabbit and dog arteries [15]. These
grafts demonstrated 100% one-year patency with no aneurysms. In another study,
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composite grafts of 74% PG910 and 26% polydioxanone (PDO/PDS) also showed 100%
patency with no aneurysms one year after implantation [16]. PDO is a colorless, crystalline,
biodegradable polymer that was developed for wound closure sutures. It exhibits high
flexibility, higher strength retention, slower absorption rate, and lower inflammatory
response as compared to poly(glycolide lactide) and poly(glycolic acid) [7]. Greisler et al.
published results utilizing PDO absorbable vascular prosthetics in a rabbit aortic model of
regeneration. The results showed no perigraft hematomas and the myofibroblast migration
paralleled the macrophage–mediated degradation of the PDO structure. A confluent EC
lining was present within two weeks, with the compliance of the explants at 1 year
resembling an artery [17]. Greisler et al. demonstrated that PDO grafts had the highest
production ratio of PGI2/TxA2 at a seven fold increase versus PGA and approximately
equal to the native aorta control. The study showed a tissue dependence response in terms
of thrombogenicity and the grafts containing PDO were less thrombogenic [18]. PDO can be
reproducibly electrospun. It is readily dissolvable in 1,1,1,3,3,3-hexafluoro-2-propanol
(HFP) and has been electrospun at concentrations between 42 and 167 mg/ml, producing
fibers diameters ranging from 180 nm to 1.4 μm respectively. Uniaxial tensile testing
performed on PDO revealed a modulus ranging from 2.0 to 46 MPa, a peak stress ranging
from 1.7 to 12.0 MPa, and a percent strain at break ranging from 31 to 240% [7, 19].
I.7 Pore-size/Porosity: a crucial material property for tissue regeneration
From the early stages of vascular prosthetic use, porosity emerged as the design
focus, out-ranking material properties. The complex nature of most prosthetic designs
makes it difficult to determine the “porosity” or basic void space requirements (defined by
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water permeability) for healing and transmural endothelialization. In many prosthetic
designs, it has been seen that the porosity is supportive of MФs and other inflammatory
cells to infiltrate, but connective tissue cells (similar cell diameters) were noticeably
absent. It was determined that the connective tissue cells (i.e. smooth muscle cells) trail
the endothelial cells (ECs) during healing. Thus, an important prosthetic design variable is
that the wall pores permit capillaries (average 10 µm diameter) to sprout while leaving
room for accompanying cells to trail.
Pore size, pore interconnectivity, and net porosity have always been a focus of tissue
engineering scaffolds and have been shown to be key determinants of a scaffold’s success
through their influence on cell infiltration, nutrient/oxygen exchange, and angiogenesis
[95, 96]. The success of electrospun scaffolds has been minimal due to the inability to
directly control pore size and overall net porosity due to fiber diameters and the
subsequent tight packing of the fibers. Because the fine pore structure restricts cell
migration into the structure, it has been suggested that the pore size should at least be the
size of the cell of interest to allow infiltration [66, 97, 98]. An additional challenge is that
the “optimal” pore size for cell adhesion, proliferation and migration varies by material
composition and cell type from 5 to 500 µm [99]. A review by Szentivanyi et al. [100]
showed that for electrospun scaffolds composed of 0.25 and 2 µm diameter fibers that a 1050 µm pore size was necessary for cell infiltration. Above 2 µm diameter fibers (resulting
pore size >10 µm [97]), the scaffolds were all conducive to cell infiltration. In order to get
50 µm pores, Pham et al. [97] showed that one needs 10 µm diameter fibers (pore size is a
function of fiber diameter). Electrospun scaffolds composed of submicron diameter fibers
generally result in pore dimensions of 1-5 µm. Thus, a fabrication technique that offers
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direct control of pore dimension, yet allows for the use of submicron diameter fibers
without significantly compromising structural integrity is needed. In terms of maximizing
angiogenesis, it has been suggested that optimal physical properties (i.e. pore size, 0.8 to 8
µm) are critical [101]. Soliman et al. [102] showed for electrospun PCL that a 50-60 µm
pore size enhanced EC infiltration versus a scaffolding composed of 10 µm pores (no
infiltration). Lowery et al. [103] showed an optimal pore size of 6-20 µm (±50% seeded
cell diameter) for electrospun PCL with cells unable to bridge the gaps in larger pores
between fibers.
To overcome electrospun scaffold pore size limitations, scaffolds composed of
blended synthetic and natural polymers (native integrin binding sites) have been created
[104-106]. While cell adhesion was enhanced, these structures had limited success in
improving cellular infiltration. The use of porogens in electrospun scaffolds has also been
utilized. Zhang et al. electrospun a blend of PCL and gelatin without cross-linking, allowing
a large percentage of the gelatin to dissolve when immersed in an aqueous media [30].
Baker et al. electrospun poly(ethylene oxide) (PEO) fibers intermingled with
simultaneously electrospun PCL fibers, with the water-soluble PEO “sacrificial fibers”
removed by post-processing [107]. Results showed that the greater the PEO in the scaffold,
the greater the cellular infiltration (majority of cells remained in the upper 25%) but at the
expense of a significant reduction in the scaffolds’ modulus and maximum stress. Nam et
al. introduced salt crystals amongst the fibers that were removed by post-processing to
create void areas that enhanced cell infiltration [108]. The major concerns with this
method include the uneven distribution of crystals and loss of scaffold integrity
(macroscopic scaffold delamination). The common result of these studies is that enhanced
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porosity/cell infiltration comes at the expense of decreased mechanical properties/scaffold
integrity. McClure et al. [109] recently published a method for scaffold fabrication that
allows consistent control over electrospun scaffold porosity by the use of an air flow
impedance mandrel. The scaffolds’ fabricated possess two seemingly contradictory
properties by having both 1) porous regions which permit rapid cell infiltration, and 2)
dense fiber regions which are less amenable to cell infiltration, but which provide ample
structural integrity. Scaffolds with these properties are made using a mandrel that is
perforated. During the electrospinning process, as fibers are deposited onto the perforated
mandrel, pressurized air emanating from the mandrel perforations is introduced into the
developing fibrous structure that are located at or near the perforation, causing the fibers
in those areas to be less dense, creating regions of increased scaffold porosity. In contrast,
fibers deposited on solid, non-perforated sections of the mandrel (e.g. located between and
adjacent to the perforations) are, in comparison, densely packed. The scaffold thus contains
regions in which the fibers are porous and regions in which the fibers are densely packed,
all within a single contiguous, seamless structure prepared during a single deposition
event, thus not requiring multiple deposition steps and/or processing steps. This now
overcomes the major limitation pertaining to the lack of control over scaffold porosity and
potentially creates an environment (defined fiber diameters and scaffold porosity) capable
of promoting MФ-mediated angiogenesis and in situ tissue regeneration.
I.7 Hypothesis and Thesis Objectives
The host response to implanted biomaterials is a complex multi-step process
consisting of various different cell types. MФ can play both beneficial and detrimental roles
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in the process of tissue remodeling due to their inherent plastic nature. An essential and
timely phenotypic switch is required for proper and functional remodeling of the tissue as
opposed to a scar tissue outcome with a loss of function. Thus, MФ can decide the fate of
the implanted biomaterial. Mast cell is another important cell type in the context of tissue
healing. Mast cells participate in the early stages of wound healing and modulate the acute
inflammatory responses to biomaterials. Mast cells can secrete a myriad of different
cytokines by the process of degranulation; the process of regulated secretion in which
preformed contents stored in their granules are rapidly released by exocytosis. Some of
these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ phenotype. The
phenotypic profile of MФ as M1 or M2 following exposure to the biomaterial (electrospun
PDO) can dictate the downstream processes of tissue remodeling and angiogenesis. MФ
participating in the host response to an implanted biomaterial are exposed to numerous
cytokines and effector molecules secreted by several types of cells. In addition, MФ are also
exposed to microbial agents, epitopes associated with the implanted biomaterial and the
degradation products of the biomaterial. The host MФ response is modulated via “crosstalk” between MФ and other cells (e.g. endothelial cells) as well as factors within the local
environment. Therefore, a complete understanding how mast cells and MФ interact with
biomaterials is crucial.
This thesis aims to gather insight into the mast cell and MФ activity on electrospun
biomaterials. A detailed analysis of mast cell interaction with electrospun PDO, PCL and
Silk is given in Chapter 2. The adhesion, proliferation and cytokine secretion of mast cells
on electrospun bioresorbable grafts was investigated in the presence or absence of IL-3,
SCF, IgE and IgE with a crosslinking antigen, DNP. We attempted to modulate the behavior
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of mast cells on electrospun scaffolds by adding these stimulating agents using tissue TCP
as the control. The stimulating agents were chosen and combined according to their
proliferation and attachment-inducing potential. The hypothesis in this study is that mast
cells would secrete more pro-M2 or pro-wound healing cytokines after interacting with
biomaterials and would thereby assist MФ and other cell types in tissue remodeling.
The next study (Chapter 3) involves the identification of the macrophage phenotype
(M1 or M2) promoted by electrospun PDO of varying fiber diameter, pore-size, surface area
to volume ratio and porosity. The hypothesis in this study is that differences in pore-size
and fiber diameters of electrospun PDO would modulate MФ phenotype (M1/M2) and thus
influence the MФ mediated angiogenesis and regeneration. A relationship between the
M1/M2 profile of MФs and the downstream angiogenic responses has also been
determined using a 3D angiogenesis bead assay described previously [110]. This study is
described in detail in Chapter 4. We hypothesized that the bigger fiber/pore-size PDO
scaffolds would shift the MФs to a functionally active M2-like phenotype, which would
support angiogenesis.
We have also tried to understand the signaling mechanism by which PDO composed
of small or large fiber/pore-size signals MФ phenotypic responses in Chapter 5. The
potential candidates tested in this study were MyD88 and TLR4. The hypothesis for this
study was that materials with different fiber/pore-sizes would signal through different
mechnisms. A complete understanding of these signaling mechanisms would allow for
development of strategies that control the regeneration of biomaterials in vivo.
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In order to evaluate the angiogenic and regeneration potential of electrospun PDO in
vivo, we used a subcutaneous directed in vivo angiogenesis assay. We hypothesized that
electrospun PDO of bigger fiber/pore-size would lead to greater angiogenic response in
vivo. Furthermore, immunostaining of electrospun PDO would allow for quantification of
M1:M2 phenotype ratios. We expected the bigger fiber/pore-size PDO would support a
predominately M2 phenotype compared to the small fiber/pore-size PDO.
Recognition of the predominant MФ phenotypic profile will provide a tool by which
a tissue regenerative outcome can be predicted and possibly promoted [111]. Overall, these
studies would provide an insight into the mechanisms by which biomaterials heal. These
studies would allow biomedical researchers to create better materials for tissue
engineering, that self-heal and integrate with the host tissue without any undesirable
immune reactions.
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II.1 Abstract
Mast cells synthesize several potent angiogenic factors and can also stimulate
fibroblasts, endothelial cells and macrophages. An understanding of how they participate in
wound healing and angiogenesis is important to further our knowledge about in situ
vascular prosthetic regeneration. The adhesion, proliferation and cytokine secretion of
bone marrow derived murine mast cells (BMMC) on electrospun polydioxanone (PDO),
polycaprolactone (PCL) and silk scaffolds, as well as tissue culture plastic (TCP) has been
investigated in the presence or absence of IL-3, SCF, IgE and IgE with a crosslinking
antigen, dinitrophenol-conjugated albumin (DNP). It was previously believed that only
activated BMMCs exhibit adhesion and cytokine secretion. However, this study shows nonactivated BMMC adhesion to electrospun scaffolds. Silk scaffold was not found to be
conducive for mast cell adhesion and cytokine secretion. Activation by IgE and DNP
significantly enhanced mast cell adhesion, proliferation, migration and secretion of TNF-α,
MIP-1α and IL-13. This indicates that mast cells might play a role in the process of
biomaterial integration into the host tissue, regeneration, and possibly angiogenesis.
II.2 Introduction
An understanding of how mast cells participate in angiogenesis is important to
further our knowledge about vascular development and remodeling [112]. Mast cells are
important to the pathogenesis of allergic, autoimmune and cardiovascular diseases, and
cancer. However, in addition to playing a critical role in host defense, they are also involved
in various physiological processes such as angiogenesis, tissue remodeling and collagen
production [113-116].
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Biological responses to implanted materials involve neutrophil mediated
detoxification, followed by macrophage activity to phagocytize debris and coordinate
remodeling events. It was reported by Ashley et al. that these events occur in the presence
of both eosinophils and mast cells [15]. They are known to mediate acute inflammatory
responses to the implanted biomaterials [1]. Mast cell-derived Interleukin-4 (IL-4) and IL13 were found to induce macrophage fusion while tumor necrosis factor alpha (TNF-α) was
responsible for biomaterial adherent macrophage apoptosis. IL-4 and IL-13 lead to
alternatively activated macrophages which play a role in allergic responses, elimination of
parasites and matrix remodeling [13].

Using implantation of fibrinogen coated

polyethylene terephthalate (PET) disks in mice, it was found that this biomaterial triggers
the activation of mast cells shortly after implantation, releasing granular products
including histamine. Mast cell-deficient mice exhibited reduced phagocyte accumulation on
the implants. Administration of histamine receptor antagonists also greatly decreased
recruitment and adhesion of neutrophils and monocytes/macrophages to implants [117].
Mast

cells can

be activated by physical

stimuli,

immunogenic stimuli

(Immunoglobulin E (IgE), complement, cytokines and growth factors) and neurogenic
stimuli (neuropeptides) [113]. Exposure of mast cells to an allergen leads to cross linking
of the IgE-loaded surface receptor, FcɛRI, with at least three biological effects. First, they
can undergo degranulation; the process of regulated secretion in which preformed
contents stored in their granules are rapidly released by exocytosis. Granule associated
mediators include proteases, histamine, proteoglycans and cytokines such as TNF-α and IL16. Following degranulation is the rapid enzymatic synthesis of lipid mediators derived
from precursors stored in the cell membranes and in lipid bodies. These include, the
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arachidonic acid metabolites prostaglandin (PG) D2, leukotrienes (LT) B4+ and C4, and
platelet activating factor (PAF). Lastly, activated mast cells initiate transcription,
translation and secretion of a variety of cytokines and chemokines depending on the mast
cell type and stimulus. These include, TNF-α, granulocyte-macrophage colony-stimulating
factor (GM-CSF), stem cell factor (SCF), IL-3, IL-4, IL-5, IL-6, IL-10, IL-13, IL-14 and IL-16,
and chemokines, such as macrophage inflammatory protein (MIP)-1α, MIP-1β, T-cell
activation gene 3, lymphotactin and monocyte chemoattractant protein -1 (MCP-1) [118121]. Under physiological conditions in several organs, mast cells are found in close vicinity
to capillaries and lymphatic vessels and a direct correlation between the number of mast
cells and blood vessel density has been demonstrated in the dermis[122]. Mast cells
synthesize several potent angiogenic factors such as vascular endothelial growth factor
(VEGF), basic fibroblast growth factor (bFGF), heparin, histamine, tumor necrosis factor
(TNF-α) and IL-8. On the other hand, endothelial cells may also express the mast cell
growth and chemotactic factor, SCF. This shows that endothelial cells may also elicit mast
cell chemotaxis and survival, demonstrating a two way relationship between them [123,
124]. It has been shown that SCF is the primary cytokine involved in mast cell
differentiation and activation [125-128]. SCF (or c-kit ligand) is critical for mast cell
survival, as mast cells cultured without SCF undergo apoptosis [129]. In addition to acting
on the vasculature, mast cells may augment wound healing by promoting extracellular
matrix deposition. In fibroblasts, mast cell extracts elicit collagen synthesis and activate an
enzyme involved in matrix remodeling; gelatinase A [130]. The addition of histamine to
cultured fibroblasts has been shown to stimulate proliferation and collagen synthesis [131,
132]. It has also been reported that tryptase, which is abundantly expressed in mast cells,
38

can act as a growth factor for human fibroblasts and can stimulate collagen type I synthesis
[133]. Similar to mast cell-endothelial cell interactions, mast cells can be attracted to
fibroblasts via their SCF expression as both membrane-bound and secreted forms.
In this study, an investigation of mast cell interaction with electrospun scaffolds has
been performed. The biomaterials chosen for this study were polycaprolactone (PCL), PDO,
and silk fibroin (silk). PCL exhibits properties (i.e. compliance) that are conducive to
arterial tissue engineering with an extended degradation time, and compatibility for
endothelial cells and smooth muscle cells [106, 134-136]. PDO has been extensively studied
by our laboratory and has shown promise in vitro [105, 106, 137-141]. Its flexibility,
excellent strength retention, shape memory, low inflammatory response and slow
degradation rate make it a suitable candidate for vascular tissue engineering. The use of
silk as a vascular tissue engineering scaffold has escalated recently. Zhang et al.
demonstrated the bioactivity of human aortic endothelial cells and human coronary artery
smooth muscle cells on electrospun silk [142]. It was established by Soffer et al. that
electrospun tubular silk constructs can withstand native arterial pressures while behaving
in a similar manner to native vessels during creep testing [143].
The adhesion, proliferation and cytokine secretion of mast cells on electrospun
bioresorbable grafts was investigated in the presence or absence of IL-3, SCF, IgE and IgE
with a crosslinking antigen, dinitrophenol-conjugated albumin (DNP). We attempted to
modulate the behavior of mast cells on electrospun scaffolds by adding these stimulating
agents using tissue culture plastic (TCP) as the control. The stimulating agents were chosen
and combined according to their proliferation and attachment-inducing potential. It is
widely accepted that IL-3 alone is capable of maintaining mouse mast cell survival.
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However, SCF is required for mast cell attachment to substrates. The presence of IgE and
antigen can further enhance the survival and attachment of mast cells induced by IL-3 and
SCF. The results of various studies show conflicting reports on the effects of IgE in the
absence of antigen. Its impact on mast cell survival and attachment has not been clearly
defined yet [144]. Overall, our data demonstrate mast cell adhesion, survival and IgE
responsiveness when cultured with bioresorbable polymers, supporting the utility of these
polymers in tissue grafts.
II.3 Materials and Methods
II.3.1 Electrospinning
Electrospinning was used to generate nanofibrous scaffolds of PCL, PDO, and silk.
Silk fibroin was extracted from the cocoons of Bombyx mori silkworms (The Yarn Tree)
through an established protocol [145]. PCL (MW 60,000 kDa, Sigma Aldrich), PDO (Ethicon,
Inc.) and silk polymer concentrations used in the study were 250, 100 and 100 mg/ml
respectively in 1,1,1,3,3,3, Hexafluoro-2-propanol (HFP) to form flat sheets on a stainless
steel mandrel (0.5 cm x 3cm x 15 cm). Disks 6 mm in diameter were punched out of these
scaffolds and were placed in a 96 well plate. Fibronectin (100 μl) at a concentration of 50
μg/ml was added on top of the disk and the plate was allowed to sit in the incubator at
37°C for an hour. After an hour, the disks were moved to a new well. The scanning electron
micrographs of the uncoated scaffolds are shown in Figure 9.
II.3.2 Cell Culture and Seeding
Bone marrow derived murine mast cells (BMMCs) were derived from C57BL/6 mice
as described previously [146]. Briefly, BMMC cultures were derived from bone marrow
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harvested from C57BL/6 mouse femurs and tibias (Jackson Labs, Bar Harbor, ME). BMMC
cultures were maintained in cRPMI supplemented with IL-3 containing supernatant from
WEHI-3B and SCF containing supernatant BHK-MKL cells. The final concentration of IL-3
and SCF was adjusted to 1 ng/ml and 10 ng/ml, respectively [147]. After 3-4 weeks in
culture, these populations were >99% mast cells, as judged by morphology and flow
cytometry staining for expression of FcɛRI, and Kit (data not shown).

The resulting

populations were generally used between weeks 4-12. The cells were rinsed with
phosphate buffered saline (PBS) and cultured in complete RPMI (cRPMI) 1640 medium
(Invitrogen Life Technologies) (10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, 100
µg/ml streptomycin, 1 mM sodium pyruvate, and 1 mM HEPES; Biofluids), supplemented
with 5 ng/ml of IL-3 (R&D systems) and 50 ng/ml of SCF (PeproTech) . The cells were
then divided into four groups and cultured for 18 hours in the presence of IL-3 (group 1),
IL-3+SCF (group 2) and IL-3+SCF+IgE (1µg/ml, clone C38-2, BD Biosciences) (group 3).
After 18 hours, Group 3 was centrifuged and suspended in media containing dinitophenylhuman serum albumin (DNP) antigen (100 ng/ml, Sigma-Aldrich) (group 4). This was done
to cross link the IgE-loaded cell surface receptor FcɛRI, triggering BMMC activation prior to
scaffold seeding.
II.3.3 Cell Adhesion
Disks 6 mm in diameter were punched from the scaffolds, disinfected (by soaking in
ethanol for 10 min followed by repeated rinses in PBS) and placed in a 96 well plate. Each
disk was then coated with 100 µl of fibronectin (50 µg/ml) and placed in the incubator at
37°C for an hour. The disks were then moved to a clean well and BMMCs were seeded on
fibronectin-coated electrospun PDO, PCL, and silk scaffolds and uncoated tissue culture
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plastic (TCP) under four different culture conditions. The culture conditions were; cRPMI
media supplemented with IL-3 (group 1), IL-3+SCF (group 2), IL-3+SCF+IgE (group 3) and
IL-3+SCF+IgE+DNP (group 4) as described in section 2.2. In all groups, mast cells were
seeded at a density of 50,000 cells/well with 170 µL of media. The cells were allowed to
attach for 7 hours in the incubator. At 7 hours, the cell seeded scaffold was moved to a
clean well and the number of attached cells was quantified by MTS assay as described
below.
II.3.4 Cell Proliferation
The numbers of cells on the scaffold were determined with a colorimetric cell titer
assay (CellTiter 96® AQueous; Promega Corp., Madison, WI). The assay is composed of
solutions

of

a

tetrazolium

compound,

MTS

[3-(4,5-dimethylthiazol-2-yl)-5-(3-

carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] and an electron coupling
reagent, PMS (phenazine methosulfate). Metabolically active cells convert MTS into the
aqueous soluble formazan product. The quantity of formazan product can be measured by
the amount of 490 nm absorbance. It is directly proportional to the number of living cells in
culture. For this assay, disks 6 mm in diameter were punched from the scaffolds,
disinfected (by soaking in ethanol for 10 min followed by repeated rinses in PBS) and
placed in a 96 well plate. Each disk was then coated with 100 µl of fibronectin (50 µg/ml)
and placed in the incubator at 37°C for an hour. The disks were then moved to a clean well
and BMMCs were seeded on fibronectin-coated electrospun PDO, PCL, and silk scaffolds
and uncoated tissue culture plastic (TCP) under four different culture conditions. The
culture conditions were; cRPMI media supplemented with IL-3 (group 1), IL-3+SCF (group
2), IL-3+SCF+IgE (group 3) and IL-3 + SCF +IgE+DNP (group 4) as described in section 2.2.
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In all groups, mast cells were seeded at a density of 50,000 cells/well with 170 µL of media.
In order to exclude any cells attached to TCP, the scaffold disks were moved to a new well
plate and 100 μl of fresh media with 20% MTS solution (20 μl) was added and placed in the
incubator for 2 hours. Simultaneously, standards were made with mast cells starting with a
concentration 200,000 cells/well to zero (media alone).

The number of cells was

determined by interpolation from the standard curve by using a log-log fit. The assay was
performed on day 1, 3 and 5. Each data point was calculated from triplicate wells.
II.3.5 Histology
For histological evaluation, disks of PDO, PCL and silk of all four groups were fixed
in formalin on day 3. The paraffin embedded disks were cross-sectioned and stained with
hematoxlin and eosin (H&E) to examine cell infiltration into the scaffolds.
II.3.6 Quantification of TNF-α, MIP-1α and IL-13
10 mm disks (disinfected) of fibronectin-coated (50 µg/ml) electrospun PDO and
PCL scaffolds were placed in a 48 well plate and an 8 mm cloning ring was placed on top of
the scaffolds to retain the cells during scaffold seeding within a defined circumference.
Cells were seeded on fibronectin-coated electrospun PDO, PCL, and silk scaffolds and
uncoated tissue culture plastic (TCP) at a concentration of ~1x106 cells/ml. Media was
added in the center of each scaffold (100 μl of cells in media incubated for 45 min and
followed by 200 μl of media). Cell culture supernatants were collected after 24 hours and
stored frozen at -20°C until analyzed by enzyme linked immunosorbent assay (ELISA). The
amounts of TNF-α, MIP-1α, IL-13 (PeproTech) secreted by the mast cells due to their
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interaction with the electrospun scaffold were quantified by ELISA as per the
manufacturer’s instructions.
II.3.7 Statistical Analysis
Data expressed in this paper is in the format of means ± standard error of mean
(S.E.M). Data of one representative experiment carried out in triplicates are given. Each
experiment was reproduced at least twice. All statistical analysis of the data was based on a
Kruskal-Wallis one-way analysis of variance on ranks and a Tukey-Kramer pairwise
multiple comparison procedure (α=0.05) performed with JMP®IN 8 statistical software
(SAS Institute).
II.4 Results
II.4.1 Mast Cell Adhesion and Proliferation
The percentage of adherent mast cells at the end of 7 hours on polymeric scaffolds
and TCP are shown in Figure 10. On PCL, PDO and TCP, cells exposed to IgE alone (group 3)
displayed greater attachment as compared to group 1 (IL-3) and group 4 (IL3+SCF+IgE+DNP). Silk exhibited little to no attachment in all groups. SCF +IL-3 (group 2)
promoted cell attachment at levels comparable to IgE on TCP and PDO.
Mast cell proliferation on the three scaffolds and TCP was studied at day 1, 3 and 5
with the results shown in Figure 11. Cells stimulated with IgE+DNP (group 4) showed
significantly higher proliferation on day 5 as compared to groups 1 and 3 on the PCL and
PDO scaffolds. By day 5, the group 4 cells proliferated 2-fold on PCL, 1.7-fold on PDO and
3.3-fold on TCP. Exposure of mast cells to IgE+DNP leads to cross linking of the IgE-loaded
surface receptor FcɛRI. Figure 3 demonstrates that although mast cells exposed to IgE+DNP
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initially adhered less than the cells exposed to IgE alone, antigen stimulation allowed for
enhanced proliferation and a net gain in cell numbers over the IgE alone group. In fact, IgE
in the absence of antigen did not support long-term proliferation and survival of mast cells
in this assay. It has been reported that FcɛRI aggregation enhances mast-cell proliferation,
perhaps owing to the autocrine effects of IL-3 and IL-4 [148]. Our data are consistent with
these findings.
SCF is a powerful mast cell co-mitogen. Mast cells treated with IL-3+SCF (Group 2)
showed a steady increase in proliferation from day 1 to day 5 for the PDO and PCL scaffolds
as well as TCP. Two pieces of data from figure 3 were notable. First, IgE crosslinkage was a
stronger mitogen than SCF when used in the presence of PDO or PCL. Second, silk not only
offered poor adhesion (Figure 2) but also failed to support mast cell proliferation even in
response to SCF or IgE crosslinkage. These data demonstrate the differential ability of the
polymer substrates to support mast cell adhesion and expansion.

Figure 8 SEM images of PCL (left) PDO (middle) and silk (right).
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Figure 9 Adherent cells expressed as percentage of seeded cells after 7 hours of culture.
Symbols ‘Ψ’ indicate a statistically significant difference from group 1 (IL3) and group 4
(SCF+IL-3+IgE+DNP) for a particular material. Symbol ‘Φ’ indicates statistical difference
from all groups for that particular material.

Figure 10 Mast cell proliferation on scaffolds and TCP. Symbols ‘Ψ’ indicate a statistically
significant difference from group 1 (IL-3) and group 3 (SCF+IL-3+IgE) for a particular
material. Symbol ‘Φ’ indicates statistical difference from all groups for that particular
material.
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II.4.2 Histology
H&E staining revealed cell infiltration into the fibrous structures of PDO (Figure
12h) and PCL (Figure 12d) on day 3. Consistent with the poor cell binding in short-term
assays, no cells were observed on the silk scaffold using H&E staining (Figure 12i, j, k, l).
Mast cell adhesion molecules include various integrins, intercellular adhesion molecule-1
(ICAM1) and c-kit. It has been shown that mast cells adhere to plate bound laminin,
fibronectin and vitronectin only when activated through FcɛRI or by pharmacological
stimuli such as phorbol 12-myristate-13-acetate (PMA) or calcium ionophore [149-152].
However, mast cells exposed to only IL-3+SCF attached to the PDO and PCL scaffolds. This
proves that a combination of fibronectin, SCF and the scaffold nanostructure can elicit mast
cell attachment. Consistent with Figure 2, mast cells exposed to IgE alone attached to the
scaffold in greater numbers than IL-3+SCF (Figure 12b, c). It has been demonstrated that
IgE primes mast cell adhesion to fibronectin using similar pathways as IgE +Ag [153].
As noted when studying proliferation in Figure 3, IgE+DNP stimulation led to the
greatest number of adherent mast cells after 3 days of culture with PDO (Figure 12d) or
PCL (Figure 12h). The increased number of cells is likely due both to strong adhesion and
cell division. The histology analysis also revealed an important difference between the
stimuli. In the presence of SCF, mast cells remained largely on the surface of the
electrospun scaffold. However, in the presence of IgE+DNP, cellular infiltration
dramatically improved. The cells migrated deeper into the fibrous structures of PDO and
PCL scaffolds. These data suggest that FcɛRI aggregation is a potent stimulus for mast cell
attachment, proliferation and migration in the presence of electrospun bioresorbable graft
structures.
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Figure 11 H&E staining of mast cell seeded PCL, PDO and silk scaffolds on day 3. The blue
arrows indicate the seeded surface.

II.4.3 Mast Cell Cytokine Secretion
To assess the functionality of mast cells adhered to electrospun scaffolds, we
measured cytokine secretion. Mast cells secrete an array of cytokines and chemokines. We
chose to measure TNF-α (Figure 13), MIP-1α (Figure 14) and IL-13 (Figure 15), which are
well known for their roles in mast cell mediated inflammation [154-165]. IL-3 alone group
and silk scaffold were omitted from this study due to their poor capacity for cell adhesion
and proliferation. When compared to the background (media alone), only group 4 cells (IgE
+ DNP) produced any cytokines on the PDO and PCL substrates. While IL-3 and SCF are
strong mast cell mitogens, neither is a potent inducer of cytokine secretion as a sole
stimulus. In keeping with this, IgE+DNP was the only stimulus to consistently elicit
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cytokine production on PDO, PCL and TCP. More importantly, mast cells cultured on PDO or
PCL showed similar cytokine responses to the control group cultured on TCP. These data
indicate that mast cell adhesion to bioresorbable polymers did not hinder their
functionality.

Figure 12 Production of TNF-alpha by mast cells on electrospun scaffolds. Symbol ‘*’
indicates statistical difference from all groups for that particular material.
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Figure 13 Production of MIP-1alpha by mast cells on electrospun scaffolds. Symbol ‘*’
indicates statistical difference from all groups for that particular material.

Figure 14 Quantification of IL-13 release by ELISA on day 1. Symbol ‘*’ indicates statistical
difference from all groups for that particular material.
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II.5 Discussion
One of the main requirements of tissue engineered scaffolds is to provide cells with
a suitable environment for cell attachment, which is the first step in the cellular growth
process. The use of electrospinning for fabricating nanofibrous tissue engineering scaffolds
has escalated at a dramatic rate in the recent years. Electrospinning is capable of producing
fibers in micro/nanometer range, which mimic the structural dimension of the native
extracellular matrix (ECM). The scaffolds produced by electrospinning possess a highly
porous microstructure with interconnected pores and extremely high surface-area-tovolume ratio, which is conducive to cellular growth, attachment and organization [166].
Material interaction with the cells is guided by its physicochemical surface properties
[167]. Surface modifications of the electrospun scaffolds can drastically improve the
biological performance while retaining all the nanostructure features and properties [168].
He et al. fabricated a collagen coated poly (L-lactic acid)-co-poly(ɛ-caprolactone) scaffold
that exhibited enhanced spreading, viability and attachment of endothelial cells (EC) [47].
It was observed in another study that fibronectin coating of polymeric substrates was
required for Human Umbilical Vein Endothelial Cell (HUVEC) attachment and spreading
[167]. In this study, fibronectin coating was found to be imperative for mast cell
attachment and spreading on the electrospun scaffolds (data not shown). Plasma
fibronectin modulates the foreign body response and fibrous encapsulation of implanted
materials [169]. Cellular transmembrane integrin receptors recognize the ArginineGlycine-Aspartic acid (RGD) sequences within fibronectin. Once integrins bind to
fibronectin, they activate a cascade of intercellular signaling pathways [167, 170].
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It has been documented that human mast cells attach to fibronectin and vitronectin
only when stimulated by phorbol 12-myristate 13 –acetate (PMA) and or calcium
ionophore [150]. In another study, it was found that following FcɛRI-mediated activation
mast cells exhibited flattening and spreading accompanied by cell translocation on laminin,
fibronectin and matrigel [149]. However, in this study mast cells adhered to fibronectincoated electrospun scaffolds in the presence of SCF and IL-3 without any activation agents.
But our data certainly did not refute the importance of mast cell activation in adhesion. In
fact, we found that FcɛRI aggregation augmented initial adhesion and supported
proliferation on electrospun bioresorbable vascular graft materials. IgE binding to mast
cells is referred to as a ‘passive presensitization’ step. In this study, IgE in the absence of
antigen greatly augmented adhesion but did not support long-term survival and
proliferation of mast cells in the absence of antigen. It is important to note that surface
FcɛRI on mast cells are nearly saturated in vivo. It has been reported previously that more
than 80% of mast cell surface FcɛRI are occupied by 7 weeks of age in mice [171].
Therefore, passive presensitization is likely to occur, and may have important effects on
mast cell adhesion to grafted polymers.
Xiang et al. showed that the survival effect of FcεRI aggregation occurs due to the
expression of the anti-apoptotic Bcl-2-family protein A1. Mast-cell survival was abolished
in A1a−/− mast cells, and the increase in the number of mast cells that is induced by FcεRI
aggregation in vivo was not observed in A1a−/− mice [172]. In Figure 3, the decline in cell
numbers by day 5 suggests that in the absence of antigen, continuous exposure to IgE is
required for mast cell survival. In this study, IgE was not added to the culture medium that
was used to feed the cells after day 1. It has been proposed that prolonged FcɛRI
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aggregation is required for augmented proliferation of mast cells [173]. It has been shown
that the binding of monomeric IgE to FcεRI does not induce DNA synthesis, but it renders
mast cells resistant to apoptosis induced by growth factor deprivation. However,
continuous presence of IgE is required for this anti-apoptotic effect [144]. It can therefore
be concluded that the effects of IgE in the absence of antigen are short lived and are more
prominent early on as compared to IgE+DNP, which has long-term effects on cells.
It should be noted that the MTS assay cannot efficiently quantify cells that have
migrated into the three-dimensional structure of the scaffold and only provides a reliable
estimation of the cell number on the surface. The polymeric materials pose unique
challenges via various mechanisms including diffusion gradients and sequestering effects.
Efforts are underway to validate the modified diphenylamine assay for cell quantification,
recently published for use with three-dimensional polymeric scaffolds [174].
The physical properties of silk and its ability to promote endothelial cell growth and
proliferation make it a promising candidate for vascular tissue engineering scaffolds.
However, this study found that silk scaffold with or without fibronectin treatment was not
conducive for mast cell adhesion. Our results are consistent with a study conducted by
Panilaitis et al. showing that silk was largely inert and even inhibitory with respect to
murine macrophage activation [175].
Tissue regeneration requires multiple cells and cytokines acting together in concert
in a proper sequence. Mast cells stimulated with IgE+DNP on PDO and PCL scaffolds as
well as TCP produced high amounts of TNF-α, MIP-1α and IL-13. It has been demonstrated
that mast cell derived TNF-α is a crucial component of host defense against bacterial
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infection and is involved in recruitment of leukocytes by establishing cytokine networks
[158, 159]. In healing wounds, MIP-1α plays a critical role in macrophage recruitment. It
has been reported that MIP-1α levels increase during the inflammatory phase, and
decrease as inflammation resolves and repair proceeds. It is essential for T-cell chemotaxis
to inflamed tissue and also plays a critical role in the regulation of trans-endothelial
migration of monocytes, dendritic cells, and natural killer cells [163-165].
IL-13 was also produced by mast cells adherent to the polymer scaffolds. IL-13
induces expression of endothelial adhesion molecules such as vascular endothelial
adhesion molecule-1 (VCAM-1) and chemokines which are required for recruitment of
granulocytes and monocytes into tissues [176]. IL-13 stimulates macrophages and
fibroblasts to synthesize collagen and promotes fibrosis by stimulating macrophages to
produce transforming growth factor (TGF-β) [177]. These results demonstrate that mast
cell cytokine synthesis can influence the biological response of various cell types that play
an important part in tissue regeneration and angiogenesis. Improved knowledge of these
mechanisms will allow us to control and modulate the reactions occurring at the
host/implant interface.
VEGF could only be produced from mast cells when they were cultured at very high
densities. Mast cells were seeded at 23x106 cells/mL in a 48 well plate and stimulated with
IgE (10 µg/mL) and DNP (100 ng/ml). Cell culture supernatants were collected after 24
hours and the VEGF levels were quantified using ELISA. Both TCP and PDO produced
similar levels of VEGF as shown in Figure 15.
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Figure 15 Production of VEGF from murine mast cells on PDO and TCP.

Although many of the differences between human and mouse mast cells appear
quite subtle, caution must be observed when interpreting animal model research for use in
clinical applications. Animal studies are important in assessing and screening for risks
associated with the use of biomaterials in humans. They also help in determining the
mechanisms of immune modulation and the cell types affected following biomaterial
exposure [116, 178]. Evaluations that understand the behavior of mast cells on electrospun
scaffolds at a molecular level may provide insight into the specific causes of effects
observed in these studies. Such evaluations will help biomedical researchers in promoting
biomaterial integration with the host tissue without any undesirable immune reactions.
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II.6 Conclusion
The present study examined for the first time the cytokine expression and adhesion
of mast cells on bioresorbable electrospun scaffold for potential use as a vascular graft. The
study demonstrates that biomaterial exposure can affect mast cell adhesion and cytokine
expression. This indicates that mast cells might play a role in the process of biomaterial
integration into the host, tissue regeneration, and possibly angiogenesis. Mast cell
attachment onto fibronectin coated electrospun scaffolds led to survival and proliferation,
and these cells retained their IgE-induced cytokine production. Improved knowledge of
mast cell responses to biomaterials will allow a better understanding of the regeneration
process and modulation of both acute and chronic inflammation of implanted biomaterials.
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III.1 Abstract
Macrophages (MΦ) are innate immune cells, crucial for tissue homeostasis,
presentation of foreign and self-antigens following infection/injury, pathogen clearance,
inflammation resolution, angiogenesis, and wound healing. MΦ display plasticity and can
acquire pro-inflammatory (M1) or angiogenic/wound healing (M2) phenotypes depending
upon the environmental stimuli. It has been well demonstrated in the literature that MΦ
play a key role in determining the fate of any acellular prosthetic/scaffold. In this study, we
analyzed how different properties of an electrospun scaffold impact the MΦ phenotype.
Bone marrow derived murine macrophages (BMMΦs, 106 cells) were seeded on TCP
(24 well plate) and PDO scaffolds (15 mm discs) electrospun from varying polymer
concentrations (60, 100, and 140 mg/ml). Scaffold evaluation showed that large polymer
concentrations led to larger fiber diameters, which in turn led to larger pore-sizes and
porosity but a smaller surface area to volume ratio. After 24 hrs of culture, the cell lysates
were analyzed for arginase (Arg1) and inducible nitric oxide synthase (iNOS) expression by
western blot and cell culture supernatants were analyzed for nitric oxide (NO2-), tumor
Necrosis Factor – alpha (TNF-α), interleukin-6 (IL-6), vascular endothelial growth factor
(VEGF), transforming Growth Factor – beta1 (TGF-β1) and basic fibroblast growth factor
(bFGF) levels.
The results indicated a correlation between Arg1 expression and increasing
fiber/pore-size, indicating that the larger fiber/pore-sizes polarize towards a M2
phenotype. Also, the expression of iNOS was downregulated on the larger fiber/pore-size.
The levels of NO2- were significantly higher on the lower fiber/pore-sizes indicating an M1
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phenotype. The levels of VEGF, TGF-β1 and bFGF increased with increasing fiber/poresizes.
Therefore, in this study we have demonstrated that by varying the fiber diameter
and the corresponding pore-size, we can modulate the macrophage phenotype. The study
also shows that electrospun scaffolds of larger fiber/pore-size polarize BMMФs towards a
M2 phenotype.
III.2 Introduction
Tissue engineered biomaterials often induce an inflammatory reaction, also known
as the FBR after in vivo implantation. Upon exposure to implanted biomaterials MФs fuse
into multinucleated giant cells called FBGCs and ultimately lead to fibrous encapsulation.
However, the presence of MФ is also essential for early remodeling processes. The
phenotypic profile of macrophages as M1 or M2 following exposure to the biomaterial can
dictate the downstream processes of remodeling and angiogenesis. These processes are
modulated via “cross-talk” between macrophages and other cells (e.g. endothelial cells) as
well as factors within the local environment. This study aims to gather insight into the
macrophage activity on electrospun PDO by identifying the macrophage phenotype (M1 or
M2). In general, M1s or classically activated MФs are pro-inflammatory and microbicidal,
whereas M2s or alternatively activated MФs are immunomodulatory, reparative, and
poorly microbicidal. The balance of these two phenotypes of MФs plays a critical role in the
phagocytosis of pathogens and bacteria, the clearance of apoptotic cells, and the
remodeling of injured tissues. These activation states of MФs are hypothetical ends of a
spectrum. The actual MФ phenotype is viewed as a continuum of functional states.
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Recently M2s were further divided into M2a, M2b and M2c based on their different
roles in tissue remodeling. M2a phenotype arises in response to IL-4 and IL-13 and these
MФ are associated with Th2 responses. The M2b phenotype is induced by immune
complexes as well as agonists of TLRs or IL-1 receptors and these MФ secrete high amounts
of IL-10 but reduced IL-12. M2c phenotype is induced by IL-10 or glucocorticoids and they
produce elevated levels of IL-10 and TGF-β1 and is associated with immune suppression
and remodeling [3, 13]. In contrast, INF-γ or TNF-α primed MФs are grouped as M1s. These
MФs have decreased phagocytic capability and (FcγR)II expression. M1s secrete proinflammatory cytokines, such as TNF-α, IL-1, IL-6, IL-12, and IL-23, possess antiproliferative functions and induce Th1 responses. In addition, M1s are also crucial in
matrix destruction and tissue reorganization at injured tissues via the production of a
variety of enzymes such as MMPs, collagenase, elastase and hyaluronidase. This allows M1s
to quickly migrate through injured tissues to clear pathogens and debris [3]. Mosser et al.
suggested a spectrum of MФ phenotypes and characterized MФ populations based on three
fundamental homeostatic activities, including host defense, wound healing, and immune
regulation. MФ are grouped into three primary phenotypes: classically activated MФ for
microbicidal activity, wound-healing MФ for tissue repair, and regulatory MФ for antiinflammatory activity [12].
MФ phenotypes exhibit plasticity, meaning that a classically activated M1 can switch
to an alternatively activated M2. Prolonged activation of M1s can lead to tissue injury.
Therefore, after disinfecting and debriding the wound site, the M1s must switch over to
M2s at later stages to facilitate proper tissue remodeling. In a recent study skin biopsies
from human patients were obtained and gene expression was analyzed on early (Day 1-2)
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and late stages (Day 4-8) of cutaneous wound healing. It was observed that the early stage
included a mix of M1 and M2 markers (11 M1 genes and 7 M2 genes) whereas the late
stage expressed predominately M2 markers (1 M1 gene and 9 M2 genes) [17].
Several biomaterial strategies have been used for the modulation of MФ phenotype.
It has been shown that the biologic scaffold can profoundly affect the MФ phenotype.
Uncrosslinked decellularized porcine small intestinal submucosa (SIS) induced a M2
response (CD163+) and showed constructive tissue remodeling after 16 weeks in a rat
model. Whereas, a carbodiimide crosslinked CuffPatch device elicited a M1 response
(CD80+ and CCR7+) leading to chronic inflammation [179]. In another study, it was found
that acellular ECM scaffolds induced a predominately M2 phenotype but cellular ECM
scaffolds supported a M1 phenotype [111].
MФ response to biomaterials is also dependent on their size. It has been shown that
when foreign materials are < 10 µm, MФ can effectively phagocytose them. The process of
phagocytosis leads to the formation of membrane bound phagosomes in the cytoplasm. The
phagosomes fuse with endosomes and lysosomes to form phagolysosomes, which contain
proteolytic and microbicidal substances to kill, digest and degrade the internalized
particles. On encountering larger foreign materials (10-100 µm) that cannot be engulfed by
a single MФ, mutltinucleated MФs or FBGCs are formed by the fusion of multiple MФs.
These FBGCs then phagocytose and digest the foreign materials. When FBGCs encounter
bulk materials that even they cannot effectively engulf, they undergo a process called
“frustrated phagocytosis”. In this process MФs release an array of substances such as
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cytokines, reactive oxygen species and proteolytic enzymes in an attempt to degrade the
implanted materials [1].
The impact of fiber diameter on MФ activation and response has been extensively
studied. In a recent study, MФ (RAW 264.7 cell line) were cultured on electrospun poly(Llactic) (PLLA) scaffolds. The impact of substrate topography of PLLA scaffold on MФs was
studied by comparing a PLLA film to electrospun aligned microfibers, aligned nanofibers,
random microfibers, and random microfibers. The results showed that nanofibrous PLLA
scaffolds (fiber diameter ~ 0.6 µm) minimized the inflammatory response when compared
to films and microfibrous (fiber diameter ~ 1.6 µm) scaffolds. Histological evaluation
demonstrated a higher number of FBGCs on the PLLA film than on the micro- and
nanofibrous scaffolds. The fiber alignment didn’t seem to have an effect on the in vitro MФ
activation and secretion of proinflammatory molecules [180]. In another study, single
polypropylene fibers of diameters ranging from 2.1 to 26.7 µm were implanted in the
subcutaneous dorsum of Sprague-Dawley rats. Results at 5 weeks showed reduced MФ
density and fibrous capsule thickness for small diameter fibers in the range of 2.1 to 6 µm
[181].
The influence of pore-size on the MФ response has also been explored in several
studies. Results have shown that pore dimensions of at least 10 µm are needed to allow
connective tissue ingrowth and to avoid global tissue encapsulation [182]. In another study
it was shown that a pore size range of 0.8-8.0 µm can facilitate neo-vascularization 80-100
fold compared to samples with pores 0.1-0.8 µm or between 8-15 µm [101]. Dr. Ratner and
co-workers fabricated poly (2-hydroxyethyl methacrylate-co-methacrylic acid) (pHEMA-
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co-MAA) hydrogel scaffolds with parallel channels by polymer fiber templating. The cardiac
implantation of these hydrogels with pore diameters of 30-40 µm showed maximum
vascularization and minimal fibrotic response and an increase in the number of M2
phenotype MФs [183].
In this study, bone marrow derived primary MФs (BMMФ) have been used instead
of commercially available cell lines (RAW 264.7, J774A.1 or IC-21). This was done because
the MФ cell lines are not equivalent in maturity or activation potential to primary MФs. A
study done by Chamberlain et al. showed that cytokine expression at the protein level
varied greatly between primary MФs and immortalized cell lines, with primary MФs
initiating stronger and more diverse responses than the cell lines [184].
III.3 Materials and Methods
III.3.1 Electrospinning of PDO Polymer
PDO (Ethicon Inc.) was dissolved in 1,1,1,3,3,3-hexafluoro-2-propanol (TCI
America) in concentrations of 60, 100 and 140 mg/ml. These solutions were then
loaded into a Becton Dickinson syringe (5.0 ml) with an 18 gauge blunt tip needle and
placed in a KD scientific syringe pump to be dispensed at a rate of 6 ml/hr. Solutions
were then electrospun onto a flat rotating stainless steel mandrel (2.5 cm wide × 10.2
cm long × 0.3 cm thick) to produce a flat sheet. All electrospinning was performed at an
applied voltage of 23 kV, while the mandrel was rotated at a rate of 500 rpm and placed
12 cm away from the needle tip. The fiber diameter of the electrospun scaffold was
measured by Image J. The pore-size, porosity and surface area to volume ratio of the
scaffolds was measured using a method described by Soliman et al. [102]. Briefly, 10
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mm disks of the electrospun scaffolds were weighed and subsequently immersed in
ethanol overnight with slight mechanical agitation. This was done to allow the ethanol
to penetrate into the scaffold pores. The surface of the samples was then blotted dry on
a filter paper and weighed once more to determine the mass of the ethanol present
within the scaffold. Measurements were made on five sample disks of each scaffold type.
The density of ethanol is 0.789 g/mL and the density of PDO is 1.34 g/mL.
The porosity (ε) was calculated as:
ε=

VETH
VETH + VPDO

VETH is the volume of the intruded ethanol and was calculated as the ratio
between the observed mass change after intrusion and ρ ETH. VPDO is the volume of PDO
fibers and was calculated as the ratio between the dry scaffold mass before intrusion
and the density of PDO (ρPDO). The pore-radius was calculated from the following
equation:

( )
where ω is the fiber diameter and ε is the scaffold porosity. The surface area to
volume ratio of the scaffolds was calculated using the formulas given by Boland et al.
[137].
Surface area to volume ratio =

L=

2* *rf*L
VPDO

MPDO
ρPDO* *r2

where L is the equivalent fiber length, r f is the average fiber radius.
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III.3.2 Endotoxin Content
The endotoxin content of the electrospun polydioxanone (PDO) was determined by
the Limulus Amebocyte Lysate (LAL) kinetic chromogenic assay (Endochrome-K™, Charles
River) following manufacturer’s protocol. Briefly, 6 mm disks of PDO were incubated in
endotoxin-free distilled water at 37⁰C for 24 h. Absorbed endotoxin was determined after
incubation of the PDO disks in endotoxin-free distilled water at 37⁰C for 60 min with
constant shaking. Afterwards, samples (water) were collected under sterile conditions and
transferred to endotoxin-free tubes. Endotoxin levels were quantified using the LAL kinetic
chromogenic assay at 450 nm [25].
III.3.3 Macrophage Isolation and Cytokine Secretion
Bone marrow derived murine macrophages (BMMΦs) interaction with electrospun
PDO (100 mg/ml, 10 mm discs) and tissue culture plastic (TCP) was evaluated by seeding
500,000 cells in a 48 well plate with or without lipopolysaccharide (LPS, Sigma-Aldrich
L6529) (100 ng/ml). The supernatants were collected after 24 hrs to quantify proinflammatory mediators (TNF-α, IL-6, Nitrite (N02 -)) and wound-healing mediators (VEGF,
TGF-β1 and bFGF) by ELISA. The C57BL/6 mouse strain was used as a source of bone
marrow. Following standard protocol in Dr. Ryan’s lab, the mice were euthanized and the
bone marrow was isolated from the femurs/tibias. To deplete the adherent stromal cells,
the harvested bone marrow was cultured overnight in complete RPMI (with 1% penicillin
and streptomycin, L-glutamine, HEPES, sodium pyruvate, 10% FBS, and 30 ng/ml
recombinant murine MФ-colony stimulating factor (rmM-CSF)). Non-adherent cells were
collected, red blood cells lysed, remaining non-adherent mononuclear cells plated, and
cultured for 7 days in the presence of rmM-CSF. Phenotype uniformity (naïve MФ (M0) vs.
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monocytes) was verified by flow cytometry with our results showing this protocol to
achieve a >96% MAC (CD68+) population. After maturation the BMMФ were divided into
three different groups and stimulated for 48 hrs in the presence of either IL-4 and IL-13 to
polarize BMMФ to a M2 phenotype or INF-γ to polarize the BMMФ to a M1 phenotype. The
INF-γ treated BMMФ were then rinsed with media and treated with LPS for additional 18
hrs. Untreated BMMФs were used as the naïve group (M0s). The morphology of polarized
MФs on TCP is shown in Figure 16. Extensive pseudopodia were observed in M1s
compared to M0s and M2s. In contrast, M2s appeared more rounded. Stimulation with IL-4
and IL-13 produced a mild proliferative effect whereas, stimulation with INF-γ led to an
apoptotic effect.

Figure 16 BMMФ polarization into M1 and M2 phenotypes on TCP.
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III.3.4 Arginase and iNOS Expression
BMMΦs (106 cells) were seeded on TCP (24 well plate) and PDO scaffolds (15 mm
discs) made from varying polymer concentrations (60, 100, and 140 mg/ml). After 24 hrs,
the cell lysates were analyzed for arginase (Arg1) and inducible nitric oxide synthase
(iNOS) expression by western blot. Cell seeded scaffolds were picked up from the well plate
and transferred to a micro-centrifuge tube. The scaffolds were rinsed with PBS and lysed
on ice in 50 µl of lysis buffer consisting of 10mM Tris-Cl, 150mM NaCl, 1mM EDTA, 1%
Triton X-100, 0.5% sodium dexoycholate, 1mM phenylmethyl sulphonylfluoride (PMSF)
and complete protease inhibitor cocktail tablet. The extracts were vortexed vigorously for
3 times at 5 min intervals. The lysates were collected and transferred to a fresh microcentrifuge tube. The lysates were centrifuged and the supernatants were obtained and
stored at -20°C until needed. Protein concentration was determined by the Bradford
method using BioRad’s protein assay reagent. Protein lysates were completely denatured
by boiling in Lammeli sample buffer for 10 mins and subjected to SDS-PAGE. The proteins
separated in the gel were transferred to a nitrocellulose membrane. The membrane was
blocked with 5% nonfat dry milk in Tris –buffered saline containing 1% Tween 20 (TBST).
The membrane was then washed four times with TBST and incubated in the primary
antibody solution (containing 5% BSA) overnight at 4°C. The membrane was washed again
four times in TBST and incubated in HRP-conjugated secondary IgG antibody-diluted
solution (in 5% non-fat dry milk) for 1h at room temperature. After the membrane is
thoroughly washed with TBST four times, chemiluminescense was detected using the ECL
western blotting detection reagent. The antibodies used in this study are Arginase I
(Abcam, ab91279, dilution 1:3000) and iNOS (Abcam, ab15323, dilution 1:2500).
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III.3.4 Comparison of fiber diameter vs. pore-size in BMMФ phenotype modulation
In order to investigate which property of the PDO scaffolds plays a more
important role in BMMФ phenotype modulation, the 60 mg/ml PDO scaffolds were
made more porous and the 140 mg/ml PDO scaffolds were made less porous without
significantly changing their fiber diameter. The 60 mg/ml PDO scaffold was made more
porous using a method described by McClure et al., called air-flow impedance
electrospinning. PDO (60 mg/ml) was loaded into a 3 mL plastic Becton Dickinson
syringe with an 18 gauge tip needle and dispensed at a rate of 6 ml/h. The needle tip
was subjected to +25kV with an air gap distance of 20 cm between the needle and the
mandrel. Perforated mandrel contained 0.75 mm diameter holes laterally spaced 2.0
mm center to center distance, while the center to center longitudnal distance was 1.50
mm. The perforated mandrel was subjected to an air pressure of 100 kPa. On one end of
the perforated mandrel, a lure lock was fitted and taped to the perforated mandrel
using electrical tape. On the other end, a 3 mm diameter solid mandrel was inserted into
the perforated mandrel and taped in place. The setup is depicted in Figure 17 [109].
The 140 mg/ml PDO scaffold was made less porous by compressing the scaffolds.
Briefly, PDO scaffold of 140 mg/ml was cut into flat rectangular sheets carefully
avoiding any raised edges. The sheets were then placed in between two flat stainless
steel blocks. This assembly was compressed to 5000 psi using a mechanical hydraulic
press (Carver, Inc. Wabash, IN) and the pressure was held for one minute. This method
of compression collapsed the pores in the scaffold. This led to a decrease in the pore size of the scaffold from 14 µm to 9 µm without severely impacting the fiber diameter.
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Figure 17 (A) Perforated mandrel used for electrospinning, (B) mandrel set up with air line
connected [109].
BMMФs (106) were seeded on 12 mm disks of 60 mg/ml PDO scaffolds
electrospun on solid and air-flow impedance impedance mandrels as well as on regular
and compressed 140 mg/ml PDO scaffolds , in a 48 well plate. The BMMФs were seeded
on these scaffolds as pre-polarized M2s as described previously. Cell culture lysates
were collected after 24 hours and analyzed for Arg1 expression.

III.3.5 Statistical Analysis
Data expressed in this chapter is in the format of means ± standard deviation. Each
experiment was done in triplicates and was reproduced at least twice. All statistical
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with
JMP®IN 8 statistical software (SAS Institute). P<0.05 was considered significantly different.
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III.4 Results
Iii.4.1 Electrospun PDO Properties
It was observed that by increasing the polymer concentration of PDO, electrospun
scaffolds of varying properties are obtained (Figure 18). Increasing the polymer
concentration led to a linear increase in the fiber diameters, pore-sizes and porosity but
decreased the surface area to volume ratio. The statistical differences were only observed
in the case of 60 mg/ml and 140 mg/ml scaffolds. The properties of 100 mg/ml and 140
mg/ml scaffolds were not statistically different from one another. It was also noted that the
60 mg/ml scaffold showed beaded fibers but this was not observed with 100 and 140
mg/ml scaffolds that showed smooth continuous fibers. It should also be noted that above
140 mg/ml, the polymer solution becomes too viscous and the scaffolds cannot be
reproducibly electrospun leading to inconsistency in data.

60 mg/ml

Concentration
(mg/ml)

100 mg/ml

Pore
Radius
(μm)

60

0.96 ± 0.09

100
140

10.57 ± 0.72
14.73 ± 0.62

140 mg/ml

Fiber
Diameter
(μm)

0.35 ± 0.2
2.2 ± 0.1
2.8 ± 0.5

Surface
Area to
Volume
Ratio
(m2/cm3)
11.4
1.8
1.4

Porosity
(%)

69.4 ± 2.33
81.16 ± 1.13
82.67 ± 0.703

Figure 18 Properties of PDO scaffolds electrospun from different concentrations.
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III.4.2 Endotoxin Content
Before proceeding with any experiments, we made sure that our PDO scaffolds were
not contaminated with bacteria. Since the most common source of bacterial contamination
is endotoxin, we determined its levels in our scaffolds. The values for endotoxin content
ranged from 0.03 – 0.09 EU/ml. Therefore, the highest endotoxin level for any scaffold was
at least 12,000 times lower than the lowest amount used to activate BMMΦs (100 ng/ml of
LPS corresponding to 1100 EU/ml) and well below the acceptable U.S. Pharmacopeia
standard for clinical applications (<0.25 EU/ml). This study indicated that the PDO
materials used in this study were endotoxin free.
III.4.3 Histological Evaluation
The histological evaluation (H&E staining) of PDO scaffolds showed greater BMMФ
(M0s and M2s) infiltration into the fibrous structures of larger fiber/pore-size scaffold
(Figure 19). BMMФ infiltration was quantified using Image J. As expected, the results
showed that with increasing fiber/pore-sizes, BMMФ infiltration of the scaffold crosssectional area for M0s and M2s increased linearly. The M0s and M2s in the case of small
fiber/pore-size PDO (60 mg/ml) scaffold were found concentrated at the surface. The
BMMФ infiltration was statistically higher in the large fiber/pore-size scaffold (140 mg/ml)
when compared to the 60 mg/ml scaffold. However, an unexpected result was observed in
BMMФ of the M1 phenotype. In the case of M1s, greater infiltration was observed on the 60
mg/ml. This observation might be attributed to the release of MMPs and other matrix
degrading proteolytic enzymes (such as collagenase, elastase and hylauronidase) secreted
by the M1 phenotype macrophages [3]. It is known that M1s make their way into tissue by
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degrading and destroying it in an attempt to clear the tissue of pathogens and debris.
Therefore, prolonged activation of M1s in the absence of M2s leads to tissue injury.
III.4.4 Arginase and iNOS Expression
The results indicated a correlation between Arg1 expression and increasing
fiber/pore-sizes in all BMMФ groups (M0, M1 and M2) on Day 1 (Figure 20). The
expression of iNOS decreased with increasing fiber/pore-sizes. Three pieces of data emerge
from these results: (1) These results indicate that the larger fiber/pore-sizes (140 mg/ml
PDO scaffold, 14 µm pore-size) polarize towards an M2 phenotype in naïve BMMФ (M0s).
(2) The larger fiber/pore-sizes are able to induce statistically higher Arg1 expression and
downregulate iNOS in M1 pre-polarized BMMФ (3) The pre-polarized M2 BMMФs induce
statistically higher Arg1 expression on the large fiber/pore-sizes on Day 1.
On Day 3, it was observed that M0s were unable to maintain Arg1 expression
(Figure 21). However, M1 and M2s were able to maintain Arg1 expression. Just like day 1,
the larger fiber/pore-sizes induced statistically higher Arg1 by M1s on Day 3 as well. The
Arg1 expression level by M2s was maintained on the large fiber/pore-size. It was also
observed that the M2s on the small fiber/pore-size PDO increased their Arg1 production on
Day 3 compared to Day 1. The expression of iNOS was totally abolished by Day 3 on all
fiber/pore-sizes of PDO. In the previous study, we have demonstrated that larger
fiber/pore-sizes allow increased M0 and M2 phenotype BMMΦ infiltration of the scaffold,
when compared to smaller fiber/pore-sizes.
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Figure 19 Histological evaluation of BMMФ infiltration into the fibrous structures of PDO.
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Figure 20 Arginase and iNOS expression by BMMФs on Day 1.
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Figure 21 Arginase and iNOS Expression Analysis on Day 3.
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Additionally, the ease of migration through the bigger pore-size material combined
with their orientation in the 3D space of the scaffold nanostructure may have a role to play
in the observed shift of BMMФ towards a M2 phenotype. In contrast, the BMMФ in case of
the 100 mg/ml scaffold are spatially confined. In case of the 60 mg/ml scaffold, the BMMФ
are concentrated at the surface likely undergoing frustrated phagocytosis. This may have a
role to play in pushing the BMMФs towards a M1 phenotype on the 60 mg/ml and 100
mg/ml scaffold. The M1s invade deeper into the 60 mg/ml scaffold but they probably do it
by causing tissue injury through MMPs. This could be the reason why these M1s are unable
to shift to an M2 phenotype.
III.4.5 BMMΦ Mediator Secretion
The production of cytokines and growth factors characteristic of both M1 and M2
phenotypes were quantified on Day 1 and 3. The level of Nitrite (NO2-, M1 phenotype)
production was measured by the Griess Assay (Promega). All ELISA kits were purchased
from Peprotech except for bFGF (Abcam) and TGF-β1 (R&D systems). The levels of TNF-α,
IL-6 (indicative of M1 phenoype) and growth factors associated with the M2 phenotype
(VEGF, bFGF, TGF-β1) were measured by ELISA. The levels of all cytokines and growth
factors were normalized to the total protein content. The results showed that PDO is a
potent activator of BMMΦs, characterized by the secretion of both pro-inflammatory (M1)
and wound healing (M2) mediators.
The production of Nitrite (NO2-) is shown in Figure 22. Nitrite is a product of
Arginine metabolism by iNOS. The levels of nitrite are often used in the literature as a
measure of iNOS activity. As seen in Figure 22, the highest levels of nitrite were produced
by M1s on Day 1. The levels were found to be much lower on Day 3 compared to Day 1. The
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level of nitrite was downregulated in M1s cultured on the larger fiber/pore-size PDO on
both Day 1 and Day 3.
The levels of TNF-α are shown in Figure 23. The highest levels of TNF-α were
produced from the M1 phenotype BMMФ (~ 300 times greater compared to M0s and M2s).
The levels of TNF-α were not found to be significantly different between PDO scaffolds of
different fiber/pore-sizes. The levels were decreased on Day 3 and trended lower on the
140 mg/ml scaffold while still remaining statistically not significant compared to the 60
mg/ml scaffold.
The quantification of IL-6 cytokine is shown in Figure 24. The levels of IL-6 were
also produced in highest quantities by M1 phenotype BMMФs. Just like TNF-α, the levels of
IL-6 could not be downregulated by the large fiber/pore-size PDO. The levels remained
fairly constant across different fiber/pore-sizes on both Day 1 and 3.
The levels of VEGF by BMMФ are shown in Figure 25. Similar levels of VEGF were
produced from M1 and M2 BMMФs and were found to be higher than M0s. In the case of
M0s, the production of VEGF was significantly higher on the larger fiber/pore-size PDO.
Continuing to look at M0s, it was observed that compared to Day 1, the level of VEGF on the
60 mg/ml scaffold were much lower on Day 3 indicating that the 60 mg/ml scaffold is
unable to maintain the expression of VEGF. In contrast, the level of VEGF on the 140 mg/ml
scaffold increased on Day 3 compared to Day 1 indicating sustained expression of VEGF on
the 140 mg/ml scaffold. In the case of M1s and M2s, no differences with respect to
fiber/pore-sizes were noted.
The cell culture supernatants were acid-activated as per manufacturer’s instructions
prior to the TGF-β1 ELISA. Comparable levels of TGF-β1 were produced by all three BMMФ
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phenotypes; M0s, M1s and M2s. The TGF-β1 expression was maintained until Day 3. The
levels of TGF-β1 increased with increasing fiber/pore-sizes in M0s, M1s and M2s. The
production of TGF-β1 was statistically higher on the 140 mg/ml scaffold compared to the
60 mg/ml scaffold on Day 1 in the case of M0s and on both Day 1 and 3 in the case of M1s
and M2s.
The quantification of bFGF is shown in Figure 27. Just like the two other angiogenic
growth factors (VEGF and TGF-β1), bFGF was also produced in comparable amounts by
BMMФ of all three phenotypes; M0s, M1s and M2s. The production of bFGF was statistically
higher on the 140 mg/ml scaffold compared to the 60 mg/ml scaffold on Day 1 in the case
of M0s and M1s and on Day 3 in the case of M2s.
The expression of two chemokines: Macrophage inflammatory factor -1 alpha (MIP1α) (Figure 28) and Macrophage chemotactic protein (MCP-1) (Figure 29) was also
analyzed by ELISA. The levels of MIP-1α were much higher in M0s compared to M1s and
M2s. The production of MIP-1α was statistically higher on the larger fiber/pore-size
scaffold (140 mg/ml) compared to the 60 mg/ml scaffold in the case of M0s, M1s and M2s.
The levels of MCP-1 were statistically higher on the 140 mg/ml PDO scaffold compared to
the 60 mg/ml scaffold in the case of M1s on Day 1.
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Figure 22 Expression of Nitrite by BMMФs indicating an M1 phenotype. The asterisk ‘*’
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 23 Expression of TNF-alpha by BMMФs indicating a M1 phenotype.
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Figure 24 Production of IL-6 by macrophages. The asterisk ‘*’ indicates a statistical
difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 25 Expression of VEGF by BMMФs indicating a M2 phenotype. The asterisk ‘*’
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 26 Production of TGF-beta1 by BMMФs indicating a M2 phenotype. The asterisk ‘*’
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 27 Expression of bFGF by BMMФs indicating a M2 phenotype. The asterisk ‘*’
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 28 Production of MIP-1alpha by BMMФs indicating either a M1 or M2 phenotype.
The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml and the 140 mg/ml
scaffold.
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Figure 29 Production of MCP-1 by BMMФs indicating either a M1 or M2 phenotype. The
asterisk ‘*’ indicates a statistical difference between the 60 mg/ml and the 140 mg/ml
scaffold.
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III.4.6 Comparison of fiber diameter vs. pore-size in BMMФ phenotype modulation
During the electrospinning process, as fibers are deposited onto the perforated
mandrel, pressurized air emanating from the mandrel perforations is introduced into the
developing fibrous structure causing the fibers near the mandrel perforations to be less
dense, creating regions of increased scaffold porosity. In contrast, fibers deposited on
solid, non-perforated sections of the mandrel (e.g. located between and adjacent to the
perforations) are, in comparison, densely packed. The scaffold thus contains regions in
which the fibers are porous and regions in which the fibers are densely packed, all within a
single contiguous, seamless structure prepared during a single deposition event, thus not
requiring multiple deposition steps and/or processing steps [109]. The properties of
scaffolds created on solid vs. perforated mandrels are shown in Figure 30. The air-flow
impedance method created a statistically significant increase in the pore-size and porosity
of the scaffold but did not impact the fiber-diameter and the surface area to volume ratio.
BMMФ were seeded on the 60 mg/ml PDO scaffolds (12 mm disks) created by
traditional and air-flow impedance electrospinning methods at a density of 106 cells/well
in a 48 well plate as pre-polarized M2s as described previously. The cell lysates were
collected after 24 hours and analyzed by western blot for Arg1 expression. The analysis is
shown in Figure 31. Compared to the solid mandrel, the air flow mandrel showed higher
expression of Arg1 on M2s. The result corroborates our theory that bigger pore-size leads
to a M2 phenotype.
The 140 mg/ml PDO scaffold that was compressed had a pore-size of 9 µm
compared to the normal 140 mg/ml PDO scaffold, which had a pore-size of 14 µm. The
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overall porosity of the compressed scaffold also decreased significantly. The method of
compression did not fuse the fibers but did flatten them out to some extent. This led to a
slight increase in the overall fiber diameter as shown in Figure 32. The Arg1 expression by
M2s was reduced on the compressed 140 mg/ml scaffold compared to the normal 140
mg/ml scaffold. This result shows that pore-size is a more crucial regulator of Arg1
expression. However, since the results were not significantly different from each other, it
might indicate a role for the fiber-diameter in the modulation of Arg1 expression as well.

Figure 30 Comparison of 60 mg/ml PDO scaffolds electrospun on the solid vs. air flow
impedance mandrel. The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml
and the 140 mg/ml scaffold.

88

Figure 31 Arginase expression by M2s on 60 mg/ml scaffold electrospun on solid vs. air
flow impedance mandrel. The asterisk ‘*’ indicates a statistical difference between the 60
mg/ml and the 140 mg/ml scaffold.
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Figure 32 Comparison of Normal vs. Compressed 140 mg/ml PDO scaffold. The asterisk ‘*’
indicates a statistical difference between the 60 mg/ml and the 140 mg/ml scaffold.
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Figure 33 Expression of Arg1 by M2s on normal and compressed 140 mg/ml PDO scaffolds.
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III.5 Discussion
The present study examined the effects of fiber/pore-size of a scaffold on MФ
polarization. The study also examined the relationship between MФ polarization. The
results of this study demonstrate that increase in the fiber/pore-size shifts the MФ
phenotype to a more M2, tissue regenerative phenotype in vitro. This shift to an M2
phenotype has been demonstrated in this study by increased Arg1, TGF-β1, VEGF, bFGF
expression and decreased iNOS and N02- expression.
The activation states of MФ are hypothetical ends of a spectrum. The actual MФ
phenotype is viewed as a continuum of functional states. In the literature M2s have been
classified into 3 main groups: M2a, M2b and M2c. M2a phenotype is induced by IL-4 and IL13 and they produce high amounts of anti-inflammatory cytokines and enzymes such as
Arg1, FIZZ1 and RELM-1α. The M2b phenotype is induced by immune complexes as well as
agonists of TLRs or IL-1 receptors and these MФ secrete high amounts of IL-10 but reduced
IL-12. M2c phenotype is induced by IL-10 or glucocorticoids and they produce elevated
levels of IL-10 and TGF-β1. We wanted to select an M2 phenotype that can function most
effectively at tissue remodelling and angiogenesis. The production of VEGF by BMMФ on
TCP in response to IL-4 combined with IL-10 and IL-13 is shown in Figure 34. IL-4 was
chosen as an M2 phenotype inducer because it is known to activate MФ to produce
arginase, fibronectin and other matrix proteins such as βIG-H3 and facilitates tissue
remodelling and organization. The highest amount of VEGF was produced by BMMФ after
treatment with both IL-4 and IL-13. Th2 cytokines, IL-4 and IL-13 are structurally similar
and share a functional signalling receptor chain. It has been shown in a previous study that
VEGF enhances IL-13 expression in the airways, suggesting a positive feedback loop with
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VEGF enhancing Th2 sensitization and inflammation and IL-13 subsequently enhancing
VEGF production [185].
The production of MCP-1 and MIP-1α was significantly higher by M0s on 140 mg/ml
scaffold when compared to M1s and M2s. Whether these chemokines fall under the M1 or
the M2 phenotype category is not clearly known in the literature. Several studies have
associated MCP-1 with Th2 or M2 macrophage phenotype responses [17, 186, 187]. It has
been shown by Varin et al. that IL-4 inhibits MCP-1 [188]. Whereas, Martinez and Gordon
documented that IL-4 induces MCP-1 [9]. Several studies have also classified MIP-1α as
pro-inflammatory [180, 189]. In another study it was documented that MIP-1α is involved
in chemotaxis and recruitment of monocytes and leukocytes during the initial
inflammatory response, followed by a transition towards pro-wound healing activity [190].
Mantovani et al. and Schutte et al. classified both MIP-1α and MCP-1 as indicators of M1
macrophage phenotype [13, 191]. It has been shown that MCP-1 recruits fibroblasts, MФs,
endothelial cells and smooth muscle cells in vitro in cell migration assays and in vivo in
murine carotid aneurysms. The same study also showed that MCP-1 mediated vascular
inflammatory repair occurs via a MIP-1α and MIP-2 dependent pathway. Blocking MIP-1α
and MIP-2 caused a significant decrease in MCP-1 mediated intra-aneurysmal tissue
healing [192]. It has also been shown that MCP-1 can stimulate IL-4 production and MCP-1
deficient mice are unable to mount Th2 responses [186]. There is also evidence for an
essential pathogenic and inflammatory role for MCP-1, in which it is required for the
accumulation of MФ. In another study, wound healing in MIP-1α and MCP-1 knockout mice
was examined. It was found that wound re-epithelialization, angiogenesis and collagen
synthesis in MIP-1α deficient mice was nearly identical to the WT controls. In contrast,
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MCP-1 deficient mice displayed significantly delayed wound re-epithelialization,
angiogenesis and collagen synthesis. Surprisingly, no change in the number of wound MФ
was observed in the MCP-1 deficient mice, suggesting that monocyte recruitment into the
wounds is independent of this chemokine [164]. In the light of this evidence, we would
classify these chemokines at the cross-roads between M1s and M2s.
The morphology of naïve (M0) and polarized MФs (M1 and M2) on electrospun PDO
(100 mg/ml) is shown in Figure 35. It was observed that both M0s and M2s were spread
out and interacting with fibers. In contrast to M0s and M2s, that had acquired a flattened
shape on the scaffold, the M1s assumed a more rounded morphology. This rounded
morphology could be due to the propensity for M1s to invade the matrix to destroy
pathogens and debris. The rounded morphology probably enables them to squeeze through
the pores in the scaffold and migrate into its structure.

Figure 34 Production of VEGF from M2/Th2 associated cytokines. The asterisk ‘*’ indicates
a statistical difference.
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There were several limitations in the present study. A limited number of cytokines
and surface markers were utilized for the characterization of the M1/M2 profile of the
BMMФ. It is also recognized that species variations do exist. The markers chosen in this
study (iNOS and Arg1) have been widely used as markers of M1 and M2 polarization in
several studies. Care must be taken when extrapolating these studies to human MФs. In
contrast to murine MФs, which can simply be identified by their ability to produce NO,
human monocyte-derived MФs do not generate NO in response to classical activating
stimuli. Therefore, human MФs must be identified by other criteria, including the
upregulation of surface molecules such as major histocompatibility complex (MHC) Class II,
co-stimulatory molecule CD86 and opsonic receptors [e.g., FcRIII (CD16)], enhanced ability
to kill and degrade intracellular microorganism and the elevated capability to process and
present antigens [3].
The 60 mg/ml scaffolds and 140 mg/ml scaffolds differ remarkably in both poresize and fiber diameter. The results show that BMMФ are polarized towards a more M2-like
phenotype on the 140 mg/ml scaffold. However, it is not known whether this result is
because of the fiber diameter or the pore-size. To investigate this we made our 60 mg/ml
scaffold more porous by electrospinning it using the air-flow impedance method. Using this
method the fiber diameter stayed the same but the pore-size and the overall porosity of the
scaffold improved. The results showed higher Arg1 expression in M2s on the 60 mg/ml
scaffold created by the air-flow impedance method compared to the 60 mg/ml scaffold
created on the solid mandrel created by traditional electrospinning. This result indicates
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that pore-size might be playing a greater role compared to fiber diameter in BMMФ
phenotype modulation.

Figure 35 BMMФ morphology on electrospun PDO (100 mg/ml). (A) M0s (B) M1s (C) M2s
(D) zoomed in view of a M2.

The 140 mg/ml PDO scaffold was made less porous by compressing it using a
hydraulic press. The Arg1 expression by M2s was reduced on the compressed 140 mg/ml
scaffold compared to the normal 140 mg/ml scaffold. This result also showed that poresize is a more crucial regulator of Arg1 expression and BMMФ phenotype modulation.
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III.6 Conclusion
In this study we have demonstrated that by varying the fiber diameter and the
corresponding pore-size, we can modulate the BMMФ phenotype. Electrospun PDO
scaffolds of larger fiber/pore-sizes upregulated Arg1 expression and downregulated iNOS
and nitrite expression in BMMФ.

In contrast, electrospun PDO scaffolds of smaller

fiber/pore-sizes upregulated iNOS and nitrite expression but not Arg1. The production of
angiogenic growth factors such as VEGF, TGF-β1 and bFGF from BMMФ was also greater on
the larger fiber/pore-size PDO scaffolds. These results indicate that fiber/pore-size can
influence the phenotype of BMMФ and that larger fiber/pore-size is capable of polarizing
BMMФ towards a M2 phenotype. It was also observed that differences in fiber/pore-size of
materials cannot modulate the expression of pro-inflammatory cytokines such as TNF-α
and IL-6. The results showed higher Arg1 expression in M2s on the 60 mg/ml scaffold
created by the air-flow impedance method compared to the 60 mg/ml scaffold created on
the solid mandrel created by traditional electrospinning. The Arg1 expression was reduced
on the compressed 140 mg/ml PDO scaffold compared to the normal 140 mg/ml scaffold.
This result indicates that pore-size might be playing a greater role compared to fiber
diameter in BMMФ phenotype modulation.
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IV.1 Abstract
In order to assess the angiogenic potential of BMMΦs cultured on PDO scaffolds, a
previously described 3D angiogenesis bead assay was performed using conditioned media
from the BMMΦ:PDO interaction [110]. Cytodex beads were coated with mouse endothelial
cells and embedded in collagen gels in a 24 well plate. The supernatants from BMMФs (M0,
M1 and M2) cultured on 12 mm disks on 60, 100 and 140 mg/ml PDO scaffolds were added
on top of the collagen gels. The endothelial cells were allowed to form sprouts in the
collagen gels for a period of 6 days. VEGF (20 ng/ml) was used as positive control in the
study. The results of the 3D angiogenesis bead assay showed that the conditioned media
from BMMФ of M0 and M2 phenotypes cultured on the bigger fiber/pore-size PDO scaffold
(140 mg/ml) induced significantly larger average length of sprout. The conditioned media
from BMMФ of M0, M1, and M2 phenotypes cultured on the bigger fiber/pore-size PDO
scaffold induced significantly higher percentage density of sprouts. These results
demonstrate that the M2 phenotype BMMФs cultured on the larger fiber/pore-size PDO
scaffold are functional and are capable of supporting angiogenesis in the right
microenvironment. The study further confirms that the naïve (M0s) and pre-polarized M1
BMMФs behave like M2s in phenotype (shown by arginase and angiogenic growth factor
expression in Chapter III) and function when cultured on the 140 mg/ml scaffold.
IV.2 Introduction
Angiogenesis is associated with degradation and reformation of the vascular
basement membrane (VBM). In response to growth factors and matrix metalloproteinases
(MMPs), the VBM undergoes degradative and structural changes. This transition from

99

mature VBM to provisional matrix promotes the proliferation and migration of vascular
endothelial cells. Growth factors, such as vascular endothelial growth factor (VEGF), basic
fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF), are released
from the VBM, and are also produced by tumour cells, fibroblasts and immune cells. This
induces formation of an intermediate, and then a new (mature) VBM. Endothelial cells
assemble as solid cords that eventually acquire a lumen. Together with the vascular
endothelial cells and pericytes, the VBM mediates formation of a new blood vessel [28].
Endothelial cell differentiation (i.e. lumen or tube formation) can be studied in vitro
both in two dimensions and in three dimensions. Endothelial cells cultured on plates
coated with matrix proteins such as Matrigel (a matrix scaffold that incorporates
extracellular matrix and basement membrane proteins), collagen, or fibrin can be induced
to differentiate and lend themselves to a common model of in vitro angiogenesis [193].
However, it has been shown in several studies that in order to mimic the in vivo features of
both cell morphological phenotype and gene expression profile, 3D culturing models
should be used [194, 195]. In this angiogenesis study, we used a 3D collagen gel as a matrix
to facilitate sprouting from endothelial cells. It has been shown in previous studies that
matrix stiffness has an inverse relationship with angiogenesis. Less rigid matrices (such as
fibrin or matrigel) promote better blood vessel formation in vitro compared to stiffer
matrices such as collagen. We observed that plain cRPMI media with 10% FBS was capable
of inducing sprouts from endothelial cell coated beads in a fibrin gel. This was not observed
in the case of collagen gels. In order to avoid background issues with fibrin gels, we decided
to pursue this assay with collagen gels. Also, the main aim of this study is to design a
vascular graft. We are mainly interested in applying the understanding and control of
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angiogenic processes to promoting vascular healing after arterial injury. Collagen is an
abundant protein of the native blood vessel and so using collagen gels for this angiogenesis
study is a better model for our overall aim of designing a vascular graft compared to fibrin
[196-198].
IV.3 Materials and Methods
IV.3.1 Three Dimensional (3D) Angiogenesis Assay
In order to assess the angiogenic potential of these M2 polarized BMMΦs, a 3D
angiogenesis bead assay was performed following the method described by Chen et al.
[110] using conditioned media from the non-stimulated BMMΦ:PDO interaction. The
BMMФ were isolated from the bone marrow of C57BL/6 mice as described in chapter
III. The BMMФ were seeded on 15 mm disks of PDO scaffolds electrospun at 60, 100 and
140 mg/ml in a 24 well plate at a density of a 10 6 cells/ml. The cell culture supernatants
were collected on Day 1 and 3. The dry Cytodex 3 microcarriers (Sigma Aldrich) were
hydrated and autoclaved. Approximately 6 million mouse endothelial cells (ECs, ATCC)
from a confluent T175 flask (passage 5) were mixed with Cytodex beads (~9000) in 25
ml of Endothelial growth media (DMEM high glucose with 10% FBS, 1% P/S) media in a
50 ml centrifuge tube. This mixture of EC and beads was incubated at 5% CO2 and 37°C
for 4-5 hours. The centrifuge tube was agitated every 30 mins to avoid clumping of the
bead-cell suspension and to ensure uniform coating. The mixture was then removed
from the centrifuge tube and placed in a T-25 flask. The mixture in the T-25 flask was
then incubated overnight to allow the cells that were not attached to the beads to attach
to the flask. The next morning the beads were washed in Ca 2+ and Mg2+ free PBS. The
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media and the beads from the T-25 flask were transferred to a sterilized 50 ml
centrifuge tube. The beads were then allowed to settle to the bottom of the centrifuge
tube. As soon as the beads had settled, it was important to remove the medium quickly
before the floating debris settled. After the medium was removed, 10 ml of Ca 2+ and
Mg2+ free PBS was gently added into the centrifuge tube to repeat the wash procedure.
A collagen solution was prepared by combining eight volumes of cold collagen type I (3
mg/ml, Sigma-Aldrich) with one volume of 10x PBS and one volume of sodium
hydroxide (0.1N). The EC coated beads were suspended in this collagen solution and
added to a 24 well plate (500 µL/well). The plates were incubated at 37°C and 5% CO 2
for 15 min to allow collagen gel formation. The EC coated beads were cultured in 500 µL
of either BMMФ: PDO conditioned media, EGM with 3% FBS (negative control) or EGM
with 20 ng/ml VEGF (positive control).
IV.3.2 Quantification of Angiogenesis
Each well containing the EC coated bead was digitally photographed under
inverted microscopy at Day 6. A special grid (Figure 36) made by dividing a circle with
radially oriented lines around 360 degrees with 10 degree intervals was used to
quantify the percentage density of sprouts. This grid has been used in a previous study
to quantify the migration of sprouts in the 3D matrix [199]. The digital photographs
were transparently overlaid with the grid in Adobe Photoshop. The number of grid
spaces with sprouts are counted and divided with the total number of grid spaces. The
length of the sprout was calculated using the Image J software (NIH). The length of
sprout was measured from the surface of the bead using the segmented line tool in the
Image J software. A sprout was defined as a structure originating from the microcarrier
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bead surface that was > 45 µm in length.

Figure 36 Grid for quantification of angiogenesis (left) and diagram showing how the
length of sprout was calculated.
IV.3.3 Statistical Analysis
Data expressed in this chapter is in the format of means ± standard deviation. Each
experiment was done in triplicates and was reproduced at least twice. All statistical
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with
JMP®IN 8 statistical software (SAS Institute).
IV.4 Results
The results of the 3D bead assay are shown in Figure 37. A representative image of
each condition done in triplicate is shown. In all cases (M0s, M1s and M2s), the images
showed greater sprouting from the conditioned media from BMMФ cultured on the larger
fiber/pore-size PDO. Angiogenesis was measured by quantification of the average sprout
length and the percentage density (Figure 38). The average sprout length induced by M0s
on the larger fiber/pore-size (140 mg/ml) was statistically higher when compared to
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smaller fiber/pore-sizes (100 mg/ml and 60 mg/ml PDO scaffolds). No sprouting was
observed from the conditioned media of M0s cultured on the 60 mg/ml scaffold. The sprout
length in the case of M0s cultured on the 140 mg/ml scaffold was statistically higher than
all other samples tested except for the M2s cultured on the 140 mg/ml scaffold. This result
shows that a naïve BMMФ (M0) cultured on the 140 mg/ml scaffold is as angiogenic as a
pre-polarized M2. The sprout lengths induced by M1s were not different across different
fiber/pore-sizes. In the case of M2s, the sprout length induced by the conditioned media
from 140 mg/ml scaffold was statistically higher compared to the 60 mg/ml scaffold.
Overall it was observed that M0s induced a ~200 fold higher and M2s induced a ~2 fold
higher length of sprout from the 140 mg/ml compared to the 60 mg/ml PDO scaffolds.
The quantification of the percentage density of sprouts is shown in Figure 34
(bottom). It was observed that significantly higher density of sprouts was induced by
BMMФs (M0s, M1s and M2s) cultured on the larger fiber/pore-sizes. Compared to the 60
mg/ml scaffolds, the 140 mg/ml scaffolds induced a 94 fold higher density of sprouts from
M0s, 7 fold higher density of sprouts from M1s and 17 fold higher density of sprouts from
M2s. Therefore, these studies show that the larger fiber/pore-size PDO scaffold has greater
potential for BMMФ mediated angiogenesis compared to the 60 mg/ml scaffold.
The positive control used in this assay was 20 ng/ml VEGF. It should be noted that
BMMФ conditioned media (especially in the case of 140 mg/ml scaffold) produced greater
average length of sprouts and higher percentage density of sprouts compared to the
positive control. This can be attributed to the fact that BMMФ conditioned media contains a
lot of growth factors besides VEGF (such as TGF-β1 and bFGF) which also play very crucial
roles in the process of angiogenesis. Therefore, it is not surprising that their combined
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effects produced greater sprouting in terms of sprout length and density. The histograms
for all the measurements of the sprout lengths are shown in Figure 39. These histograms
were generated using MATLAB® R2011a. The dfittool of MATLAB® was used to fit a
‘gamma’ distribution to the data. It can be clearly seen that the 140 mg/ml has the highest
sprout length across all the groups of BMMФ tested (i.e. M0, M1 and M2).
IV.5 Conclusion
The assay showed the potential for PDO scaffolds to support MФ mediated
angiogenesis. The conditioned media from BMMФ:PDO interaction was capable of inducing
sprouts in the 3D angiogenesis assay. It was observed that the BMMФ of M0, M1 and M2
phenotypes cultured on the PDO scaffolds with bigger fiber/pore-size induced higher
percentage density of sprouts. However, the conditioned media from BMMФ of only M0
and M2 phenotypes cultured on the bigger fiber/pore-size PDO scaffold (140 mg/ml)
induced significantly larger average length of sprout. Overall, the study confirms that the
BMMФs of M2 phenotype are functional and support angiogenesis and that the naïve
BMMФs acquire a functional M2-like phenotype when in contact with the bigger
fiber/pore-size scaffold.
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Figure 37 Sprouting from endothelial cell coated beads in response to conditioned media
from BMMФ and PDO interaction (magnification 10x).
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Figure 38 (Top) Quantified Average length of sprouts from the BMMФ conditioned media.
(Bottom) Quantified Percentage density of sprouts from BMMФ conditioned media.
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Figure 39 Density histograms of the measured sprout lengths.
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V.1 Abstract
Toll-like receptors (TLRs) have been well recognized for their pivotal role in the
detection of pathogen associated molecular patterns (PAMPs). Twelve TLRs, each detecting
a distinct set of PAMPs, have been identified in mammals. TLR signaling is mostly MyD88
dependent except for TLR3 signaling, which requires a TRIF adaptor. In the previous
chapters, we have shown that BMMФs acquire different phenotypes on small vs. large
fiber/pore-size materials. In this study we sought to investigate if they signal these
responses via different mechanisms. We decided to assess TLR4 and MyD88 as potential
candidates. BMMФs were isolated from TLR 4 and MyD88 knock-out mice and compared to
BMMФs from WT mice. BMMФs were cultured on 60 mg/ml and 140 mg/ml PDO scaffolds
in three different conditions: M0s (naïve), M1 (classically activated) and M2 (alternatively
activated). The Arginase and iNOS expression of WT and TLR4 or MyD88 knockout mice
was compared by western blot. No significant differences between 60 mg/ml and 140
mg/ml scaffolds were observed in the case of TLR4 deficient and WT BMMФs. However,
severely impaired iNOS and Arginase expression was observed in the case of MyD88
deficient M1 BMMФs on the 140 mg/ml scaffold. This result indicates a potential role for
MyD88 in regulating the signaling mechanisms for BMMФs of M1 phenotype on the large
vs. small fiber/pore-size PDO scaffold.
V.2 Introduction
The mammalian TLRs are germline-encoded receptors expressed by the cells of the
innate immune system. They recognize specific patterns of microbial components that are
conserved among pathogens, but are not found in mammals. These patterns
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characteristically expressed by bacteria, viruses and fungi are known as PAMPs. TLR
interactions trigger the expression of proinflammatory cytokines as well as the functional
maturation of antigen presenting cells of the innate immune system [21].
TLR family consists of 12 members (TLR1-TLR12) and each TLR has been shown to
recognize specific components of pathogens (Figure 40). TLR1–TLR7 and TLR9 have been
characterized to recognize microbial components. TLR2 is essential for the recognition of
microbial lipopeptides. TLR1 and TLR6 associate with TLR2, and discriminate subtle
differences between triacyl- and diacyl lipopeptides, respectively. TLR4 recognizes LPS.
TLR9 is the CpG DNA receptor, whereas TLR3 is implicated in the recognition of viral
dsRNA. TLR5 is a receptor for flagellin. Thus, the TLR family discriminates between
specific patterns of microbial components. Different TLRs use different combinations of
adaptor proteins to determine downstream signaling. The majority of TLR’s signal through
an adapter protein called MyD88, which couples the TLR to downstream signaling kinases,
eventually leading to the activation of NFκB by translocation from the cytoplasm to the
nucleus. However, MyD88 independent signaling pathways do exist for TLR3 and TLR4.
TLR4 possesses two options for signal transduction, either to signal through MyD88 or
through TIR domain containing adapter inducing interferon-beta (TRIF), while TLR3 can
signal only through TRIF [22].
TLR4 is an important sensor for LPS. LPS stimulation of mammalian cells occurs
through a series of interactions with several proteins including LPS binding protein (LBP),
CD14, MD-2 and TLR4. LBP functions as a soluble shuttle protein that directly binds to LPS
and facilitates its association between LPS and CD14. The transfer of LPS to the TLR4/MD-2
receptor complex is facilitated by CD14. Upon LPS recognition, TLR4 undergoes
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oligomerization and recruits TIR (toll-interleukin-1 receptor) domains. There are five TIR
domain containing adaptor proteins: MyD88 (myeloid differentiation primary response
gene 88), TIRAP (TIR domain containing adaptor protein, also known as Mal, MyD88adapter-like), TRIF (TIR domain-containing adaptor inducing IFN-β), TRAM (TRIF-related
adaptor molecule) and SARM (sterile α and HEAT- Armadillo motifs-containing protein).
TLR4 signaling has been divided into MyD88 dependent and MyD88-independent (TRIFdependent) pathways (Figure 41). MyD88 contains a death domain (DD), which can recruit
other DD-containing molecules through homotypic interactions. Upon LPS stimulation,
MyD88 recruits and activates IL-1 receptor associated kinase 4 (IRAK-4). IRAK-4 is
responsible for the subsequent recruitment, activation and degradation of IRAK-1. Another
adaptor protein TRAF6 (TNF receptor associated factor 6), is critical for the MyD88
dependent pathway downstream of IRAK4 and IRAK1. TRAF 6 activates TAK1
(transforming growth factor-β-activated kinase 1). TAK1 then activates downstream IKK
(inhibitor of κ light chain gene enhancer in B cells (IκB) kinase) and MAPK (mitogenactivated protein kinase) pathways. IKK complex phosphorylates IκB proteins. This
phosphorylation leads to the degradation of IκB proteins and subsequent translocation of
the transcription factor NFκB, which controls the expression of proinflammatory cytokines,
in addition to other immune related genes. The MyD88-dependent pathway can also
activate p38 and c-Jun N-terminal kinase (JNK), leading to AP-1 activation followed by
transcription of genes involved in regulation of cell proliferation, morphogenesis,
apoptosis, and differentiation.
TLR4 can also signal via a MyD88-independent pathway to stimulate the production
of the antiviral protein interferon (IFN)-β. TLR4 can recruit another TIR-domain112

containing adaptor called TRIF. Like MyD88, activated TRIF can bind to TRAF-6 to activate
NFκB. Unlike MyD88, TRIF can also bind to kinases called IκKε and TBK1. These kinases
activate transcription factors called IRFs (interferon regulatory factors) that are involved in
stimulating IFN-β transcription. Thus, the adaptor TRIF enables TLR4 signaling to induce
production of IFN-β in addition to activation of NFκB [23].

Figure 40 TLRs and their ligands [200].
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Figure 41 TLR4 Signaling pathways: MyD88 dependent and independent pathways [201].

V.3 Materials and Methods
The involvement of TLR4 was studied by isolating BMMФ from the bone marrow of
both Balb/c wild type and TLR4 knockout (KO) mice (Jackson Laboratories). To investigate
the role of MyD88 in this phenotypic switch, BMMΦs were isolated from the bone marrow
of both B6.129 wild type and MyD88 knockout (KO) mice (Jackson Laboratories). Following
standard protocol in Dr. Ryan’s lab, the mice were euthanized and the bone marrow was
isolated from the femurs/tibias. To deplete the adherent stromal cells, the harvested bone
marrow was cultured overnight in complete RPMI (with 1% penicillin and streptomycin, Lglutamine, HEPES, sodium pyruvate, 10% FBS, and 30 ng/ml recombinant murine MФcolony stimulating factor (rmM-CSF)). Non-adherent cells will be collected, red blood cells
lysed, remaining non-adherent mononuclear cells plated, and cultured for 7 days in the
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presence of rmM-CSF. Phenotype uniformity (naïve MФ (M0) vs. monocytes) was verified
by flow cytometry with our results showing this protocol to achieve a >96% MAC (CD68+)
population. After maturation the BMMФ were divided into three different groups and
stimulated for 48 hrs in the presence of either IL-4 and IL-13 to polarize BMMФ to a M2
phenotype or INF-γ to polarize the BMMФ to a M1 phenotype. The INF-γ treated BMMФ
were then rinsed with media and treated with LPS for additional 18 hrs. Untreated BMMФs
were used as the naïve group (M0s). The BMMФ were cultured on PDO (106 /disc) and TCP
for 24 hrs and their Arg1 and iNOS expression was analyzed by western blot. PDO scaffolds
electrospun at 60 mg/ml and 140 mg/ml were used in this study since they showed
markedly different induction of BMMФ phenotypes in the previous studies. Data expressed
in this chapter is in the format of means ± standard error of mean. Each experiment was
done in triplicates and was reproduced at least twice. All statistical analysis of the data was
based on a Kruskal-Wallis one-way analysis of variance on ranks and a Tukey-Kramer
pairwise multiple comparison procedure (α=0.05) performed with JMP®IN 8 statistical
software (SAS Institute).
V.4 Results
In the absence of TLR4, no significant changes in iNOS or Arginase expression were
observed in the case of large vs. small fiber/pore-size materials (Figure 42). This
observation can be explained by the overlap and redundancy in function of the TLRs and
also in their ability to elicit responses by forming receptor complexes with other TLRs.
The MyD88 knockout and wild-type (WT) M0s and M2s expressed similar levels of
Arg1 and iNOS. The only difference was observed in the case of M1s cultured on the 140
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mg/ml scaffold (Figure 43). The MyD88 knockout M1s showed severely impaired ability to
express both Arg1 and iNOS on the 140 mg/ml scaffold when compared to the WT M1s. No
differences were observed in MyD88 knockout and WT M1s cultured on the 60 mg/ml
scaffold. This indicates that scaffolds with large and small fiber/pore-sizes signal
differently in the case of M1s. This result also shows that MyD88 is a key component
involved in the BMMФ and 140 mg/ml scaffold interaction and signalling. It should also be
noted that in this particular experiment we were unable to turn off iNOS with the larger
fiber/pore-size scaffold. This could be due to the difference in the background of the mice
used. It should be noted that both the MyD88 knockout and the WT mice were of the
B6x129 background.
In support of MyD88-dependent monocyte motility, Cote et al. [202] have
demonstrated that in MyD88-/- mice exposed to the toxin 1-Methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP), infiltration of monocytes/MФ to the CNS was significantly
lower as compared with WT mice. In another study it has been shown that MФ isolated
from MyD88 deficient mice did not migrate to hydrogen peroxide treated fibroblasts in a
transwell model compared to the WT MФ [203]. Fibroblasts were treated with hydrogen
peroxide to put them in a state of oxidative stress. The authors also showed that monocytes
placed over stressed fibroblasts demonstrated a rounded shape with cells protruding into
the pores in contrast to a more flattened morphology of control cells (i.e., placed over
media or mock treated cells). In contrast, monocytes placed over stressed fibroblasts and
treated with MyD88 inhibitory peptide acquired a more rounded shape. These data suggest
that soluble factors released from oxidized cells can influence monocyte motility and can
selectively attract them in a MyD88-dependent manner [203]. It has also been reported
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that LPS-mediated Src induction led to increased FAK activation and cell migration in MФs,
and which was iNOS-dependent [204]. We believe that autrocrine signals acting on M1
phenotype BMMФs after LPS stimulation might be influencing their motility and migration
capacity. We have shown in chapter III that BMMФ migration into the large pore
electrospun scaffold (140 mg/ml) can influence and shift the phenotype of pre-polarized
M1s to M2. Therefore, we believe that this impaired ability of MyD88 deficient BMMФ to
migrate into the fibrous structure of 140 mg/ml scaffold leads to an impaired ability to turn
into M2s (as demonstrated by decreased Arginase production).
We have also observed that BMMФ from C57BL/6, B6x129 and Balb/c mice induce
varying levels of Arg1 and iNOS expression in BMMФ. It is known that C57BL/6 mice are
pro-Th1 whereas Balb/c and 129/Sv are pro-Th2. It has been reported that the outcome of
myocardial infarct healing in mice strongly depends upon the genetic background. It was
shown in that 129/Sv mice display an augmented inflammatory response after myocardial
infarction compared with other mouse strains such as Balb/c or C57BL/6 [205]. It has also
been documented that 129/Sv mice have high levels of circulating IgE and increased
expression of IgE receptor (FcεRI) and greater sensitivity to anaphylaxis when compared to
C57BL/6 mice [206]. These inherent differences in the genetic background of mice might
explain the observed results.
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V.5 Conclusion
The result of this study indicates a potential role for MyD88 in regulating the
signaling mechanisms for BMMФs of M1 phenotype on the large vs. small fiber/pore-size
PDO scaffold. No significant differences between 60 mg/ml and 140 mg/ml scaffolds were
observed in the case of TLR4 deficient and WT BMMФs. The redundancy in function of
TLRs and also their ability to signal by forming receptor complexes with other TLRs could
explain this result. On the other hand, severely impaired iNOS and Arginase expression was
observed in the case of MyD88 deficient M1 BMMФs on the 140 mg/ml scaffold. We
believe that reduced mobility of MФs in the absence of MyD88 leads to impaired migration
into the scaffold. This impaired migration doesn’t allow them to shift their phenotype to
M2s (shown by impaired Arginase expression).
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Figure 42 Involvement of TLR4 in BMMФ signaling.
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Figure 43 Role of MyD88 in BMMФ signaling. The asterisk ‘*’ indicates a statistical
difference between the WT and MyD88 KO BMMФ on the 140 mg/ml scaffold.
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VI.1 Abstract
Using the Directed in vivo angiogenesis assay (DIVAA), we have attempted to
quantify in vivo angiogenesis and MФ phenotypes in response to PDO electrospun scaffolds
(composed of small and large fiber/pore-size). This assay typically consists of
subcutaneous implantation of semiclosed silicone cylinders (angioreactors) into nude mice.
Angioreactors are filled with only 20 µl of Trevigen’s basement membrane extract (BME)
premixed with or without angiogenic factors. Vascularization within angioreactors is
quantified by the intravenous injection of fluorescein isothiocyanate (FITC)-dextran before
their recovery, followed by spectrofluorimetry. This assay was modified to examine the
angiogenic response of PDO. Tubes of 1 mm internal diameter were fabricated from 60
mg/ml and 140 mg/ml concentrations and cut to length (9.2 mm) for insertion into the
angioreactors. The PDO tubes were then filled with BME and implanted into the dorsal
flanks of nude mice in quadruplicate. BME mixed with PBS was used as the negative control
and BME mixed with VEGF/FGF-2 was used as the positive control in this assay. The results
of spectrofluorimetry showed statistically higher signal intensity for the 140 mg/ml
scaffold compared to the 60 mg/ml scaffold. However, problems of high background were
observed in this assay with the use of materials such as PDO. We hypothesize that the
reason for the observed high background is the formation of complexes between dextran
and adsorbed plasma proteins on the surface of the PDO. More studies are needed to
optimize this assay for use with biomaterials such as PDO. The PDO tubes (60 mg/ml and
140 mg/ml) were also analyzed by H&E staining. The cross-sections of these tubes showed
greater cell recruitment and infiltration into the fibrous structures of the 140 mg/ml tube
compared to the 60 mg/ml tube. This result is in agreement with the in vitro result of
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BMMФ infiltrating deeper into the structures of the 140 mg/ml scaffold compared to the 60
mg/ml scaffold. The scaffolds were also analyzed by immunostaining for iNOS (indicative of
M1 phenotype of MФs). The results showed statistically higher ratios of iNOS
positive:negative areas on the 60 mg/ml scaffold compared to the 140 mg/ml scaffold.
Overall, these studies indicate that 140 mg/ml scaffold supports greater cell recruitment
and cell infiltration in vivo but a smaller ratio of iNOS positive:negative areas compared to
the 60 mg/ml scaffold, which supports a predominately M1 MФ phenotype.
VI.2 Introduction
In vitro angiogenesis assays, based on endothelial cell cultures or tissue explants
(e.g. aortic ring assays), focus on isolated endothelial cell functions such as proliferation,
migration or invasion and fail to examine the coordination of cell functions required for a
successful angiogenic response. In contrast, in vivo angiogenesis assays examine the entire
spectrum of molecular and cellular processes, with the endpoint being formation of new,
functional blood vessels. Previous angiogenesis assays have been helpful in developing our
understanding of the angiogenic process, but have been difficult to objectively quantify
[207-209]. Trevigen’s directed in vivo angiogenesis assay (DIVAATM), is the first in vivo
system for the study of angiogenesis that provides quantitative and reproducible results
[210]. Typically in this assay, implant grade silicone cylinders closed at one end called
angioreactors are filled with 20 µL of Trevigen’s basement membrane extract (BME)
premixed with or without angiogenesis modulating factors. These angioreactors were then
implanted subcutaneously in the dorsal flanks of nude mice. If the angioreactor is filled
with angiogenic factors, vascular endothelial cells migrate into and proliferate in the BME
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to form vessels in the angioreactor. This assay is a modification of the Matrigel plug assay.
The main improvement is in the design of the angioreactor that prevents errors due to the
absorption of the BME by the mouse. Additionally, the technique also allows material
contained in the assay to be recovered for additional biochemical, cellular, genetic or
histological testing. The BME used in this study is basically an extract of the basement
membrane proteins from the murine Englebreth-Holm-Swarm tumor (also known as
Matrigel). Due to the presence of low concentrations of endogenous growth factors in
Matrigel alone, there have been reports of minimal angiogenic responses to Matrigel alone.
VI.3 Materials and Methods
VI.3.1 Quantification of DIVAA by Measuring FITC-Dextran Intensity
Growth factor reduced BME (rBME) was thawed at 4⁰C, on ice, overnight prior to
assay. rBME was kept on ice until gelling. Pipette tips, angioreactors, AngioRackTM, and
angiogenesis modulating factors were all pre-chilled at 4⁰C, and rBME was kept on ice.
Working on ice, angiogenic factors were added to one tube (200 μL) of rBME. Each tube of
rBME (200 μl) was used to fill 8 angioreactors. FGF-2 (1.8 μg)/VEGF (600 ng) and 1 μl of
heparin solution was added per 200 μL of rBME to be used as positive control
angioreactors. Sterile PBS (11 μL) was added per 200 μL rBME to be used for the negative
control angioreactors. The PDO tubes were fabricated on a 1 mm diameter mandrel (wall
thickness = 300 µm) from 60 mg/ml and 140 mg/ml concentrations and cut to length (9.2
mm) for insertion after ethanol disinfection and UV light sterilization (30 mins) into
angioreactors. The dimensions of the angioreactor and the PDO tube are shown in Figure
44. Angioreactors were kept chilled on ice prior to filling. rBME (20 μl) was added to each
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angioreactor using an insulin syringe. Bubbles if any were eliminated by centrifuging 250 x
g for 5 minutes at 4⁰C. The angioreactors were then subcutaneously implanted into the
dorsal flanks of athymic nude mice. Four angioreactors, one of each condition (negative
control, positive control, 60 mg/ml PDO tube, 140 mg/ml PDO tube) were implanted in
each mouse, two on each side of the dorsal midline. Ten days after the implantation the
angioreactors were harvested. Before collection of the angioreactors, mice received a 100
µL injection of 25 mg/ml FITC-dextran in PBS via tail vein. The rBME from the tubes was
removed and digested in 200µL of dispase solution for 3 hours at 37⁰C. After digestion the
incubation mix was centrifuged and the fluorescence of the supernatant was measured in a
96 well plate (excitation 485 nm, emission 510 nm). A diagram of the protocol is shown in
Figure 45.
VI.3.2 Histological Evaluation and Immunostaining
The PDO tubes collected from the angioreactors were immediately fixed in 10%
formalin for histological analysis. iNOS staining of the samples was done by
immunohistochemistry-paraffin (IHC-P). The unstained sections of the samples on the
slides were heated in 10 mM sodium citrate buffer (pH 6) at 95-100⁰C for 20 minutes. The
heat was removed and the slides were incubated at room temperature in buffer for 20
minutes. The slides were rinsed in Tris-buffered saline containing 0.05% tween-20 (TBST)
for 1 minute. Blocking of the samples was done with 100 µl of 1% bovine serum albumin
(BSA) for 20-30 minutes at room temperature. The blocking solution was drained from the
slides. This was followed by staining with 100 µl of primary antibody (rabbit anti-mouse
iNOS, Abcam 1:50) overnight at 4⁰C. The slides were washed 4 times in TBST for 5 minutes.
A biotinylated goat anti-rabbit polyclonal antibody was used as the secondary antibody. A
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100 µl of the secondary antibody diluted to 1:300 was used and the slides were incubated
for 30 minutes at room temperature. The slides were washed again in TBST 4 times for 5
minutes. A 100 μL DAB substrate solution (freshly made just before use: 0.05% DAB 0.015% H2O2 in PBS) was applied to the sections on the slides to reveal the color of the
antibody staining. The color development was allowed to go on for 10-15 min until the
desired color intensity was reached. The slides were washed in 300 ml PBS for 2 changes 5
min each. The slides were counterstained by immersing the slides in Hematoxylin for 1-2
mins. The slides were washed in running tap water for > 15 min. The slides were then
dehydrate through 4 changes of alcohol (95%, 95%, 100% and 100%), 5 min each. The
slides were cleared in 3 changes of xylene and coverslip using mounting solution. The exact
same procedure was followed for the negative control slides except that they were not
treated with the primary antibody.
VI.3.3 Quantification of Histology
The quantification of immunohistological stains (brown or blue) in the samples
were analyzed by MATLAB® R2011a. A code on the MathWorks website called “Color
segmentation by Delta E color difference” was modified to be used in this study. In the code
an RGB image is converted to LAB color space. The RGB color space defines a color as the
percentages of red, green, and blue hues mixed together. The LAB color space is based on
one channel for luminance (L) or brightness and two color channels; a and b. The a axis
extends from green to red and the b axis from blue to yellow. After the image is converted
into a LAB color space, the user draws a freehand irregularly shaped region to identify a
color. The Delta E (the color difference in LAB color space) is then calculated for every pixel
in the image between that pixel’s color and the average LAB color of the drawn region. The
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user can then specify a number that says how close to that color would they like to be. The
software will then find all pixels within that specified Delta E of the color of the drawn
region. The extracted pixels of the matching colors are then displayed as “white” in a binary
image. The number of non-zero (or white) pixels in the image are then counted and this
value then serves as an intensity of the chosen color in the image.

Figure 44 Dimensions of the (A) silicon angioreactor, (B) electrospun polymer tube, used in
the study.
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Figure 45 Diagram showing the protocol used for the modified DIVAA assay.
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VI.3.4 Statistical Analysis
Data expressed in this chapter is in the format of means ± standard deviation. Each
experiment was done in triplicates and was reproduced at least twice. All statistical
analysis of the data was based on a Kruskal-Wallis one-way analysis of variance on ranks
and a Tukey-Kramer pairwise multiple comparison procedure (α=0.05) performed with
JMP®IN 8 statistical software (SAS Institute).
VI.4 Results
VI.4.1 Quantification of DIVAA by Measuring FITC-Dextran Intensity
Quantification of vascularization within the angioreactor is shown in Figure 46.
Direct quantification of the angiogenic response is obtained by intravenous injection of
FITC-dextran (average molecular weight, 150,000 Da) 20 mins prior to sacrificing the mice.
Quantification of the fluorescence within the angioreactors reflects the internal vascular
volume and is expected to correlate with the extent of angiogenic response. The results
showed statistically higher signal intensity of FITC-dextran in case of the 140 mg/ml
scaffold compared to all other conditions tested. Intravenous injection of the FITC-dextran
is a measurement of blood volume within the angioreactor and is not necessarily a direct
measure of the endothelial cell responses. Although the FITC-dextran signal intensity was
greater in the positive control (containing FGF-2 and VEGF), the results showed only a 2
fold increase between the positive control and the negative control (PBS). Previous reports
of the DIVAA assay have also demonstrated high background associated with the assay
[210]. FITC-dextran is functionally similar to tagged RBCs. Tagged RBCs give accurate
blood volume determination because even in leaky capillaries RBCs due to their shape and
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size rarely leak out in the intravascular space. Also, there have been reports of dextran
interacting and forming complexes with plasma proteins such as fibrinogen. It is also
known that when implanted in vivo, biomaterials acquire a layer of protein on their surface.
It is possible that the higher signal observed in the case of PDO tubes compared to the
positive control is because of the interaction between dextran and the layer of protein on
the PDO surface. The PDO tube electrospun at 140 mg/ml had statistically higher signal
intensity for FITC-dextran compared to the 60 mg/ml PDO tube indicating greater
angiogenesis on the 140 mg/ml scaffold. Due to the high background associated with the
use of PDO material, this study must be confirmed by histological evaluation and CD31
staining. Furthermore, this study was only performed once. More studies are required to
optimize this assay for biomaterials such as PDO.
VI.4.2 Histological Evaluation of PDO Tubes
The PDO tubes (60 mg/ml and 140 mg/ml) were also analyzed by H&E staining. The
results are shown in Figure 47. The cross-sections of these tubes showed greater cell
recruitment and infiltration into the fibrous structures of the 140 mg/ml tube compared to
the 60 mg/ml tube. Figure 47 shows the sections analyzed from different parts of the tube.
The top panel shows the open part of the tube that had direct contact with the surrounding
tissue. The bottom panel shows the bottom half of the tube that was at the closed end of the
silicon angioreactor. The 60 mg/ml PDO tube shows cells concentrated at the surface of the
scaffold and don’t migrate through the cross-section of the scaffold. In contrast, the 140
mg/ml tube showed cells infiltrating through its fibrous structure. The number of cells at
the open end of the tube were quantified by MATLAB
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R2011a using the previously

described method. The intensity of cells at the open end of the 140 mg/ml tube was
130

statistically higher compared to the 60 mg/ml tube. The quantification of cellular
infiltration into the fibrous structures of the scaffolds was done using Image J. Analysis
showed statistically greater depth of cellular infiltration through the cross-section of the
140 mg/ml tube compared to the 60 mg/ml tube. This result is in agreement with the in
vitro result of BMMФ infiltrating deeper into the structures of the 140 mg/ml scaffold
compared to the 60 mg/ml scaffold.

Figure 46 Evaluation of angiogenesis in DIVAATM angioreactors. The asterisk ‘*’ indicates a
statistical difference between the 140 mg/ml scaffold and all other conditions tested.
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Figure 47 (A) Histological evaluation of the cross section of PDO tubes harvested from the
angioreactors after 10 days of implantation in vivo (magnification 20x). (B, C)
Quantification of cellular infiltration into the scaffolds. The asterisk ‘*’ indicates a statistical
difference between the 60 mg/ml and the 140 mg/ml scaffold.
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VI.4.3 Immunostaining of PDO Tubes
The color segmentation method described in materials and methods was used for
quantification. Briefly, each image was uploaded in MATLAB

®

R2011a and the brown

regions and blue regions were separated into two binary images as shown in Figure 48 and
49. The total number of white pixels was counted in the 2 binary images. The ratio of these
pixel counts then served as the intensity of iNOS positive (brown) vs. iNOS negative (blue)
areas for each image. Immunostaining for iNOS showed a mixed population of iNOS
positive (brown) and iNOS negative (blue) cells in the 140 mg/ml scaffold. In case of 60
mg/ml scaffold majority of the recruited cells were stained positive for iNOS (Figure 50).
Statistical analysis showed that 60 mg/ml scaffold had significantly higher ratio of iNOS
positive: iNOS negative areas compared to the 140 mg/ml scaffold. Overall, this experiment
demonstrated that the small fiber/pore-size scaffold (60 mg/ml) recruits less number of
cells compared to the bigger fiber/pore-size (140 mg/ml) scaffold and the recruited cells
on the 60 mg/ml scaffold are predominately of an M1 phenotype. Therefore, we have
shown in a subcutaneous in vivo model that the 60 mg/ml scaffold supports the M1
phenotype of MФ much strongly compared to the 140 mg/ml scaffold.
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Figure 48 (A) Immunostained section of 60 mg/ml scaffold for iNOS (magnification 40x).
(B) Binary image showing white pixels for all brown areas (positive for iNOS) in the
original image. (C) Binary image showing white pixels for all blue areas (negative for iNOS)
of the original image.
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Figure 49 (A) Immunostained section of 140 mg/ml scaffold for iNOS (magnification 40x).
(B) Binary image showing white pixels for all brown areas (positive for iNOS) in the
original image. (C) Binary image showing white pixels for all blue areas (negative for iNOS)
of the original image.
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Figure 50 iNOS staining of histological samples of scaffolds from the in vivo study
(magnification 40x). The asterisk ‘*’ indicates a statistical difference between the 60 mg/ml
and the 140 mg/ml scaffold.
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VI.5 Conclusion
The DIVAA assay showed statistically higher FITC-dextran signal intensity for the
140 mg/ml scaffold compared to the 60 mg/ml scaffold indicating greater angiogenic
response in the 140 mg/ml tube. However, problems of high background were observed in
this assay with the use of electrospun PDO. The observed high background was probably
due to the formation of complexes between dextran and adsorbed plasma proteins on the
surface of the PDO. More studies are needed to optimize this assay for use with
biomaterials such as PDO. H&E staining of the harvested PDO tubes (60 mg/ml and 140
mg/ml) was also performed. The cross-sections of these tubes showed greater cell
recruitment and infiltration into the fibrous structures of the 140 mg/ml tube compared to
the 60 mg/ml tube. This result corroborates the in vitro result of BMMФ infiltrating deeper
into the structures of the 140 mg/ml scaffold compared to the 60 mg/ml scaffold. The
scaffolds were also analyzed by immunostaining for iNOS (indicative of M1 phenotype of
MФs). The results showed statistically higher ratios of iNOS positive:negative areas on the
60 mg/ml scaffold compared to the 140 mg/ml scaffold. Overall, these studies indicate that
140 mg/ml scaffold supports greater cell recruitment and cell infiltration in vivo but a
smaller ratio of iNOS positive:negative areas compared to the 60 mg/ml scaffold, which
supports a predominately M1 MФ phenotype.
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Chapter VII: Future Work and Concluding
Remarks
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VII.1 Summary
MФ and mast cells are important cell types in the context of tissue remodeling and
regeneration. Mast cells participate in the early stages of wound healing and modulate the
acute inflammatory responses to biomaterials. Mast cells can secrete a myriad of different
cytokines by the process of degranulation; the process of regulated secretion in which
preformed contents stored in their granules are rapidly released by exocytosis. Some of
these cytokines such as IL-4, IL-13 and TNF-α can modulate the MФ phenotype.
In Chapter 2, the adhesion, proliferation and cytokine secretion of bone marrow
derived murine mast cells (BMMC) on electrospun polydioxanone (PDO), polycaprolactone
(PCL) and silk scaffolds, as well as tissue culture plastic (TCP) were investigated in the
presence or absence of IL-3, SCF, IgE and IgE with a crosslinking antigen, dinitrophenolconjugated albumin (DNP). It was previously believed that only activated BMMCs exhibit
adhesion and cytokine secretion. However, this study showed non-activated BMMC
adhesion to electrospun scaffolds. Silk scaffold was not found to be conducive for mast cell
adhesion and cytokine secretion. Activation by IgE and DNP significantly enhanced mast
cell adhesion, proliferation, migration and secretion of TNF-α, MIP-1α and IL-13. This
indicates that mast cells might play a role in MФ polarization, biomaterial integration into
the host tissue, regeneration, and possibly angiogenesis.
In the next study (Chapter 3) we have demonstrated that by varying the fiber
diameter and the corresponding pore-size, we can modulate the macrophage phenotype.
Electrospun PDO scaffolds of larger fiber/pore-sizes upregulated Arg1 expression and
downregulated iNOS and nitrite expression in BMMФ. The production of angiogenic factors
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such as VEGF, TGF-β1 and bFGF from BMMФ was also greater on the larger fiber/poresizes. The expression of TNF-α and IL-6 could not be modulated by electrospun PDO of
different fiber/pore-sizes.
BMMФ mediated angiogenesis was examined using an in vitro bead assay in Chapter
4. It was observed that the BMMФ of M0, M1 and M2 phenotypes cultured on the PDO
scaffolds with bigger fiber/pore-size induced higher percentage density of sprouts.
However, the conditioned media from BMMФ of only M0 and M2 phenotypes cultured on
the bigger fiber/pore-size PDO scaffold (140 mg/ml) induced significantly larger average
length of sprout. Overall, the study confirms that the BMMФs of M2 phenotype are
functional and support angiogenesis and that the naïve BMMФs acquire a functional M2like phenotype when in contact with the bigger fiber/pore-size scaffold.
The role for MyD88 and TLR4 in regulating the signaling mechanisms for BMMФs of
M1/M2 phenotypes on the large vs. small fiber/pore-size PDO scaffolds was also
investigated. This study is described in detail in Chapter 5. No significant differences
between 60 mg/ml and 140 mg/ml scaffolds were observed in the case of TLR4 deficient
and WT BMMФs. The redundancy in function of TLRs and also their ability to signal by
forming receptor complexes with other TLRs could explain this result. On the other hand,
severely impaired iNOS and Arginase expression was observed in the case of MyD88
deficient M1 BMMФs on the 140 mg/ml scaffold. We believe that reduced mobility of MФs
in the absence of MyD88 leads to impaired migration into the scaffold. This impaired
migration doesn’t allow them to shift their phenotype to M2s (shown by impaired Arg1
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expression). Overall, this result indicates a potential role for fiber/pore-size in the signaling
mechanism of BMMФ.
A subcutaneous mouse model (described in Chapter 6) was used to evaluate the
angiogenic and regenerative potential of PDO scaffolds in vivo. The DIVAA assay showed
statistically higher FITC-dextran signal intensity for the 140 mg/ml scaffold compared to
the 60 mg/ml scaffold indicating greater angiogenic response in the 140 mg/ml tube.
However, problems of high background were observed in this assay with the use of
electrospun PDO. The observed high background was probably due to the formation of
complexes between dextran and adsorbed plasma proteins on the surface of the PDO. More
studies are needed to optimize this assay for use with biomaterials such as PDO. H&E
staining of the harvested PDO tubes (60 mg/ml and 140 mg/ml) was also performed. The
cross-sections of these tubes showed greater cell recruitment and infiltration into the
fibrous structures of the 140 mg/ml tube compared to the 60 mg/ml tube. This result
corroborates the in vitro result of BMMФ infiltrating deeper into the structures of the 140
mg/ml scaffold compared to the 60 mg/ml scaffold. The scaffolds were also analyzed by
immunostaining for iNOS (indicative of M1 phenotype of MФs). The results showed
statistically higher ratios of iNOS positive:negative areas on the 60 mg/ml scaffold
compared to the 140 mg/ml scaffold. Overall, these studies indicate that 140 mg/ml
scaffold supports greater cell recruitment and cell infiltration in vivo but a smaller ratio of
iNOS positive:negative areas compared to the 60 mg/ml scaffold, which supports a
predominately M1 MФ phenotype.
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VII.2 Limitations and Future Studies
There were several limitations in the present study. A limited number of MФ
phenotype markers were used in this study. Although, iNOS and Arginase are widely
accepted markers of M1 and M2 macrophages in a mouse model, care must be taken when
extrapolating these studies to human MФs. Human M1/M2 phenotype MФs do not express
iNOS or Arginase. Human MФs are identified by other criteria, including the upregulation of
surface molecules such as major histocompatibility complex (MHC) Class II, co-stimulatory
molecule CD86 and opsonic receptors [e.g., FcRIII (CD16)], enhanced ability to kill and
degrade intracellular microorganism and the elevated capability to process and present
antigens [3].
In this dissertation, TCP is not exactly included in the studies as control but as a
measure of the baseline activity of macrophages. We created films of PDO on 24 well plates.
PDO films would have been the perfect 2D control for the 3D PDO scaffolds created by
electrospinning. We could not successfully culture macrophages on films of PDO for 3 days.
The macrophages did not survive on the PDO films past ~ 24 hours.
Future studies would include investigation into the role of NFκB as a potential
mediator in the signaling mechanism of small vs. large fiber/pore-size electrospun PDO.
Since NFκB is the main downstream transcription factor of both MyD88 dependent and
independent signaling mechanisms, and is the main regulatory factor of pro-inflammatory
cytokines, it would be interesting to investigate the outcome of NFκB inhibition. If by
inhibiting NFκB, we are able to suppress M1 phenotype on the electrospun PDO, strategies
could be devised to incorporate NFκB inhibitor into the fibrous structures of PDO. A
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scaffold that suppresses M1 phenotype responses could prove to be more angiogenic and
regenerative when implanted in vivo. Care must be taken when studying BMMФ responses
to NFκB activation inhibitor (Cat. No. 481406) from Calbiochem. This inhibitor is typically
reconstituted in dimethyl sulfoxide (DMSO). I have found that BMMФ treatment with DMSO
induces iNOS expression. Other studies have indicated that treatment with DMSO induces
increased phagocytic ability in MФ. Alternatives to DMSO, such as ethanol can be explored
to reconstitute the NFκB inhibitor. The siRNA technique could also be explored to look at
the involvement of NFκB.
To identify the particular TLRs involved in MФ interactions with electrospun
scaffolds, double or triple knock out models of TLR2, 4 or 6 could be used. It has been
shown that these TLRs mediate the dendritic cell interaction with biomaterials [25]. Since,
DCs and BMMФ share many similarities in lineage and function; it is possible that TLR-2, 4
and 6 might be involved in BMMФ signaling mechanisms as well. The involvement of TLR9
can also be investigated by using siRNA technology. TLR9 could be involved since MФs are
capable of degrading the electrospun scaffolds and internalize parts of them. They can then
present particles of these scaffolds as antigens to T cells and elicit immune responses to the
materials.
In chapter 3, we have speculated that the increased infiltration of M1 phenotype
BMMФ into the 60 mg/ml scaffold is due to the expression of MMPs and proteolytic
enzymes that degrade the electrospun matrix, facilitating the migration of BMMФ into the
scaffold. A degradation study of PDO (60 mg/ml and 140 mg/ml) must be done to confirm
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this hypothesis. A quantification of the secreted MMPs and enzymes should also be done to
identify the particular factors released by MФs that degrade electrospun matrices.
This study also needs to be extended to electrospun scaffolds created by polymers
other than PDO. This model of fiber/pore-size modulating MФ phenotype needs to be
validated by scaffolds of other polymers. Also, these studies have been performed in
BMMФ, which are typically considered to be relatively immature. It needs to be
investigated whether these phenotypic switches can be induced in more mature MФs such
as peritoneal MФs. Also, the differences in genetic background of mice and its influence on
the phenotype of BMMФ also needs to be explored. We have observed that BMMФ from
C57BL/6, B6x129 and Balb/c mice induce varying levels of Arg1 and iNOS expression in
BMMФ. It is known that C57BL/6 mice are pro-Th1 whereas Balb/c and 129 are pro-Th2. It
has been reported that the outcome of myocardial infarct healing in mice strongly depends
upon the genetic background. It was shown in the study that 129 mice display an
augmented inflammatory response after myocardial infarction compared with other mouse
strains such as Balb/c or C57BL/6 [205]. It has also been documented that 129 mice have
high levels of circulating IgE and increased expression of IgE receptor (FcεRI) and greater
sensitivity to anaphylaxis when compared to C57BL/6 mice [206].
This dissertation work primarily dealt with the involvement of mast cell and MФ
involvement in biomaterial healing. The involvement of neutrophils in the process of
biomaterial healing must also be explored since they are first responders and are capable
to producing several cytokines and growth factors such as TNF-α, IL-1β, IL-8, MIP-1α and
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VEGF [211]. They could therefore be involved in phenotype modulation of MФs at the
implant site.
A study analyzing the regenerative or wound healing potential of BMMФ also needs
to be performed. The main focus of this thesis was the potential for angiogenesis. The
M1/M2 phenotypic responses in relation to scar tissue formation and tissue remodeling
have not been explored.
VII.3 Concluding Remarks
In conclusion, this study demonstrates that biomaterial architecture can influence
MФ activation to either M1 (pro-inflammatory) or M2 (anti-inflammatory/tissue
regenerative). MФ phenotype was studied as a mechanism by which biomaterial
architectures promoted angiogenesis and healing. Overall, the study demonstrates that
electrospun PDO scaffolds with large fiber/pore-size induce a M2 phenotype, promote
angiogenesis and are more efficient at cell recruitment and infiltration in vivo . Majority of
these recruited cells in vivo are of a M1 phenotype (iNOS positive) in the small fiber/poresize scaffold whereas, the large fiber/pore-size scaffold shows a mixed population of iNOS
positive and negative cells. We have also shown that the PDO scaffold of large fiber/poresize also signals differently than the small fiber/pore-size scaffold.

145

Literature Cited

146

1.

Anderson, J.M., A. Rodriguez, and D.T. Chang, Foreign body reaction to biomaterials.
Semin Immunol, 2008. 20(2): p. 86-100.

2.

Brown, B.N., et al., Macrophage polarization: an opportunity for improved outcomes in
biomaterials and regenerative medicine. Biomaterials. 33(15): p. 3792-802.

3.

Kou, P.M. and J.E. Babensee, Macrophage and dendritic cell phenotypic diversity in the
context of biomaterials. J Biomed Mater Res A.

4.

Anderson, J.M., Biological Response to Materials. Annual Review of Materials
Research, 2001. 31: p. 81-110.

5.

Park, J.E. and A. Barbul, Understanding the role of immune regulation in wound
healing. Am J Surg, 2004. 187(5A): p. 11S-16S.

6.

Sunderkotter, C., et al., Macrophages and angiogenesis. J Leukoc Biol, 1994. 55(3): p.
410-22.

7.

Lamagna, C., M. Aurrand-Lions, and B.A. Imhof, Dual role of macrophages in tumor
growth and angiogenesis. J Leukoc Biol, 2006. 80(4): p. 705-13.

8.

Gordon, S., Alternative activation of macrophages. Nat Rev Immunol, 2003. 3(1): p.
23-35.

9.

Martinez, F.O., L. Helming, and S. Gordon, Alternative activation of macrophages: an
immunologic functional perspective. Annu Rev Immunol, 2009. 27: p. 451-83.

10.

Martinez, F.O., et al., Macrophage activation and polarization. Front Biosci, 2008. 13:
p. 453-61.

11.

Mosser, D.M. and X. Zhang, Activation of murine macrophages. Curr Protoc Immunol,
2008. Chapter 14: p. Unit 14 2.

12.

Mosser, D.M. and J.P. Edwards, Exploring the full spectrum of macrophage activation.
Nat Rev Immunol, 2008. 8(12): p. 958-69.
147

13.

Mantovani, A., et al., The chemokine system in diverse forms of macrophage activation
and polarization. Trends Immunol, 2004. 25(12): p. 677-86.

14.

Dagtekin, G., et al., Modulation of angiogenic functions in human macrophages by
biomaterials. Biomaterials, 2003. 24(20): p. 3395-401.

15.

Ashley, R.A., et al., Leukocyte inflammatory response in a rat urinary bladder
regeneration model using porcine small intestinal submucosa scaffold. Tissue Eng Part
A, 2009. 15(11): p. 3241-6.

16.

Biswas, S.K. and A. Mantovani, Macrophage plasticity and interaction with
lymphocyte subsets: cancer as a paradigm. Nat Immunol. 11(10): p. 889-96.

17.

Deonarine, K., et al., Gene expression profiling of cutaneous wound healing. J Transl
Med, 2007. 5: p. 11.

18.

Xia, Z. and J.T. Triffitt, A review on macrophage responses to biomaterials. Biomed
Mater, 2006. 1(1): p. R1-9.

19.

Zakrzewska, M., E. Marcinkowska, and A. Wiedlocha, FGF-1: from biology through
engineering to potential medical applications. Crit Rev Clin Lab Sci, 2008. 45(1): p.
91-135.

20.

Berton, G. and C.A. Lowell, Integrin signalling in neutrophils and macrophages. Cell
Signal, 1999. 11(9): p. 621-35.

21.

Lu, Y.C., W.C. Yeh, and P.S. Ohashi, LPS/TLR4 signal transduction pathway. Cytokine,
2008. 42(2): p. 145-51.

22.

Pearl, J.I., et al., Role of the Toll-like receptor pathway in the recognition of orthopedic
implant wear-debris particles. Biomaterials. 32(24): p. 5535-42.

23.

Murphy, K., P. Travers, and P. Walter, Janeway's Immunobiology, 7th edition.
Immunobiology. 2008, New York: Garland Science.

148

24.

Macedo, L., et al., Wound healing is impaired in MyD88-deficient mice: a role for
MyD88 in the regulation of wound healing by adenosine A2A receptors. Am J Pathol,
2007. 171(6): p. 1774-88.

25.

Shokouhi, B., et al., The role of multiple toll-like receptor signalling cascades on
interactions between biomedical polymers and dendritic cells. Biomaterials. 31(22): p.
5759-71.

26.

Carmeliet, P., Mechanisms of angiogenesis and arteriogenesis. Nat Med, 2000. 6(4): p.
389-95.

27.

Li, J., et al., TGF-beta3, but not TGF-beta1, protects keratinocytes against 12-Otetradecanoylphorbol-13-acetate-induced cell death in vitro and in vivo. J Biol Chem,
1999. 274(7): p. 4213-9.

28.

Kalluri, R., Basement membranes: structure, assembly and role in tumour
angiogenesis. Nat Rev Cancer, 2003. 3(6): p. 422-33.

29.

Zheng-Ming Huang, Y.-Z.Z., M. Kotaki, S. Ramakrishna, A review on polymer
nanofibers by electrospinning and their applications in nanocomposites. Composite
Science and technology, 2003(63): p. 2223-2253.

30.

Zhang, Y., et al., Electrospinning of gelatin fibers and gelatin/PCL composite fibrous
scaffolds. J Biomed Mater Res B Appl Biomater, 2005. 72(1): p. 156-65.

31.

Greiner, A. and J.H. Wendoeff, Electrospinning: A Fascinating Method for the
Preparation of Ultrathin Fibers. Angew Chem Int Ed Engl, 2007. 46: p. 5670-5703.

32.

Ashammakhi, N., et al., Tissue engineering: a new take-off using nanofiber-based
scaffolds. J Craniofac Surg, 2007. 18(1): p. 3-17.

33.

Burger, C., B.S. Hsiao, and B. Chu, Nanofibrous materials and their applications.
Annual reviews in material science, 2006. 36: p. 333-68.

149

34.

Boland, E.D., et al., Utilizing acid pretreatment and electrospinning to improve
biocompatibility of poly(glycolic acid) for tissue engineering. Journal of Biomedical
Materials Research Part B: Applied Biomaterials, 2004. 71B: p. 144-152.

35.

Bhattarai, S.R., et al., Novel biodegradable electrospun membrane: scaffold for tissue
engineering. Biomaterials, 2004. 25(13): p. 2595-602.

36.

Zhang, Y., et al., Electrospinning of gelatin fibers and gelatin/PCL composite fibrous
scaffolds. Journal of Biomedical Materials Research Part B: Applied Biomaterials,
2005. 72B: p. 156-165.

37.

Lee, C.H., et al., Nanofiber alignment and direction of mechanical strain affect the ECM
production of human ACL fibroblast. Biomaterials, 2005. 26: p. 1261-1270.

38.

Sell, S.A., et al., Electrospinning of collagen / biopolymers for regenerative medicine
and cardiovascular tissue engineering. Advanced Drug Delivery Reviews, 2009. In
Press.

39.

Sell, S.A., et al., The Use of Natural Polymers in Tissue Engineering: A Focus on
Electrospun Extracellular Matrix Analogues. Polymers, 2010. 2(4): p. 522-553.

40.

Kolacna, L., et al., Biochemical and biophysical aspects of collagen nanostructure in
the extracellular matrix. Physiol Res, 2007. 56 Suppl 1: p. S51-60.

41.

Matthews, J.A., et al., Electrospinning of Collagen Nanofibers. Biomacromolecules,,
2002. 3: p. 232-238.

42.

Matthews, J.A., et al., Electrospinning of collagen type II: A feasibility study. Journal of
Bioactive and Compatible Polymers, 2003. 18: p. 125-134.

43.

Barnes, C.P., et al., Nanofiber technology: designing the next generation of tissue
engineering scaffolds. Advanced Drug Delivery Reviews., 2007. 59: p. 1413-1433.

150

44.

Barnes, C.P., et al., Preliminary investigation of electrospun collagen and
polydioxanone for vascular tissue engineering applications. International Journal of
Electrospun Nanofibers, 2007. 1: p. 73-87.

45.

Boccafoschi, F., et al., Biological performances of collagen-based scaffolds for vascular
tissue engineering. Biomaterials, 2005. 26(35): p. 7410-7.

46.

Chen, Z.G., et al., Electrospun collagen-chitosan nanofiber: a biomimetic extracellular
matrix for endothelial cell and smooth muscle cell. Acta Biomater. 6(2): p. 372-82.

47.

He, W., et al., Fabrication of collagen-coated biodegradable polymer nanofiber mesh
and its potential for endothelial cells growth. Biomaterials, 2005. 26(36): p. 7606-15.

48.

He, W., et al., Fabrication and endothelialization of collagen-blended biodegradable
polymer nanofibers: Potential vascular graft for blood vessel tissue engineering.
Tissue Eng, 2005. 11(9): p. 1574-1588.

49.

Jeong, S.I., et al., Tissue-engineered vascular grafts composed of marine collagen and
PLGA fibers using pulsatile perfusion bioreactors. Biomaterials, 2007. 28: p. 11151122.

50.

McClure, M.J., et al., Electrospun polydioxanone, elastin, and collagen vascular
scaffolds: Uniaxial cyclic distension. Journal of Engineered Fibers and Fabrics, 2009.
4(2): p. 18-25.

51.

Tillman, B.W., et al., The in vivo stability of electrospun polycaprolactone-collagen
scaffolds in vascular reconstruction. Biomaterials, 2009. 30(4): p. 583-8.

52.

Venugopal, J., et al., In vitro study of smooth muscle cells on polycaprolactone and
collagen nanofibrous matrices. Cell Biol Int, 2005. 29(10): p. 861-7.

53.

Venugopal, J.R., Y.Z. Zhang, and S. Ramakrishna, In vitro culture of human dermal
fibroblasts on electrospun polycaprolactone collagen nanofibrous membrane.
Artificial Organs, 2006. 30(6): p. 440-446.

151

54.

Chen, P.J., G.Y. Chang, and J.K. Chen, Electrospun collagen/chitosan nanofibrous
membrane as wound dressing. Colloids and Surfaces A: Physicochemical and
Engineering Aspects, 2008. 313-314: p. 183-188.

55.

Rho, K.S., et al., Electrospinning of collagen nanofibers: effects on the behavior of
normal human keratinocytes and early-stage wound healing. Biomaterials, 2006.
27(8): p. 1452-61.

56.

Aszodi, A., et al., What mouse mutants teach us about extracellular matrix function.
Annu Rev Cell Dev Biol, 2006. 22: p. 591-621.

57.

Daamen, W.F., et al., Preparation and evaluation of moleculary-defined collagenelastin-glycosaminoglycan scaffolds for tissue engineering. Biomaterials, 2003. 24: p.
4001-4009.

58.

Hafemann, B., et al., Use of a collagen/elastin-membrane for the tissue engineering of
dermis. Burns, 1999. 25(5): p. 373-384.

59.

Barnes, C.P., Design of an Electrospun Type II Collagen Scaffold for Articular Cartilage
Tissue Engineering, in Biomedical Engineering. 2007, Virginia Commonwealth
University: Richmond, VA. p. 164.

60.

Shih, Y.R., et al., Growth of mesenchymal stem cells on electrospun type I collagen
nanofibers. Stem Cells, 2006. 24(11): p. 2391-7.

61.

Kim, H.W., J.H. Song, and H.E. Kim, Bioactive glass nanofiber-collagen nanocomposite
as a novel bone regeneration matrix. J Biomed Mater Res A, 2006. 79(3): p. 698-705.

62.

Gentleman, E., et al., Development of ligament-like structural organization and
properties in cell-seeded collagen scaffolds in vitro. Annals of Biomedical Engineering,
2006. 34(5): p. 726-736.

152

63.

Kimura, Y., et al., Regeneration of anterior cruciate ligament by biodegradable
scaffold combined with local controlled release of basic fibroblast growth factor and
collagen wrapping. Tissue Engineering Part C, 2008. 14(1): p. 47-57.

64.

Schnell, E., et al., Guidance of glial cell migration and axonal growth on electrospun
nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone
blend. Biomaterials, 2007. 28(19): p. 3012-25.

65.

Berglund, J.D., R.M. Nerem, and A. Sambanis, Incorporation of intact elastin scaffolds
in tissue-engineered collagen-based vascular grafts. Tissue Eng, 2004. 10: p. 15261535.

66.

Boland, E.D., et al., Electrospinning collagen and elastin: preliminary vascular tissue
engineering. Front Biosci, 2004. 9: p. 1422-32.

67.

Buijtenhuijs, P., et al., Tissue engineering of blood vessels: characterization of smoothmuscle cells for culturing on collagen-and-elastin-based scaffolds. Biotechnology and
Applied Biochemistry, 2004. 39: p. 141-149.

68.

Buttafoco, L., et al., Electrospinning of collagen and elastin for tissue engineering
applications. Biomaterials, 2006. 27(5): p. 724-734.

69.

McClure, M.J., et al., A three-layered electrospun matrix to mimic native arterial
architecture using polycaprolactone, elastin, and collagen: A preliminary study. Acta
Biomater, 2010. 6(7): p. 2422-33.

70.

Boland, E.D., P.G. Espy, and G.L. Bowlin, Tissue Engineering Scaffolds, in Encyclopedia
of Biomaterials and Biomedical Engineering. 2004. p. 1-7.

71.

Altman, G.H., et al., Silk matrix for tissue engineered anterior cruciate ligaments.
Biomaterials, 2002. 23: p. 4131-4141.

153

72.

Fan, H., et al., Enhanced differentiation of mesenchymal stem cells co-cultured with
ligament fibroblasts on gelatin/silk fibroin hybrid scaffold. Biomaterials, 2008. 29: p.
1017-1027.

73.

Fan, H., et al., In vivo study of anterior cruciate ligament regeneration using
mesenchymal stem cells and silk scaffold. Biomaterials, 2008. 29: p. 3324-3337.

74.

Liu, H., et al., Modification of sericin-free silk fibers for ligament tissue engineering
application. Journal of Biomedical Materials Research Part B: Applied Biomaterials,
2006. 10: p. 129-138.

75.

Sell, S.A., Tissue Engineering Cellularized Silk-Based Ligament Analogues, in
Biomedical Engineering. 2009, Virginia Commonwealth University: Richmond, VA. p.
322.

76.

Sell, S.A., et al., Preliminary investigation of airgap electrospun silk fibroin-based
structures for ligament analogue engineering. J Biomater Sci Polym Ed, 2010.

77.

Seo, Y.-K., et al., The biocompatibility of silk scaffold for tissue engineered ligaments.
Key Engineering Materials, 2007. 342: p. 73-76.

78.

Toh, S.L., et al., Novel silk scaffolds for ligament tissue engineering applications. Key
Engineering Materials, 2006. 326-328(1): p. 727-730.

79.

McClure,

M.,

et

al.,

Electrospinning-aligned

and

random

polydioxanone-

polycaprolactone-silk fibroin-blended scaffolds: geometry for a vascular matrix.
Biomedical Materials, 2009. 4(5): p. 1-13.
80.

Soffer, L., et al., Silk-based electrospun tubular scaffolds for tissue-engineered vascular
grafts. J. Biomater. Sci. Polymer Edn., 2008. 19(5): p. 653-664.

81.

Zhang, X., C.B. Baughman, and D.L. Kaplan, In vitro evaluation of electrospun silk
fibroin scaffolds for vascular cell growth. Biomaterials, 2008. 29: p. 2217-2227.

154

82.

Li, C., et al., Electrospun silk-BMP-2 scaffolds for bone tissue engineering. Biomaterials,
2006. 27(16): p. 3115-24.

83.

Meinel, L., et al., Engineering bone-like tissue in vitro using human bone marrow stem
cells and silk scaffolds. J Biomed Mater Res A, 2004 Oct 1. 71(1): p. 25-34.

84.

Yeo, I.S., et al., Collagen-based biomimetic nanofibrous scaffolds: preparation and
characterization of collagen/silk fibroin bicomponent nanofibrous structures.
Biomacromolecules, 2008. 9(4): p. 1106-16.

85.

Ayres, C., et al., Nanotechnology in tissue scaffolding / organ development for
transplant. Wiley Interdisciplinary Reviews: Nanomedicine, 2009. In Review.

86.

Sell, S., et al., Extracellular matrix regenerated: tissue engineering via electrospun
biomimetic nanofibers. Polymer International, 2007. 56: p. 1349-1360.

87.

Kumbar, S.G., et al., Electrospun nanofiber scaffolds: engineering soft tissues. Biomed
Mater, 2008. 3(3): p. 034002.

88.

Kenawy, E., et al., Release of tetracycline hydrochloride from electrospun
poly(ethylene-co-vinylacetate), poly(lactic acid), and a blend. J Control Release, 2002.
81: p. 57-64.

89.

Kim, K., et al., Incorporation and controlled release of a hydrophilic antibiotic using
poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release,
2004. 98(1): p. 47-56.

90.

Zeng, J., et al., Biodegradable electrospun fibers for drug delivery. J Control Release,
2003. 92(3): p. 227-31.

91.

Zeng, J., et al., Influence of the drug compatibility with polymer solution on the release
kinetics of electrospun fiber formulation. J Control Release, 2005. 105(1-2): p. 43-51.

92.

Xu, X., et al., Ultrafine medicated fibers electrospun from W/O emulsions. J Control
Release, 2005. 108(1): p. 33-42.
155

93.

Huang, Z.M., et al., Encapsulating drugs in biodegradable ultrafine fibers through coaxial electrospinning. J Biomed Mater Res A, 2006. 77(1): p. 169-79.

94.

Chunder, A., et al., Fabrication of ultrathin polyelectrolyte fibers and their controlled
release properties. Colloids Surf B Biointerfaces, 2007. 58(2): p. 172-9.

95.

Yannas, I.V., et al., Synthesis and characterization of a model extracellular matrix that
induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A, 1989.
86(3): p. 933-7.

96.

Dagalakis, N., et al., Design of an artificial skin. Part III. Control of pore structure. J
Biomed Mater Res, 1980. 14(4): p. 511-28.

97.

Pham, Q.P., U. Sharma, and A.G. Mikos, Electrospun poly(epsilon-caprolactone)
microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds
and measurement of cellular infiltration. Biomacromolecules, 2006. 7(10): p. 2796805.

98.

Tuzlakoglu, K., et al., Nano- and micro-fiber combined scaffolds: a new architecture for
bone tissue engineering. J Mater Sci Mater Med, 2005. 16(12): p. 1099-104.

99.

Yang, S., et al., The design of scaffolds for use in tissue engineering. Part I. Traditional
factors. Tissue Eng, 2001. 7(6): p. 679-89.

100.

Szentivanyi, A., et al., Electrospun cellular microenvironments: Understanding
controlled release and scaffold structure. Adv Drug Deliv Rev. 63(4-5): p. 209-20.

101.

Brauker, J.H., et al., Neovascularization of synthetic membranes directed by membrane
microarchitecture. J Biomed Mater Res, 1995. 29(12): p. 1517-24.

102.

Soliman, S., et al., Controlling the porosity of fibrous scaffolds by modulating the fiber
diameter and packing density. J Biomed Mater Res A. 96(3): p. 566-74.

156

103.

Lowery, J.L., N. Datta, and G.C. Rutledge, Effect of fiber diameter, pore size and seeding
method on growth of human dermal fibroblasts in electrospun poly(epsiloncaprolactone) fibrous mats. Biomaterials. 31(3): p. 491-504.

104.

Li, M., et al., Electrospun protein fibers as matrices for tissue engineering.
Biomaterials, 2005. 26(30): p. 5999-6008.

105.

Sell, S.A., et al., Electrospun polydioxanone-elastin blends: potential for bioresorbable
vascular grafts. Biomed Mater, 2006. 1(2): p. 72-80.

106.

McClure,

M.J.,

et

al.,

Electrospinning-aligned

and

random

polydioxanone-

polycaprolactone-silk fibroin-blended scaffolds: geometry for a vascular matrix.
Biomed Mater, 2009. 4(5): p. 055010.
107.

Baker, B.M., et al., The potential to improve cell infiltration in composite fiber-aligned
electrospun scaffolds by the selective removal of sacrificial fibers. Biomaterials, 2008.
29(15): p. 2348-58.

108.

Nam, J., et al., Improved cellular infiltration in electrospun fiber via engineered
porosity. Tissue Eng, 2007. 13(9): p. 2249-57.

109.

McClure, M.J., et al., The use of air-flow impedance to control fiber deposition patterns
during electrospinning. Biomaterials. 33(3): p. 771-9.

110.

Chen, Z., et al., In vitro angiogenesis by human umbilical vein endothelial cells
(HUVEC) induced by three-dimensional co-culture with glioblastoma cells. J
Neurooncol, 2009. 92(2): p. 121-8.

111.

Brown, B.N., et al., Macrophage phenotype and remodeling outcomes in response to
biologic scaffolds with and without a cellular component. Biomaterials, 2009. 30(8):
p. 1482-91.

112.

Blair, R.J., et al., Human mast cells stimulate vascular tube formation. Tryptase is a
novel, potent angiogenic factor. J Clin Invest, 1997. 99(11): p. 2691-700.

157

113.

Noli, C. and A. Miolo, The mast cell in wound healing. Vet Dermatol, 2001. 12(6): p.
303-13.

114.

Hiromatsu, Y. and S. Toda, Mast cells and Angiogenesis. Microscopy research and
technique, 2003. 69: p. 60-64.

115.

Rao, K.N. and M.A. Brown, Mast cells: multifaceted immune cells with diverse roles in
health and disease. Ann N Y Acad Sci, 2008. 1143: p. 83-104.

116.

Maltby, S., K. Khazaie, and K.M. McNagny, Mast cells in tumor growth: Angiogenesis,
tissue remodelling and immune-modulation. Biochim Biophys Acta, 2009. 1796(1): p.
19-26.

117.

Tang, L., T.A. Jennings, and J.W. Eaton, Mast cells mediate acute inflammatory
responses to implanted biomaterials. Proc Natl Acad Sci U S A, 1998. 95(15): p. 88416.

118.

Metcalfe, D.D., D. Baram, and Y.A. Mekori, Mast cells. Physiol Rev, 1997. 77(4): p.
1033-79.

119.

Mekori, Y.A. and D.D. Metcalfe, Mast cells in innate immunity. Immunol Rev, 2000.
173: p. 131-40.

120.

Galli, S.J., Complexity and redundancy in the pathogenesis of asthma: reassessing the
roles of mast cells and T cells. J Exp Med, 1997. 186(3): p. 343-7.

121.

Galli, S.J. and C.S. Lantz, Allergy. Fundamental Immunology, ed. W.E. Paul. 1999,
Philadelphia: Lippincott-Raven Press. 1137-1184.

122.

Eady, R.A., et al., Mast cell population density, blood vessel density and histamine
content in normal human skin. Br J Dermatol, 1979. 100(6): p. 623-33.

123.

Nilsson, G., et al., Stem cell factor is a chemotactic factor for human mast cells. J
Immunol, 1994. 153(8): p. 3717-23.

158

124.

Yamaguchi, H., et al., Umbilical vein endothelial cells are an important source of c-kit
and stem cell factor which regulate the proliferation of haemopoietic progenitor cells.
Br J Haematol, 1996. 94(4): p. 606-11.

125.

Coleman, J.W., et al., Regulation of mouse peritoneal mast cell secretory function by
stem cell factor, IL-3 or IL-4. J Immunol, 1993. 150(2): p. 556-62.

126.

Galli, S.J., et al., Reversible expansion of primate mast cell populations in vivo by stem
cell factor. J Clin Invest, 1993. 91(1): p. 148-52.

127.

Valent, P., et al., Induction of differentiation of human mast cells from bone marrow
and peripheral blood mononuclear cells by recombinant human stem cell factor/kitligand in long-term culture. Blood, 1992. 80(9): p. 2237-45.

128.

Wershil, B.K., et al., The rat c-kit ligand, stem cell factor, induces c-kit receptordependent mouse mast cell activation in vivo. Evidence that signaling through the c-kit
receptor can induce expression of cellular function. J Exp Med, 1992. 175(1): p. 24555.

129.

Iemura, A., et al., The c-kit ligand, stem cell factor, promotes mast cell survival by
suppressing apoptosis. Am J Pathol, 1994. 144(2): p. 321-8.

130.

Berton, A., et al., Activation of fibroblasts in collagen lattices by mast cell extract: a
model of fibrosis. Clin Exp Allergy, 2000. 30(4): p. 485-92.

131.

Hatamochi, A., K. Fujiwara, and H. Ueki, Effects of histamine on collagen synthesis by
cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res, 1985. 277(1):
p. 60-4.

132.

Russel, J.D., S.B. Russell, and K.M. Trupin, The effect of histamine on the growth of
cultured fibroblasts isolated from normal and keloid tissue. J Cell Physiol, 1977. 93(3):
p. 389-93.

159

133.

Cairns, J.A. and A.F. Walls, Mast cell tryptase stimulates the synthesis of type I collagen
in human lung fibroblasts. J Clin Invest, 1997. 99(6): p. 1313-21.

134.

Duling, R.R., et al., Mechanical characterization of electrospun polycaprolactone
(PCL): a potential scaffold for tissue engineering. J Biomech Eng, 2008. 130(1): p.
011006.

135.

Del Gaudio, C., et al., Structural characterization and cell response evaluation of
electrospun PCL membranes: micrometric versus submicrometric fibers. J Biomed
Mater Res A, 2009. 89(4): p. 1028-39.

136.

Pektok, E., et al., Degradation and healing characteristics of small-diameter
poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation.
Circulation, 2008. 118(24): p. 2563-70.

137.

Boland, E.D., et al., Electrospinning polydioxanone for biomedical applications. Acta
Biomater, 2005. 1(1): p. 115-23.

138.

Garg, K., et al., Angiogenic potential of human macrophages on electrospun
bioresorbable vascular grafts. Biomed Mater, 2009. 4(3): p. 031001.

139.

Smith, M.J., et al., Suture-reinforced electrospun polydioxanone-elastin small-diameter
tubes for use in vascular tissue engineering: a feasibility study. Acta Biomater, 2008.
4(1): p. 58-66.

140.

Smith, M.J., et al., Modulation of murine innate and acquired immune responses
following in vitro exposure to electrospun blends of collagen and polydioxanone. J
Biomed Mater Res A. 93(2): p. 793-806.

141.

Smith, M.J., et al., In vitro evaluations of innate and acquired immune responses to
electrospun polydioxanone-elastin blends. Biomaterials, 2009. 30(2): p. 149-59.

142.

Zhang, X., C.B. Baughman, and D.L. Kaplan, In vitro evaluation of electrospun silk
fibroin scaffolds for vascular cell growth. Biomaterials, 2008. 29(14): p. 2217-27.

160

143.

Soffer, L., et al., Silk-based electrospun tubular scaffolds for tissue-engineered vascular
grafts. J Biomater Sci Polym Ed, 2008. 19(5): p. 653-64.

144.

Asai, K., et al., Regulation of mast cell survival by IgE. Immunity, 2001. 14(6): p. 791800.

145.

Jin, H.J., et al., Human bone marrow stromal cell responses on electrospun silk fibroin
mats. Biomaterials, 2004. 25(6): p. 1039-47.

146.

Ryan, J.J., et al., IL-4 inhibits mouse mast cell Fc epsilonRI expression through a STAT6dependent mechanism. J Immunol, 1998. 161(12): p. 6915-23.

147.

Macey, M.R., et al., IL-4 and TGF-beta 1 counterbalance one another while regulating
mast cell homeostasis. J Immunol. 184(9): p. 4688-95.

148.

Plaut, M., et al., Mast cell lines produce lymphokines in response to cross-linkage of Fc
epsilon RI or to calcium ionophores. Nature, 1989. 339(6219): p. 64-7.

149.

Thompson, H.L., L. Thomas, and D.D. Metcalfe, Murine mast cells attach to and
migrate on laminin-, fibronectin-, and matrigel-coated surfaces in response to Fc
epsilon RI-mediated signals. Clin Exp Allergy, 1993. 23(4): p. 270-5.

150.

Kruger-Krasagakes, S., et al., Adhesion of human mast cells to extracellular matrix
provides a co-stimulatory signal for cytokine production. Immunology, 1999. 98(2): p.
253-7.

151.

Thompson, H.L., et al., Laminin promotes mast cell attachment. J Immunol, 1989.
143(7): p. 2323-7.

152.

Bianchine, P.J., P.R. Burd, and D.D. Metcalfe, IL-3-dependent mast cells attach to platebound vitronectin. Demonstration of augmented proliferation in response to signals
transduced via cell surface vitronectin receptors. J Immunol, 1992. 149(11): p. 366571.

161

153.

Lam, V., et al., IgE alone stimulates mast cell adhesion to fibronectin via pathways
similar to those used by IgE + antigen but distinct from those used by Steel factor.
Blood, 2003. 102(4): p. 1405-13.

154.

Artuc, M., et al., Mast cells and their mediators in cutaneous wound healing--active
participants or innocent bystanders? Exp Dermatol, 1999. 8(1): p. 1-16.

155.

Compton, S.J., et al., The role of mast cell tryptase in regulating endothelial cell
proliferation, cytokine release, and adhesion molecule expression: tryptase induces
expression of mRNA for IL-1 beta and IL-8 and stimulates the selective release of IL-8
from human umbilical vein endothelial cells. J Immunol, 1998. 161(4): p. 1939-46.

156.

Galli, S.J., J.R. Gordon, and B.K. Wershil, Mast cell cytokines in allergy and
inflammation. Agents Actions Suppl, 1993. 43: p. 209-20.

157.

Goebeler, M., et al., Interleukin-13 selectively induces monocyte chemoattractant
protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R
alpha and Stat6 phosphorylation. Immunology, 1997. 91(3): p. 450-7.

158.

Gordon, J.R. and S.J. Galli, Mast cells as a source of both preformed and
immunologically inducible TNF-/cachectin. Nature, 1990. 346: p. 274-6.

159.

Malaviya, R., et al., Mast cell modulation of neutrophil influx and bacterial clearance at
sites of infection through TNF-alpha. Nature, 1996. 381(6577): p. 77-80.

160.

Norrby, K., Mast cells and angiogenesis. Apmis, 2002. 110(5): p. 355-71.

161.

Walsh, L.J., et al., Human dermal mast cells contain and release tumor necrosis factor
alpha, which induces endothelial leukocyte adhesion molecule 1. Proc Natl Acad Sci U
S A, 1991. 88(10): p. 4220-4.

162.

McLachlan, J.B., et al., Mast cell-derived tumor necrosis factor induces hypertrophy of
draining lymph nodes during infection. Nat Immunol, 2003. 4(12): p. 1199-205.

162

163.

DiPietro, L.A., et al., MIP-1alpha as a critical macrophage chemoattractant in murine
wound repair. J Clin Invest, 1998. 101(8): p. 1693-8.

164.

Low, Q.E., et al., Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol,
2001. 159(2): p. 457-63.

165.

Maurer, M. and E. von Stebut, Macrophage inflammatory protein-1. Int J Biochem Cell
Biol, 2004. 36(10): p. 1882-6.

166.

Li, D. and Y. Xia, Electrospinning of Nanofibers: Reinventing the Wheel? Advanced
Materials, 2004. 16(14): p. 1151-1170.

167.

Campillo-Fernández, A., et al., Analysis of the Biological Response of Endothelial and
Fibroblast Cells Cultured on Synthetic Scaffolds with Various Hydrophilic/Hydrophobic
Ratios: Influence of Fibronectin Adsorption and Conformation. Tissue Engineering:
Part A, 2009. 15: p. 1331-41.

168.

Liang, D., B.S. Hsiao, and B. Chu, Functional electrospun nanofibrous scaffolds for
biomedical applications. Adv Drug Deliv Rev, 2007. 59(14): p. 1392-412.

169.

Keselowsky, B.G., et al., Role of plasma fibronectin in the foreign body response to
biomaterials. Biomaterials, 2007. 28(25): p. 3626-31.

170.

Clark, R.A., Potential roles of fibronectin in cutaneous wound repair. Arch Dermatol,
1988. 124(2): p. 201-6.

171.

Odom, S., et al., Negative regulation of immunoglobulin E-dependent allergic
responses by Lyn kinase. J Exp Med, 2004. 199(11): p. 1491-502.

172.

Xiang, Z., et al., Essential role of the prosurvival bcl-2 homologue A1 in mast cell
survival after allergic activation. J Exp Med, 2001. 194(11): p. 1561-69.

173.

Kawakami, T. and J. Kitaura, Mast cell survival and activation by IgE in the absence of
antigen: a consideration of the biologic mechanisms and relevance. J Immunol, 2005.
175(7): p. 4167-73.
163

174.

Pham, E.A., et al., Modification of the diphenylamine assay for cell quantification in
three-dimensional biodegradable polymeric scaffolds. J Biomed Mater Res B Appl
Biomater. 92(2): p. 499-507.

175.

Panilaitis, B., et al., Macrophage responses to silk. Biomaterials, 2003. 24(18): p.
3079-85.

176.

Bochner, B.S., et al., IL-13 selectively induces vascular cell adhesion molecule-1
expression in human endothelial cells. J Immunol, 1995. 154(2): p. 799-803.

177.

Lee, C.G., et al., Interleukin-13 induces tissue fibrosis by selectively stimulating and
activating transforming growth factor beta(1). J Exp Med, 2001. 194(6): p. 809-21.

178.

Mestas, J. and C.C. Hughes, Of Mice and Not Men: Differences between Mouse and
Human Immunology. Journal of Immunology, 2004. 172: p. 2731-2738.

179.

Badylak, S.F., et al., Macrophage phenotype as a determinant of biologic scaffold
remodeling. Tissue Eng Part A, 2008. 14(11): p. 1835-42.

180.

Saino, E., et al., Effect of electrospun fiber diameter and alignment on macrophage
activation

and

secretion

of

proinflammatory

cytokines

and

chemokines.

Biomacromolecules. 12(5): p. 1900-11.
181.

Sanders, J.E., C.E. Stiles, and C.L. Hayes, Tissue response to single-polymer fibers of
varying diameters: evaluation of fibrous encapsulation and macrophage density. J
Biomed Mater Res, 2000. 52(1): p. 231-7.

182.

von Recum, A.F. and T.G. van Kooten, The influence of micro-topography on cellular
response and the implications for silicone implants. J Biomater Sci Polym Ed, 1995.
7(2): p. 181-98.

183.

Madden, L.R., et al., Proangiogenic scaffolds as functional templates for cardiac tissue
engineering. Proc Natl Acad Sci U S A. 107(34): p. 15211-6.

164

184.

Chamberlain, L.M., et al., Phenotypic non-equivalence of murine (monocyte-)
macrophage cells in biomaterial and inflammatory models. J Biomed Mater Res A,
2009. 88(4): p. 858-71.

185.

Faffe, D.S., et al., Interleukin-13 and interleukin-4 induce vascular endothelial growth
factor release from airway smooth muscle cells: role of vascular endothelial growth
factor genotype. Am J Respir Cell Mol Biol, 2006. 34(2): p. 213-8.

186.

Gu, L., et al., Control of TH2 polarization by the chemokine monocyte chemoattractant
protein-1. Nature, 2000. 404(6776): p. 407-11.

187.

Fairweather, D. and D. Cihakova, Alternatively activated macrophages in infection
and autoimmunity. J Autoimmun, 2009. 33(3-4): p. 222-30.

188.

Varin, A. and S. Gordon, Alternative activation of macrophages: immune function and
cellular biology. Immunobiology, 2009. 214(7): p. 630-41.

189.

He, Z., et al., The interaction between different types of activated RAW 264.7 cells and
macrophage inflammatory protein-1 alpha. Radiat Oncol. 6: p. 86.

190.

Chen, S., et al., Characterization of topographical effects on macrophage behavior in a
foreign body response model. Biomaterials. 31(13): p. 3479-91.

191.

Schutte, R.J., A. Parisi-Amon, and W.M. Reichert, Cytokine profiling using
monocytes/macrophages cultured on common biomaterials with a range of surface
chemistries. J Biomed Mater Res A, 2009. 88(1): p. 128-39.

192.

Hoh, B.L., et al., Monocyte chemotactic protein-1 promotes inflammatory vascular
repair of murine carotid aneurysms via a macrophage inflammatory protein-1alpha
and macrophage inflammatory protein-2-dependent pathway. Circulation. 124(20):
p. 2243-52.

193.

Ucuzian, A.A. and H.P. Greisler, In vitro models of angiogenesis. World J Surg, 2007.
31(4): p. 654-63.

165

194.

Abbott, A., Cell culture: biology's new dimension. Nature, 2003. 424(6951): p. 870-2.

195.

Velazquez, O.C., et al., Fibroblast-dependent differentiation of human microvascular
endothelial cells into capillary-like 3-dimensional networks. FASEB J, 2002. 16(10): p.
1316-8.

196.

Rao, R.R., et al., Matrix composition regulates three-dimensional network formation by
endothelial cells and mesenchymal stem cells in collagen/fibrin materials.
Angiogenesis. 15(2): p. 253-64.

197.

Dietrich, F. and P.I. Lelkes, Fine-tuning of a three-dimensional microcarrier-based
angiogenesis assay for the analysis of endothelial-mesenchymal cell co-cultures in
fibrin and collagen gels. Angiogenesis, 2006. 9(3): p. 111-25.

198.

Allen, P., J. Melero-Martin, and J. Bischoff, Type I collagen, fibrin and PuraMatrix
matrices provide permissive environments for human endothelial and mesenchymal
progenitor cells to form neovascular networks. J Tissue Eng Regen Med. 5(4): p. e7486.

199.

Vernon, R.B. and E.H. Sage, A novel, quantitative model for study of endothelial cell
migration and sprout formation within three-dimensional collagen matrices.
Microvasc Res, 1999. 57(2): p. 118-33.

200.

Takeda, K. and S. Akira, TLR signaling pathways. Seminars in Immunology, 2004. 16.

201.

Yamamoto, M., et al., Essential role for TIRAP in activation of the signalling cascade
shared by TLR2 and TLR4. Nature, 2002. 420(6913): p. 324-9.

202.

Cote, M., et al., The critical role of the MyD88-dependent pathway in non-CNS MPTPmediated toxicity. Brain Behav Immun. 25(6): p. 1143-52.

203.

Geiger-Maor, A., et al., Cells exposed to sublethal oxidative stress selectively attract
monocytes/macrophages via scavenger receptors and MyD88-mediated signaling. J
Immunol. 188(3): p. 1234-44.

166

204.

Maa, M.C., et al., The iNOS/Src/FAK axis is critical in Toll-like receptor-mediated cell
motility in macrophages. Biochim Biophys Acta. 1813(1): p. 136-47.

205.

van den Borne, S.W., et al., Mouse strain determines the outcome of wound healing
after myocardial infarction. Cardiovasc Res, 2009. 84(2): p. 273-82.

206.

Yamashita, Y., et al., Cutting edge: genetic variation influences Fc epsilonRI-induced
mast cell activation and allergic responses. J Immunol, 2007. 179(2): p. 740-3.

207.

Jain, R.K., et al., Quantitative angiogenesis assays: progress and problems. Nat Med,
1997. 3(11): p. 1203-8.

208.

Auerbach, R., et al., Angiogenesis assays: problems and pitfalls. Cancer Metastasis Rev,
2000. 19(1-2): p. 167-72.

209.

Staton, C.A., M.W. Reed, and N.J. Brown, A critical analysis of current in vitro and in
vivo angiogenesis assays. Int J Exp Pathol, 2009. 90(3): p. 195-221.

210.

Guedez, L., et al., Quantitative assessment of angiogenic responses by the directed in
vivo angiogenesis assay. Am J Pathol, 2003. 162(5): p. 1431-9.

211.

Kasama, T., et al., Neutrophil-derived cytokines: potential therapeutic targets in
inflammation. Curr Drug Targets Inflamm Allergy, 2005. 4(3): p. 273-9.

167

VITAE
Koyal Garg was born in Meerut, U.P., India on 29th September 1985. She received a
Bachelor’s of Engineering degree in Biomedical Instrumentation Engineering from
Avinashilingam Deemed University, India in May 2006. In fall of 2008, she completed her
Master’s in Biomedical Engineering from Virginia Commonwealth University under Dr.
Gary L. Bowlin. She continued with her Ph.D. work in Biomedical Engineering under the
mentorship of Dr. Gary L. Bowlin and Dr. John J. Ryan from spring 2009. She had also
worked as a Teaching Assistant from Fall 2006 - Spring 2012 for several courses, such as
Biomedical Instrumentation, Computational Methods and Biomedical Signal Processing.
During the course of her doctoral studies, she was awarded the Alex M. Clark award for
excellence in Biomedical Engineering in 2012 and 2nd runner-up for the outstanding
graduate teaching assistant award by Graduate School of Engineering for the academic year
2010-2011. During her graduate work at VCU, she has published eight peer reviewed
journal articles and two book sections. She has also presented her work at various
conferences including Annual Hilton Head Workshop, Biomedical Engineering Society
(BMES) annual fall meeting, The International Society for Applied Cardiovascular Biology
(ISACB) Biennial meeting and The Tissue Engineering and Regenerative Medicine
International Society (TERMIS) meeting.

168

